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Abbreviations
The conventions of the Biochemical Journal have been used
throughout. Most abbreviations are indicated in the text, however,
those more frequently used are also listed below.
APP - Avian Pancreatic Polypeptide
ATP - Adenosine 5'-triphosphate
ADP - Adenosine 5'-diphosphate
AMP - Adenosine 5'-monophosphate
cAMP - Adenosine 3'51-monophosphate, cyclic
Bt^cAMP - ,2'-O-Dibutyryl-adenosine-31:5'-monophosphate, cyclic
GTP - Guanosine 5'-triphosphate
cGMP - Guanosine 35'-monophosphate, cyclic
2
Bt^cGMP - N ,2'-O-Dibutyryl-guanosine-351-monophosphate, cyclic
BSA - Bovine serum albumin
KRB - Krebs Ringer Bicarbonate
DNA - Deoxyribonucleic acid
PCA - Perchloric acid
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SUMMARY
A recirculating type perfusion method was developed for the isolation
of hepatocytes from chicken liver. The method adopted resulted in
relatively high yields of metabolically active hepatocytes capable of
responding to physiological concentrations of hormones. However,
hormonal sensitivity was found to depend on the batch of collagenase
used to prepare the cells.
Hepatocytes were used to investigate the binding characteristics
and intracellular metabolic effects of the pancreatic hormones, insulin,
glucagon and Avian Pancreatic Polypeptide (APP).
Although insulin was found to have a high affinity receptor present
on the cell membrane (K_ 3 x 10 ^°M> 2000 sites/cell) the hormone failed
d
to induce any physiologically significant effect on the intracellular
processes studied. Physiological concentrations of insulin failed to
alter basal or glucagon stimulated cyclic AMP levels in the cello Cyclic
GMP levels were also unaffected. Other negative responses were found
when directly examining adenylate cyclase or phosphodiesterase activities
in cell homogenates. Consistent with these findings, no effect of insulin
was found on glycogenolysis, glycogen synthesis, gluconeogenesis or
lipogenesis.
Glucagon was also found to bind to a high affinity receptor site on
-9
the cell surface (K, 9 x 10 M; 13,000 sites/cell), and to stimulated
-9
adenylate cyclase(ED,_-12.9 x 10 M) resulting in up to 60 fold increases50
in intracellular cAMP. In the presence of glucagon the cyclic nucleotide
rapidly accumulated in the cell cytosol. After two to five minutes,
production rapidly stopped, resulting in a gradual reduction of the
cyclic nucleotide concentration due to hydrolysis by phosphodiesterase
and escape of the nucleotide to the external medium.
iv.
Metabolic profiles in the hepatocyte were highly sensitive to
-9
glucagon with up to 200% stimulation of glycogenolysis(ED 1.1 x 10 M),50
30% stimulation of gluconeogenesis (ED 4.8 x 10 1C>M) and 90% inhibition
50
-9
of lipogenesis(ED^qI.0 x 10 M). Isolated cells were found to vary in
their sensitivity to glucagon depending on the batch of collagenase
used during tissue digestion. One particular collagenase preparation
greatly increased the apparent affinity of glucagon in stimulating
cellular glycogenolysis (ED^qI.7 x lO ^°M) .
Adrenaline was also capable of stimulating cAMP levels in the
—G
hepatocytes (ED 1.7 x 10 M) to a maximum of 30% that found with glucagon.50
Despite the lower maximum stimulation of cAMP levels, adrenaline
-7
increased glycogenolysis(ED^1.36 x 10 M) and gluconeogenesis
_8 _0
(ED1__l2.1 x 10 M) and inhibited lipogenesis(ED 6.9 x 10 M) to the same50 50
extent as found with glucagon. Values found for the affinity of
adrenaline for the various metabolic effects were also dependent on
the batch of collagenase used to prepare the cells.
No high affinity receptor was found on the cell membrane for APP;
this was consistent with the lack of effects of the hormone on cellular
cAMP and cGMP levels and also its inability to directly alter adenylate
cyclase or phosphodiesterase activities. Although APP slightly
potentiated glycogenolysis in the presence of sub-saturating
concentrations of glucagon and also showed a small inhibition of glycogen
breakdown it is questionable whether the effects were of any
physiological importance.
The methylxanthines theophylline and caffeine were found to be
effective in inhibiting cyclic nucleotide phosphodiesterase and were also
capable of inhibiting basal and hormone stimulated effects on glycogeno¬
lysis, gluconeogenesis and lipogenesis. The site of action of theophylline
and caffeine on these metabolic pathways may well be related to cellular
respiration, as both a decrease in cellular oxygen consumption and ATP




Introduction to avian metabolism and its hormonal control
The metabolic actions of the endocrine pancreatic hormones on hepatic
tissue have been well investigated over recent years, especially since
the discovery of glucagon's 'second messenger', adenosine 3':5'-monophosphate
(cAMP), by Sutherland and co-workers in 1957 (Rail et al. 1957) . The
majority of experiments have been carried out using the mammalian liver
as the experimental model, with the rat as the predominant laboratory
species, and there is a considerable volume of information about the
regulation of metabolism by these hormones. During this time however,
very little interest has been shown in birds, and thus investigations
using avian liver as the model system have been relatively scarce.
Consequently many aspects of the hormonal control of metabolism in birds
have not kept pace with those of their mammalian counterparts.
The actions of insulin and glucagon on mammalian metabolism have
been the subject of numerous review articles covering work in vivo and
in vitro (DeBodo et al_. 1963; Robison et al. 1971; Assan 1972; Exton
and Park 1972; Exton et al. 1972; Nuttal 1972; Park and Exton 1972;
Samols et al. 1972; Unger and Lefebrve 1972; Pilkis et al. 1978).
Aspects of regulation of avian carbohydrate and lipid metabolism have
mostly been restricted to whole body investigations in vivo and, as yet,
little information is available on pancreatic hormone action at the
cellular level. Reviews on the control of avian carbohydrate and lipid
metabolism are not so common (Langslow and Hales 1971; Hazelwood 1972;
Hazelwood 1976) . From those investigations already reported, using
mainly domestic fowl, pigeon, duck and goose as the experimental species,
all metabolic pathways common to the mammalian liver are present in the
avian hepatic tissue, although the actual flux through particular pathways
is often different.
In chicken, the liver shows a remarkable lipogenic activity compared
to adipose tissue and in fact is the major site of lipid synthesis
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(Goodridge and Ball 1967; Goodridge 1968a; Goodridge 1968b; O'Hea and
Leveille 1969a). The liver accounts for at least 90% of the total
de novo fatty acid synthesis whereas in mammals the main lipogenic activity
is in adipose tissue (Favarger 1965; Leveille 1967; O'Hea and Leveille
1969b). Surprisingly however, the activity of the pentose phosphate
pathway, which supplies the NADPH necessary for lipogenesis, is very low
(O'Hea and Leveille 1969a) and thus the reduced cofactor must be supplied
from other sources, mainly from malic enzyme activity (Goodridge 1969).
Avian adipose tissue therefore only serves as a lipid store with lipolysis
in this tissue being activated predominantly by glucagon (Carlson et_ al.
1964; Goodridge 1964; Goodridge and Ball 1965; Grande and Prigge 1970)
and not the catecholamines as in most mammals (DePlaen and Galansino 1966;
Sokal et a]^. 1966; Burns and Langley 1968) . Lipid metabolism in
general seems to play a much more significant role in birds than in
mammals, perhaps due to weight conservation in flight, especially in
migrating birds (Blem 1976), and also as a high calorific energy supply
for embryo development within the confines of the egg. Both the site of
lipogenesis in the liver, and the control of lipolysis by glucagon may
be of paramount importance in the integration and control of these
important pathways with that of carbohydrate metabolism.
Of the other biochemical dissimilarities between birds and mammals,
the most obvious must be the apparent diabetic-like blood glucose
concentrations of 12-15 mM which are two to three times higher than in
mammals. This immmediatelv raises questions about the blood insulin:
glucagon balance, which has been shown to be important in the regulation
of blood sugar levels in mammals (Gliemann 1967; Exton and Park 1968;
Mackrell and Sokal 1969; Unger 1972a,b; Seitz et al. 1977; Felig
et al. 1979). In chickens, starvation for up to 7 days produces little
decrease in total blood sugar (Hazelwood and Lorenz 1959) although age
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and sex of the bird along with housing temperature can vary the response
(Langslow et ad. 1970). Glycogen stores, which are generally lower in
birds (Langslow and Hales 1971), are quickly depleted but then after a
few days partially replenished. Increasing levels of non-protein nitrogen
(Hazelwood and Lorenz 1959) and increasing loss of body weight (Langslow
et al. 1970) suggest that gluconeogenesis is responsible for this
carbohydrate homeostasis.
These differences in metabolic profile, although interesting in
their own right, may help to resolve the finer points of hormonal control
which have been difficult, if not impossible to determine when using
mammalian models. The effect of the pancreatic hormones, insulin and
glucagon, in the control of carbohydrate and lipid metabolism, obviously
must allow for these distinctive avian characteristics.
Another possible metabolic regulator, which could explain these
dissimilarities, came to light after the discovery of a third hormone,
avian pancreatic polypeptide (APP) by Kimmel and coworkers during the
routine isolation of chicken insulin (Kimmel et_ ad. 1968). The hormone
was later isolated and the amino acid sequence derived (Kimmel et. al.
1971; Kimmel et ad. 1975). This new hormone has been shown to be
present in the pancreases of eight different species of bird (Langslow
et al. 1973) and has its site of origin in cells which are cytologically
distinct from either the A, B or D cells of the pancreas (Larsson et ad.
1974). Similar proteins have been found in mammalian pancreases (Lin
and Chance 1972; Lin et al. 1973; Lin and Chance 1974) and some of
T.M.,
their biological actions investigated (Linnet ad. 1977) . Extracts of
reptilian pancreas but not that of amphibians nor mammals showed cross-
reactivity with antisera raised against APP (Langslow el: ajU 1973).
As yet the main role, if any, of this new pancreatic hormone has not been
found, although many effects have been noted (see review by Floyd et_ al.
1977) .
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The avian pancreas and its internally secreted hormones, insulin,
glucagon and perhaps APP, therefore allow a different carbohydrate and
lipid homeostasis from that of mammals. For a clearer understanding of
the actions of the avian pancreatic hormones, the historical background
of recent developments requires review. The information obtained and
the hypotheses and concepts developed are of great importance when trying
to establish the physiological significance of results in vitro at the
cellular level.
Early experiments using the endocrine pancreas and its secreted hormones
The first insight into the role of the endocrine pancreas was made
in 1889 by Minkowski and von Mehring, who repeated the inconclusive
experiments in pancreatectomy carried out by Bernard in 1877. The
excision of the canine pancreas induced conditions of severe diabetes
mellitus indicated by a subsequent rapid and large rise in blood glucose
levels, glucosuria and eventually convulsions and death. Similar experiments
on ducks and geese by Minkowski in 1893 failed to produce a noticeable
'diabetic' effect on the already high blood glucose levels. This
supported the earlier work of Langendorff (1879), who ligated the
pancreatic ducts of pigeon, but failed to induce glucosuria even after
the ingestion of large amounts of sugar. The birds subsequently died
6-12 days later through apparent inanition. Experiments by Weintraud
(1894) on pancreatectomy and partial enterectomy of nineteen ducks showed
four cases of glucosuria while Kausch (1896) found no glucosuria in
over eighty operated birds, but noted a transient hyperglycaemia which
soon returned to normal. Similar results to those of Kausch were reported
by other investigators using ducks (Paton 1905; Fleming 1919; Seitz and
Ivy 1929; Sprague and Ivy 1936; Mirsky et ad. "1941; Mirsky and Gitelson
1957). Subsequent work using fowls also showed no apparent effect on
carbohydrate homeostasis apart from an initial transient hyperglycaemia
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sometimes reaching levels of 50-70 mM before returning to normal
(Giaja 1912; Koppanyi et al. 1926; Hazelwood 1958; Lepkovsky et al.
1964; Koike et al_. 1964) .
Insulin
For many years the search for this hypoglycaemia factor, which
seemed to be much more effective in mammals than birds, had proved
unsuccessful. Various workers had shown that pancreatic extracts could,
when injected intravenously, decrease blood glucose and excreted glucose
in diabetic animals (Murlin and Kramer 1913; Kleiner 1919) but it was
not until it was realized that the factor itself was degraded by pancreatic
enzymes that the first stable extract of insulin was achieved (Banting
and Best 1922). Four years later insulin was isolated in crystalline
form (Abel 1926) which then allowed numerous physical and biochemical
investigations into its properties.
The chemical properties of insulin have been reviewed (Humbel et al.
1972). Insulin, molecular weight 5734 (bovine hormone) was the first
protein to be sequenced (Ryle et a^. 1955) and was found to comprise
two polypeptide chains of twenty-one and thirty amino acids linked by two
disulphide bridges. Except for the guinea pig there are only slight
variations in amino acid sequence between different mammalian insulins
with resulting minor changes in biological activity (Humbel et. al. 1972) .
The amino acid sequence of chicken insulin varies in six positions from
that of the bovine hormone (Smith 1966) and has been reported as being
more potent than the mammalian hormones (Humbel et al_. 1972) especially
when administered to fowls (Hazelwood et. al. 1968) . Turkey insulin has
the same amino acid sequence as chicken (Weitzel et ad. 1972) but the
duck hormone shows variation in three positions (Markusson and Sundby
1973) .
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Insulin was found to be present in much lower concentrations in
chicken pancreas (1-2 mg/100 g tissue) than in mammals (10-15 mg/100 g
tissue-bovine)(Kimmel et al. 1968). Plasma levels of insulin are similar
between birds and humans (Sands et al. 1968; Langslow and Hales 1971;
Goodner and Porte 1972) but are more stable in chickens than mammals
with very little change in concentration even after prolonged starvation
(Langslow et a]^. 1970) . Concentrations can vary from 0.5 to 10 ng/ml in
peripheral blood although higher concentrations must be present in the
hepatic portal vein.
The early experiments of pancreatectomy indicated a major difference
in the pancreatic regulation of carbohydrate metabolism between mammals
and birds. The extent of the pancreatectomy in these experiments was
first questioned by Mialhe (1958) and then later by Mirsky et_ al^. (1964) .
Due to the diffuse nature of the endocrine pancreas, complete pancreatectomy
is very difficult. Complete pancreatectomy of ducks, carried out by
Mialhe (1958) resulted in hypoglycaemia which could be antagonized by
intravenous injection of glucagon or glucose. Mialhe concluded that in
previous experiments, a small inaccessible portion of the splenic lobe
of the pancreas was not removed. The avian pancreas has a very high
glucagon content (Vuylsteke and DeDuve 1953) which is secreted by the
a-cells. These cells are only found in the third and splenic lobes of
the fowl pancreas v/hereas the B-cells (insulin secretory) are found
throughout the gland (Mikami and Ono 1962). Removal of the dorsal and
ventral lobes of the pancreas, which contain few or no a-cells results
in a transient hyperglycaemia while removal of the third and splenic
lobes is followed by the development of a pronounced hypoglycaemia in
chicken (Mikami and Ono 1962) and in goose (Sitbon 1967) . Mialhe
suggested on the basis of these experiments, that insulin plays a relatively
insignificant role compared with glucagon in the maintenance of blood
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glucose levels. However the avian need for insulin was shown by Mirsky
et al. (1964) who observed an immediate hyperglycaemia in normal and
supposedly depancreatised ducks, after the administration of antiinsulin
serum. Blood glucose levels returned to basal levels after three to four
hours in normal and after five hours in the depancreatised birds. Data
from depancreatised ducks indicated the presence of a remnant of the
splenic lobe of the pancreas or some extra pancreatic source of insulin.
Similar results have been reported in chickens (Bondareva 1970). Various
other experiments have indicated the possibility of another source of
insulin apart from the recognised pancreatic 3 cell (Redenbaugh at al.
1926; Hazelwood 1958; Colca and Hazelwood 1976).
Insulin therefore appears to be essential for the control of avian
metabolism as it is with mammals, although its effects may not be as
widespread nor as intense. Injections of large doses of mammalian
insulins into fowls, ducks and pigeons failed to induce the hypoglycaemic
coma and convulsions seen with mammals (Chen et al. 1945). Chickens
showed an apparent resistance to insulin, surviving up to one thousand
times that to induce convulsions in rabbits. In other studies the
extent of hypoglycaemia induced by varying intravenous mammalian insulin
loads, was less intense in birds than in mammals (Hazelwood and Lorenz
1959; Heald et al. 1965; Lepkovsky et al. 1967; Langslow et al. 1970).
This difference in the effect of insulin cannot be explained by
insensitivity of chicken tissues to low concentrations of mammalian
insulins. Adipose tissue and muscle isolated from both rats and chickens
showed the same sensitivity to bovine or chicken insulins (Goodridge 1968;
Hazelwood et ad. 1968; Langslow 1969; Langslow and Hales 1969).
At lower concentrations, intravenous injections of bovine or chicken
insulins induce similar effects on plasma glucose levels in chickens
although the chicken hormone was potent over a longer period (Hazelwood
8.
et al. 1968). Depancreatised birds also showed the same insensitivity
to high doses of insulin suggesting that pancreatic glucagon was not
antagonizing the hypoglycaemic action of insulin. The extent of the
reported pancreatectomy however is obviously very important. As a
result of earlier studies the adrenal catecholamines were not expected
to effect the response as preinjection of reserpine which depletes
catecholamine stores did not alter the apparent resistance to insulin
(Heald et al. 1965). Later work by Pittman and Hazelwood (1973),
however showed an increase of four to eight fold in the plasma concentration
of adrenaline after insulin administration. Besides a possible antagonistic
effect on insulin by the catecholamines plasma binding factors have also
been described in an attempt to explain the apparent insulin insensitivity
(Chen et al. 1945; Hazelwood et al. 1971). Increased insulin uptake
by the liver with subsequent biliary excretion was not responsible
(Turner and Hazelwood 1974) and the half life of both chicken and bovine
insulins in chicken plasma of 4.5 minutes (Langslow 1976) was similar
to that in man (Cesari and Luft 1969; Orskov and Christensen 1969).
Intravenous injection of insulin in fowls and ducks leads to an
increase in plasma free fatty acids (FFA) (Heald et al. 1965; Lepkovsky
1967; Langslow et_ chL. 1970). Similar injections in mammals lead to
decreased FFA levels (Dole 1956; Gordon and Cherkes 1956; Bierman et al.
1957; Shoemaker et al_. 1962) due to a decreased rate of release from
adipose tissue (Bierman and Dole 1957). The avian response to insulin
injection is an increased glucagon secretion (Sands et al_. 1969;
Hazelwood and Langslow 1978) since there is no change in plasma FFA
concentration in depancreatised birds (Mialhe 1969).
Glucagon
Glucagon, the second pancreatic hormone to be discovered, was
isolated in crystalline form by Staub, Sinn and Behrens (1953 and 1955)
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long after the hyperglycaemic factor was found in waste pancreatic
extracts during the extraction of insulin (Murlin et al. 1923; Kimball
and Murlin 1923). The relatively low concentration of the hormone in
mammalian pancreas (10 ]ig/g tissue) compared to insulin made extraction
and isolation difficult. Because of the excitement of the isolation of
insulin and its association with the recognised disease state of diabetes
mellitus little interest was shown in this hyperglycaemic factor, and
progress made into the isolation and study of its biological actions was
slow (Burger and Brandt 1935) . Much later, when the pancreatic cells
became well characterised, glucagon was recognised as a hormone and
its importance in carbohydrate metabolism acknowledged. Glucagons isolated
from various mammalian species consist of a single polypeptide chain of
twenty-nine amino acids which are identical in sequence and hence have
the same molecular weight of 3485 (Bromer et_ al_. 1971; Thompson et; al.
1972). Details of the chemistry of the hormone has been reviewed
(Bromer 1972a,b). Chicken or turkey glucagons have an amino acid
structure identical to that of porcine, bovine or human glucagons except
for serine replacing asparagine as position 28 of the amino acid sequence
(Markussen et_ al_. 1972; Hazelwood 1976) . As well as serine replacing
asparagine, duck glucagon also differs at position 16 where threonine
replaces a serine residue (Sundby et al. 1972; Hazelwood 1976).
Despite such a small change in amino acid composition chicken glucagon
is reported to be more active in avian and mammalian tissues than the
mammalian hormone (Hazelwood 1976). Glucagon's action on avian metabolism
is not entirely consistant with that of mammals. Intravenous glucagon
in chickens raises plasma glucose, free fatty acid and plasma insulin
concentrations (Langslow and Hales 1971; Hazelwood and Langslow 1978).
In mammals intravenous injection is accompanied by an increase in plasma
glucose with a decrease in free fatty acids. The latter effect is due to
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the increase in plasma insulin levels stimulated by the administration
of glucagon (Samols et al. 1965) which inhibits fatty acid release from
mammalian adipose tissue (Mahler et al. 1964; Froesch et ad. 1965;
Fain et al. 1966; Chlouverakis 1967). The absence of a similar effect
in chicken reflects the imbalance between the two hormones.
The avian pancreatic content of glucagon is some four to eight times
higher than in mammals and peripheral plasma levels in ducks starved
overnight can reach 1.5 ng/ml, some six times that found in Man (Samols
et al. 1969). Hazelwood (1976) also reports circulating levels of
glucagon of three to four times that of mammals. Although it is generally
accepted that high levels of glucagon are present in avian plasma,
accurate quantitation of pancreatic glucagon is difficult due to interactions
of antibodies with the glucagon-like proteins (GLI) from the gut.
For a review see Maier and Pfeiffer (1978) . Due to this difficulty
various ranges in plasma glucagon have been reported using various assay
methods (Lawrence 1966; Unger 1969; Langslow and Hales 1970). The
high sensitivity of chicken tissues to this hormone and its high levels
in blood indicate that it may play a dominant role compared with insulin
in the regulation of lipid and carbohydrate metabolism.
Avian Pancreatic Polypeptide
Avian pancreatic polypeptide (APP), the most recent hormone to be
discovered comprises a single chain of thirty six amino acids with a
molecular weight of 4258 (Kimmel et al_. 1971; Kimmel and Pollock 1973) .
The amino acid sequence has been determined (Kimmel et al. 1975).
Similar polypeptides have since been isolated from bovine (BPP), porcine
(PPP), ovine (OPP) and human (HPP) pancreases by Lin and Chance (1974).
The avian hormone exists in very high concentrations in the pancreas
(8 to 9 mg/lOO g tissue) and in blood where peripheral concentrations
vary from 4 to 12 ng/ml (Kimmel et al. 1971). During fasting these
levels are markedly reduced but are quickly restored to normal on re-feeding.
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Intravenous injections of APP at physiological levels (1 to 25 yg/Kg body
weight) show a gastrin-like action on chicken proventriculus with increases
in volume, free acid, pepsin and total protein content of the fluid
secreted (Hazelwood et al. 1973; Hazelwood and Langslow 1978). At much
higher doses (100 yg/Kg body weight) the polypeptide stimulates hepatic
glycogenolysis but with no apparent hyperglycaemia, and decreases blood
glycerol levels. APP also lowers plasma free fatty acids despite
stimulating the release of glucagon (Hazelwood and Langslow 1978).
♦
Hormone Action at the Cellular Level
Early experiments into the action of the peptide hormones employed
mostly experiments in vivo. It was soon clear that the precise mode of
action of the hormones could not be determined from these experiments alone
due to the complexity of the interacting systems of the whole animal.
Investigations thus turned increasingly to experiments in vitro utilising
the techniques of perfused organs, tissue slices, broken and eventually
intact cell preparations to study the more direct effects of various
hormones. At the same time however the use of birds as experimental models
for work in vitro seemed to loose favour and thus studies into the role
of hormones at the cellular level were carried out almost entirely using
tissues isolated from mammals, mainly the rat.
Early investigations into the actions of adrenaline and glucagon on
glycogen phosphorylase activation in liver by Sutherland and co-workers
was the first major step towards elucidation of hormone action (Rail
et al. 1956; Rail et al_. 1957) . The discovery of adenylate cyclase
and adenosine 3'51-phosphate (cAMP) as the mediator of hormone action
in a variety of target tissues opened up numerous new corridors of
investigation. Very quickly it was apparent that cAMP was implicated in
the action of many other non-related hormones which stimulated the membrane
bound adenylate cyclase. Cyclic AMP was then recognised as a general
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second messenger for hormone action. The mode of action of the hormones
acting on adenylate cyclase and cAMP has been extensively reviewed
(Robison et ad. 1970; Robison et al. 1971; Pohl 1972; Rodbell 1972;
Catt and Dufau 1976; Helmreich 1976; Helmreich e_t ad. 1978) . Glucagon
has been shown to bind specifically to receptor proteins in particulate
fractions of rat liver membranes (Pohl et ad. 1971; Birnbaumer et ad.
1971; Rodbell et. ad. 1971a,b) . Bound glucagon could be exchanged with
free glucagon but not with biologically inactive glucagons, secretin,
adrenocorticotrophic hormone (ACTH) nor insulin. The dissociation constant
for the hormone receptor protein complex was in the nanomolar range which
was similar to that found for adenylate cyclase activation. The cAMP
produced by hormonal stimulation was found to activate a cytosolic enzyme
capable of phosphorylating various proteins (Krebs 1972; Krebs 1973;
Langan 1973). Activation of this protein kinase resulted in the phosphoryl¬
ation of various key regulatory enzymes of metabolism with concomitant
alterations in activity. Substrates for this protein kinase have only
been shown in a few cAMP sensitive tissues and include liver phosphorylase
kinase and glycogen synthetase and adipocyte triglyceride lipase
(Soderling et. ad. 1970; Corbin et ad. 1970; Khoo et ad. 1973) . Pyruvate
kinase has also recently been shown to be regulated by a phosphorylation-
dephosphorylation mechanism which is sensitive to a cAMP dependent protein
kinase (Ljungstrdm and Ekman 1977; Riou et ad. 1978) and fructose
diphosphatase has also been suggested as a substrate (Riou et al. 1977).
As yet, it is not known if this cAMP dependent protein kinase is involved
in all the actions of glucagon on the liver, which include stimulating
glycogenolysis and gluconeogenesis, induction of potassium and calcium
efflux, amino acid uptake and urea synthesis (Menahan and Wieland 1967;
Exton and Park 1968; Friedmann and Park 1968; Mallette et al. 1969;
Chambers and Bass 1970).
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The action of adrenaline, although inducing similar effects to that
of glucagon is not so clear cut. There are at least two types of
catecholamine receptor (a and 6) on liver cell membranes. Only occupancy
of the 3 receptor induces the classical stimulation of cAMP by activation
of adenylate cyclase. Catecholamines exert their action on the liver
through both a and 3 receptors with occupancy of the former not affecting
cAMP or cAMP dependent protein kinase (Sherline et_ ad. 1972; Cherrington
1976; Keppens et ad. 1977; Birnbaum and Fain 1977). Stimulation of
gluconeogenesis in liver by catecholamines has been inhibited by a blocking
agents such as phentolamine and dihydroergotamine but not by the 3 blocker
propranolol (Tolbert et al. 1973; Tolbert and Fain 1974). Isoproterenol,
a pure 3 agonist, has also been shown to bind to its receptor and elevate
intracellular cAMP but with no resulting effect on gluconeogenesis.
Hutson et al. 1976 report that adrenergic activation of hepatic glucose
output is regulated mainly through the a receptor. Others have indicated
that adrenergic activation of glucose output is independent of cAMP and
acts by the a mechanism which is mediated by alterations in calcium flux
(Sherline et al. 1972; Cherrington et al. 1976; Assimacopoulos-Jeannet
et al. 1977; Chan and Exton 1977; Keppens et al. 1977; Parizaet al.
1977; Van de Werve et ad. 1977; Le Cam and Freychet 1978). Both a,
cAMP-independent, and 3, cAMP dependent, actions of the catecholamines
can be inhibited by insulin (Claus and Pilkis 1976). Insulin is thought
to suppress 3 activation by lowering the elevated cAMP levels, but it is
not known how insulin antagonises the a adrenergic response.
The investigation of the cellular action of insulin has not progressed
as rapidly as that of glucagon or adrenaline. The actions of insulin
were mainly investigated in tissues other than liver, including adipose
tissue and muscle. Early studies showed insulin could bind to a variety
of tissues (reviewed by Cuatrecasas and Hollenberg 1976) . Insulin can
14.
regulate the transport of many solutes, including glucose, some amino
acids and a number of ions, across the cell membrane (Battaglia and
Randle 1960; Crofford and Renold 1965; Margoulies 1968; Park et al.
1968; Wool 1968) and also antagonise hormone stimulated lipolysis in
adipose tissue (Rodbell and Jones 1966; Fain 1967). Insulin was also
shown to decrease catecholamine or glucagon stimulated cAMP levels with
a subsequent reduction in the expected metabolic effect (Exton et al.
1966; Exton and Park 1968; Lewis et al. 1970).
Cuatrecasas (1969) provided the first strong evidence that the
insulin receptor was present on the external surface of the cell membrane,
but the validity of his experiments using Sepharose-bound insulin was
questioned by others (Katzen and Vlahakes 1973). However many other
workers using different experimental techniques have also found that
insulin binds to specific receptor sites on the cell surface (Pastan
et al. 1966; Kono 1969; Freychet et ad. 1971; Bennet and Cuatrecasas
1973; Jarret and Smith 1975). Since no definite intracellular second
messenger has been found for insulin other workers have investigated
and reported specific insulin binding sites within the cell which may be
responsible for the intracellular and long term effects on metabolism
with the cell plasma membrane receptors only influencing transport
processes in and out of the cell (Goldfine and Smith 1976; Goldfine et al.
1977). It has been suggested that insulin binding sites present in the
Golgi fraction of a cellular homogenate are present only to maintain
receptor density after exocytosis of various intracellular substances
from the cell where the golgi vesicles are continually adding to the
plasmalemma (Bergeron et al. 1973; Bergeron et a_l. 1978; Posner et ad.
1978). This model system could also be used to explain the method of
receptor turnover.
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Iodinated insulin bound to liver membranes was shown to dissociate
rapidly in the presence of excess cold hormone (Freychet et al. 1971) .
Insulin analogues with a wide range of biological potencies inhibited
the binding of iodinated hormone to liver membranes in direct proportion
to their ability to stimulate glucose oxidation in fat cells. Similar
results were found for the insulin receptor of liver and fat cells
(Cuatrecasas 1972a). A receptor protein has been isolated from the
external surface of the plasma membrane by using the nonionic detergents
Triton X-lOO and Lubrol WX and found to be a glycoprotein with molecular
weight of about 300,000 (Cuatrecasas 1972b,c) • The receptor shows a
-10 -9
high affinity for insulin (K 10 -10 M) which is in the same range as
circulating insulin levels in blood (Cuatrecasas 1972b,c; Kahn et al.
1974) . How the signal of insulin binding is transmitted to and manifested
in the cell cytosol is still unclear. Under various conditions insulin
was reported to reduce hormone elevated intracellular levels of cAMP
(Exton et al. 1971; Exton and Park 1972; Pilkis et al_. 1975; Claus and
Pilkis 1976). An elevated content of cellular cAMP was found in diabetic
rats or normal rats injected with anti-insulin serum indicating that
insulin plays a role in.the maintenance of basal cAMP levels as well as
reducing those stimulated by glucagon or adrenaline (Jefferson et al.
1968). A direct inhibition of adenylate cyclase by insulin has been
reported (Illiano and Cuatrecasas 1972; Flawia and Torres 1973; Renner
et al. 1974) but this has not been confirmed by others (Rosselin and
Freychet 1973; Thompson et al_. 1973; Pilkis et ad. 1974) . An insulin-
sensitive cAMP phosphodiesterase has also been reported (Loten and Sneyd
1970; House et al. 1972; Manganiello and Vaughan 1973; Kono et al.
1975; Loten et al. 1978) although others have failed to note any effect
(Thompson et al_ 1973; Menahan et ad. 1969; Pilkis et_ a)L. 1975) .
Although an insulin sensitive guanylate cyclase has been reported in rat
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fat cells (Illiano et al. 1973; Fain and Butcher 1976) and liver cells
(Pointer et_ al. 1976) very little additional evidence for cGMP as the
possible second messenger has been shown. Fain and Butcher (1976) and
Pointer et al. (1976) have both shown that catecholamines, carbachol,
insulin, calcium ionophore A23187 and glucagon all increase intracellular
levels of cGMP with resulting extremes of effects on metabolism.
Insulin also has marked effects on the fluxes of several ions such as
potassium, calcium and phosphate (Zietler 1966; Hepp et al. 1968;
Williams et al. 1971). The possibility that one of these cations,
particularly calcium, could be a possible second messenger for insulin
is continually being suggested. The role of calcium in the hormonal,
control of cellular processes has been reviewed (Rassmusen et ad. 1972;
Berridge 1975) . It appears that intracellular calcium concentrations are
as important as those of cAMP in enzyme regulation, particularly in
tissues which respond to hormones by contraction or secretion.
Despite the fact that no definite intracellular second messenger
for insulin has been found insulin is capable of stimulating glycogen
synthesis (Nuttal 1972), protein synthesis (Pilkis and Park 1974),
lipogenesis (Avruch et ad. 1972) and inhibiting gluconeogenesis (Claus
and Pilkis 1976), glucose release (Jefferson et ad. 1968) and lipolysis
(Avruch et ajL. 1972) .
The study of the effects in vitro of insulin, glucagon and adrenaline
on chicken tissues has been confined mostly to actions on adipose tissue
(for review see Langslow and Hales, 1971) . There have been very few
studies to date on hormone action on the isolated chicken hepatocyte.
Goodridge and co-workers have studied the effects of glucagon and
insulin on lipogenesis in hepatocytes isolated from neonatal chicks
(Goodridge 1973; Goodridge et al. 1974; Goodridge 1975; Goodridge and
Adelman 1976) but only a few reports have been made on hormonal effects
in hepatocytes isolated from older chickens (Anderson and Langslow 1975;
Dickson 1977; Dickson and Langslow 1978; Dickson et ad. 1978).
While this summarises the background to the present work a more
detailed account of recent studies on the actions of the hormones will
be given in the following chapters.
The mode of action of glucagon, and perhaps to a lesser extent
insulin, in mammalian hepatic metabolism is reasonably well quantified.
It is now possible to estimate with considerable accuracy the affinity
of hepatic receptors for either of the two hormones and gauge the
extent of the metabolic response to a particular hormone at a given
concentration. This preliminary investigation allows a more complete
understanding of individual molecular interactions which take place
between hormone and receptor, receptor and adenylate cyclase, cAMP and
protein kinase, ion and ion binding protein etc. The finer details of
hormone action and metabolic regulation are now under study. Although
brief reports have been made about some metabolic actions of insulin
and glucagon on chicken hepatocytes no complete investigation into the
mode of action of these hormones or that of APP has been carried out.
In the present work the actions of the pancreatic hormones and to a
lesser extent that of adrenaline, have been investigated at the level
of hormone receptor, second messenger and the ultimate physiological
response using the chicken hepatocyte as the model system. A direct
quantitative comparison can then be made between the mammalian and avian
systems; it is hoped that this will help to explain the apparent




1. Determination of adenosine phosphates in cell extracts
The intracellular concentration of all three adenosine phosphates
was determined by a bioluminescent assay using the enzyme luciferase.
Extracts of firefly lanterns are capable of emitting light when ATP,
oxygen, a divalent cation and a fluorescent compound called luciferin are
added (McElroy and Strehler 1949). Under certain conditions the light
emitted is proportional to the amount of ATP added. Using this system
the concentration of ATP in biological extracts can be determined
(Strehler 1969; Bihler and Jeanrenaud 1970). Preincubating extracts,
under appropriate conditions, with pyruvate kinase (PK) and myokinase (MK)
converts ADP and AMP to ATP and therefore mono and diphosphorylated
derivatives can also be estimated (Kimmich et. a^. 1975) .
A simple modification in the basic spectrophotometric assay of ADP
and AMP (Adam 1965; Jaworek et_ ad. 1974) was used to quantitatively
convert these two adenylates to ATP with their subsequent determination
by the luciferase system.
Extraction of adenylates Cell suspension (1 ml) was added to ice cold
o
6% PCA (1 ml), shaken vigorously and left at 0 C for 10 minutes.
The protein precipitate was pelleted by centrifugation (2750 g; 30 s)
and the supernatant neutralised by 3M potassium carbonate (K^CO^) and
left at 0°C for a further 15 minutes to allow maximum precipitation of
perchlorate. Samples were re-centrifuged (2750 g; 30 s) and supernatants
stored at -20°C for adenylate determination by the luciferase assay.
Preparation of lantern extract Firefly lantern extract (FLE-50) was
obtained from the Sigma Chemical Company and kept dessicated at 4°C until
use. One vial containing 50 mg of extract was suspended in 1 ml of
distilled water containing a trace of apyrase (grade 1, Sigma Chemical
Company), 5 mg of dithiothreitol (DTT) and 50 mg of bovine serum albumin
(BSA). The vial was incubated with constant agitation at 30°C for
15 minutes and then added to 200 ml of sodium arsenate buffer, 50 mM
pH 7.5, containing 20 mM magnesium sulphate. The medium was stirred
for a further 5 minutes and finally filtered through glass wool. Apyrase
which removes any endogenous ATP in the lantern extract is inhibited by
arsenate and therefore does not effect the response to subsequent additions
of ATP. The medium was kept at room temperature for 30 minutes before
use to allow activity of extract to stabilise. No advantage was obtained
in keeping the extract on ice but stability throughout the duration of
the assay was much improved by the addition of the DTT and BSA (Fig. 2.1).
Preparation of adenylate samples In order to estimate the concentrations
of ADP and AMP it was first necessary to enzymatically convert them to
ATP. The conversion was carried out by adding 0.4 ml of unknown extract
or suitably diluted standard to 0.3 ml of a tris-HCl buffered reaction
medium consisting of 50 mM tris-HCl pH 7.4, 2.5 mM phosphoenolpyruvate,
4.5 mM magnesium sulphate 387 mM potassium chloride and 2.75 mM ethyl-
enediamine tetraacetic acid (EDTA). Unknowns were assayed in triplicate.
The first tube contained no additions to the above mixture and was a
direct measure of ATP. The second tube contained pyruvate kinase (15 yg/ml)
to convert ADP to ATP while the third contained myokinase (10 yg/ml) as
well as pyruvate kinase for the conversion of all adenylates to ATP.
Stock solutions (10 yM) of the adenylate standards, ATP, ADP and a ATP/AMP
mixture (1:1), was each diluted to give four or five different concentrations
for the assay. Myokinase and/or pyruvate kinase was added as necessary
to the standard tubes. In the AMP standard, ATP is required to initiate
the myokinase reaction. Tubes were shaken and then incubated at 30°C
for 50 minutes. Reaction was then stopped by placing tubes on ice and
adding 0.7 ml of 5% PCA. Samples were neutralised with 3M K^CO^, tubes









Fig. 2.1 Luminescence recorded on addition of 40 (A-A) , 60 (□-□)
and 100 (0-0) pmols AT? to Luciferin-luciferase extract incubated at
room temperature for the time shown.
A. - Normal luciferin medium.
B. Luciferin medium containing Dithiothreitol and BSA.
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Luciferase assay Aliquots (2 ml) of luciferase extract were added to
4.5 x 1.2 cm vials supported in 5.8 x 2.5 cm scintillation vials. Samples
(10-30 )il) of processed unknowns and standards were added to" the extract
and immediately counted for 12 seconds in a Tracerlab scintillation counter.
Since the square root of the resulting count is directly proportional to
the amount of ATP added, the concentration of the adenylate in each sample
was determined. An equimolar concentration of ATP to AMP was needed in
the standards to initiate the myokinase reaction under these experimental
conditions (Fig. 2.2). The ATP plus ADP concentrations in the unknown
extracts were always much higher than the AMP concentration. Adding an
excess amount of ATP to the unknowns did not increase the AMP converted.
Approximately 95% of ADP and 87% of AMP is converted to ATP by this method
(Fig. 2.3) which compares favourably with other workers (Kimmich et al.
1975). The ratios of ATP:ADP:AMP in each unknown was found by the
roots
difference in the square^of the counts between triplicate tubes and the
subsequent determination of the nucleotide concentration by using the
appropriate adenylate standard graph.
2. Cyclic nucleotide determination (cAMP, cGMP)
The determination of both nucleotides was carried out using the
radioimmunoassay method of Steiner et a^. (1969) as modified by Siddle
et al. (1973). Specific antibodies to cAMP and cGMP were raised in
rabbits by injections of 2'-O-succinyl-cyclic AMP or 2'-O-succinyl cyclic
GMP coupled to human albumin. Antisera for cAMP and cGMP were kind gifts
from Dr. K. Siddle, Department of Medical Biochemistry, Addenbrooke1s
Hospital, Cambridge.
Radioimmunoassay method. The assay was carried out in polyethylene microfuge
tubes (Sarstedt 46/6 or Beckman EET23). An antibody-tracer solution was
made up by the addition of 20-30 yl antiserum and 1-2 yl tracer (^yH^j-cAMP
or [~Hj-cGMP) to 2 ml of 100 mM potassium phosphate buffer pH 7.0.
pmol aden>late added
Fig. 2.2 Luminescence recorded after conversion of a range of AMP
concentrations to ATP by myokinase and pyruvate kinase.
AMP:ATP ratios of 20:1 10:1 2:10-0, 1:1 0-0.
pmnl adenylate added
Fig. 2.3 Luminescence recorded from various concentrations of ATP (0-0);
also ADP ( □-□ ) and AMP (A-A) converted to AT? by myokinase and/or
pyruvate kinase.
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An aliquot (20 ]il) of this medium was added to each microfuge tube -
20 yl samples were taken before the addition of the antiserum to estimate
non-specific binding. Standards or samples (40 yl) were then added and
mixed thoroughly giving a final assay volume of 60 yl containing sample
or standard (0.1 to 16 pmol); tracer (approximately 0.66 pmol or 15,000
cpm for cAMP; 0.5 pmol or 7000 cpm for cGMP) and antiserum at final
dilution of 1:200. Samples were then incubated overnight on ice. Bound
tracer was separated by adsorption onto Millipore filters (HAWP - 0.45 ym
2
pore size_25 mm ) under suction. Microfuge tubes were washed out once
with ice cold phosphate buffer and applied to filters. Filters were
further washed with 5 ml of ice cold buffer, placed in 5.8 x 2.5 cm
scintillation vials and dissolved in 1.5 ml of 2 methoxyethanol or 2
ethoxyethanol (approx. 1 hr). Scintillant (see method 14) (10 ml) was
then added and radioactivity determined - Tracerlab scintillation counter.
Cell extracts Cell suspensions were deproteinised by adding an equal
volume of 6% PCA and neutralised with 3M K2C°3 as adenylates or an
equal volume of 10% TCA and neutralised by washing with 4 x 5 ml water
saturated ether. When assaying extracted cAMP both of these procedures
reduced the sensitivity of the assay. The shape of the standard binding
curve was found to be less consistant when using TCA in preference to PCA.
Incomplete removal of TCA from the extract was indicated by a greatly
reduced sensitivity of the assay (Fig. 2.4). At least four vigorous
extractions in water saturated ether are necessary for maximal removal of
TCA (Fig. 2.5). Sensitivity was less affected by PCA extraction which,
unlike that of TCA, gave consistently reproducible curves (Fig. 2.6).
Antibody-tracer binding was affected when PCA or TCA was incompletely
removed. There was a linear fall in tracer binding when adding PCA
directly to the assay mixture. Similar additions of TCA show a large
drop in tracer binding above 15 mM (Fig. 2.7).
[ i \ Mr] pmol / 40^11
Fig. 2.4 cAMP radioimmunoassay binding curve.
Normal standards (O-O), or standards pre-treated with TCA and
neutralised ( □ - □ ) .
Kthvr »ash
Fig. 2.5 Radioactive tracer binding to antibody: Effect of ether
washing a TCA extracted cAMP solution (0.5 pmol/40 yl) (•-•).
■ - counts bound in the absence of TCA extraction.
[ camp] pmol/40 fjl
Fig. 2.6 cAMP radioimmunoassay binding curve.
0-0 Normal standards.
Standards previously extracted with 6% PCA.
[acid] mm
Fig. 2.7 Effect of adding TCA (0-0) or ?CA (□-□) directly to the
radioimmunoassay. Counts bound in the presence of 0.5 pmol cAMP/40 yl.
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For the reasons mentioned above plus the greater ease in handling
large numbers of samples the PCA extraction procedure was used throughout
when measuring cAMP. Standard cAMP samples were also extracted before
each radioimmunoassay. Cross reactivity between cAMP antiserum and other
nucleotides in the cell was very low (Table 2.1). Therefore the antibody
was suitable for use in deproteinised extracts without further purification.
The cAMP content in extracts of unstimulated cells could be decreased by
90% and that in stimulated cells by nearly 100% after incubation with
commercial phosphodiesterase. However when the intracellular level of
cGMP was estimated the cAMP which was also present in the acid extracts
was at such a concentration to effectively crossreact with the antiserum
for cGMP. Therefore after acid precipitation of protein the cGMP was
further purified from the other cell nucleotides and then concentrated
by freeze drying in order to estimate the low intracellular levels present.
The separation of the nucleotides was carried out using an anion exchange
column of Bio-Rad AGl X2 200-400 mesh, chloride form and necessitated
the use of the TCA extraction procedure. Procedure was basically that
of Siddle et_ al. (1976) .
Preparation of columns Anion exchange resin was washed in alternate acid
and alkali solutions (0.5M HC1: 0.5M NaOH). After the final acid wash
the resin was further washed in distilled water until the pH of the
effluent was greater than 5. The resin was then suspended in a 1:1 slurry
(vol/vol) with 20 mM NaCl containing 0.01% sodium azide as a preservative.
Columns were prepared by adding 1 ml slurry to a 1 ml syringe with a
Whatman No. 1 filter disc in the bottom. Columns were then washed with
1.5 ml 50 mM HC1 and then with 6 ml H^O. A 5 ml syringe connected by
a microfuge tube with excised tip was used as a reservoir for each column.
Purification procedure After four vigorous ether washes the sample (1 to
2 ml) was neutralised to pH 7 by addition of 50 to 100 ]il of 0.1M tris
Table 2.1: Cross-reactivity of cAMP anti-serum with other nucleotides.
All values are averages of duplicate observations.
Nucleotide Concentration { h}cAMP Nucleotide Concentration { h}cAMP




CAMP 0.125 4281 ATP 0.1 5201
0.25 3840 1.0 5266
0.5 2931 5.0 5240
1.0 2163 10.0 5076
2.0 1399
4.0 868 ADP 0.1 5105
8.0 564 1.0 5056
16.0 325 5.0 5237
10.0 5306
CGMP 1 5076
5 5240 AMP 0.5 5350
10 5266 1.0 5364
20 5281 5.0 5267
10.0 5051


















base and applied to the column. The column was washed sequentially with
3 ml distilled water, 3 ml 5 mM HC1, 4 ml 50 mM HC1 and finally 3 ml 300 mM
HC1. Cyclic AMP was eluted in the 50 mM HC1 wash with the cGMP collected
by the 300 mM HC1 wash. Table 2.2 shows the elution pattern of [-H]-cAMP
3
and [-H]-cGMP from this type of column.
If isolation of cAMP is not required then the column can be washed directly
with 4 ml of 50 mM HC1 before eluting cGMP. The adenylate nucleotide was
eluted into 1.5 x 4.0 cm plastic tubes, frozen to -40°C and freeze dried.
The samples were resuspended in a small volume of phosphate buffer (0.1-
0.2 ml) to concentrate the cGMP and were refrozen and thawed once more.
This last step increases the recovery of cGMP from the tube (C.J. Davies,
personal communication) (Fig. 2.8). Samples (40 |il) were then taken for
radioimmunoassay as outlined previously. Standard cGMP standards put
through the complete extraction and purification procedures showed nearly
100% recovery even at the lower concentrations (Fig. 2.8). It was
therefore considered unnecessary to process standards through extraction
procedures with each experiment.
3. Adenylate cyclase assay
Method used was as Luzio et a_l. 1976. The cAMP produced from cell
extracts incubated with theophylline and an ATP regenerating system,
was measured by radioimmunoassay as given under cAMP/cGMP determinations.
4. Phosphodiesterase assay
Phosphodiesterase activity in cell extracts was measured by the method
3 3
of Arch and Newsholme (1976). The [-h]-5'AMP produced from [-H]-cAMP
hydrolysis was converted to [-h]-adenosine by the inclusion of 5'nucleotidase
in the incubation medium. Unreacted [-h]-cAMP was bound by the addition
of anion exchange resin AG1 x 2 200-400 mesh chloride form (prepared as
described above) leaving -adenosine free in the supernatant. Samples
(0.4-0.5 ml) were removed and added to scintillant (see method 14 for
composition) for radioactive determination in the Tracerlab scintillation
counter.
3 3
Table 202: Elution of { h}cAMP and/or { h}cGMP from anion exchange
column.
Application Column No. - Total counts/min in eluate
2 I 3
Sample ^ ml) 2140 40 1860
H20 (3 ml) 6990 1260 2010
5 mM HC1 (3 ml) 30 717 1110
50 mM HC1 (2 ml) 740 58120 31500
50 mM HCl (2 ml) 60 8020 4620
50 mM HCl (2 ml) 600 500 120
300 mM HCl (3 ml) 45630 450 24030
300 mM HCl (2 ml) 540 10 20
Column No. Cyclic counts/min % %
Nucleotide applied total 50 mM
recovery
cAMP approx. 87 84 0.6
78,500
cGMP approx. 99 2.4 80
57,500
( cAMP 39,250 )
3 | | Ave 88













[c(,\ip] p mol / 40jjl
Fig. 2.8 cGMP radioimmunoassay standard curves.
0-0 standard solutions added directly to immunoassay.
standards put through complete TCA extraction and purification
procedures.
A. Freeze dried standards resuspended and used immediately.
B. Freeze dried standards resuspended and then refrozen and thawed
before use.
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5. Iodination and purification of hormones
For a review of most of the possible techniques available for iodination
and purification of hormones see Cuatrecasas and Hollenberg 1976.
The chloramine T iodination procedure (Hunter and Greenwood 1962;
Greenwood et al. 1963; Greenwood 1971) was used for all protein iodinations.
Slight modifications to the original procedures were employed to reduce
the extent of multiple iodination of the sample molecule (Freychet et al.
1972). All solutions were prepared fresh before each iodination. Hormone
solutions were made up with 0.01MHC1 giving the following concentrations:
Insulin 0.5 mg/ml 86 nmol/ml
Glucagon 2.2 or 0.22 mg/ml 630 or 63 nmol/ml
APP 0.33 mg/ml 79 mmol/1.
Iodination was carried out in a small glass tube in as small a volume
as possible by adding 10 yl of the hormone solution to 20 yl of 0.25M
sodium phosphate buffer pH 7.4 containing 1 mCi of radioactive iodide
125
(Na I IMS.30;100 yCi/yl-63 nmol/ml). Iodination was initiated by
adding 10 yl of chloramine T (2.5 mg/ml) and then after shaking gently
terminated 15 seconds later by the further addition of 100 yl sodium
metabisulphite (0.5 mg/ml). Both the chloramine T and sodium metabisulphate
solutions were made up with 50 mM phosphate buffer pH 7.4. Carrier
protein was then introduced by the addition of 200 yl of 50 mM sodium
phosphate buffer pH 7.4 containing potassium iodide (5 mg/ml), bovine
serum albumin-radioimmunoassay grade (2.5%) or gelatine (0.25%).
Under the above conditions approximately 80% of the total radioactive
iodide was incorporated into protein as judged by chromatoelectrophoresis,
PCA or TCA precipitation and dialysis (see later sections).
Purification procedures The following column purification methods were
used to isolate the iodinated hormone.
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a) I-insulin
Gel filtration Sephadex G25 or G50 (fine grade) was swollen in 50 mM
phosphate buffer pH 7.4 containing 0.25% gelatine, and packed in a
8.0 x 1.5 cm glass column. Columns were prewashed with 5 ml of buffer
containing 250 mg BSA (RIA grade) and finally with 20 ml of original
buffer. This helped minimise irreversible adsorption of iodinated hormone
to the column. The iodination mixture was applied and eluted in 0.5 ml
fractions with gelatine containing buffer. After recovery of the protein
peak, buffer containing 2% BSA or 2% horse serum was passed through the
column to facilitate rapid recovery of remaining radioactive iodide.
Adsorption columns Viable insulin binds in a specific manner to a
number of inert supports including talc and pure cellulose powders
(Cuatrecasas and Hollenberg 1976; Freychet 1977). Adsorption purification
procedures utilise insulin's ability to bind to the column while other
iodination products, including any damaged insulin, are eluted.
Talc or cellulose was soaked in 30 mM barbitone buffer pH 8.6 and
after removal of fines poured to a height of 2.5 cm in a glass pasteur
pipette plugged with non-absorbent glass wool. The iodination mixture
was then applied and the column washed with 6 x 1.0 ml aliquots of
125
barbitone buffer to elute unwanted reaction products. Viable I-insulin




Gel filtration Method of glucagon purification carried out exactly
as with insulin.
Adsorption columns As with insulin, but with the following
modifications and additions.
Talc was not used as an inert support. Pure cellulose columns were
125
eluted with 2 ml barbitone buffer and 2 ml distilled water. I -glucagon
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was then collected with 2 ml 25 mM phosphate buffer pH 7.4 in 50% ethanol.
Iodinated hormone was eluted into tubes containing 50 mM phosphate buffer
pH 7.4 and 1% BSA (RIA grade) as carrier protein.
DEAE cellulose columns were also used to isolate the monoiodoglucagon
product of the iodination (Nottey and Rosselin 1971) . Iodinations were
carried out using a glucagon to iodide ratio of 10:1 to prevent multiple
incorporation of iodide into the same glucagon molecule. DEAE cellulose
(Whatman DE52) was equilibrated with a 50 mM tris-HCl buffer containing
7M urea pH 9.3 at 4°C and packed in a 0.9 x 22 cm Pharmacia column under
a flow rate of 36 ml/hr. The iodination mixture was added to 5 ml of
running buffer and applied to the column. The column was eluted at 36 ml/hr.
After a column volume (approx. 12 ml) of buffer had been collected, a 100 ml
linear salt gradient up to 0.2M NaCl was applied and 2 ml fractions were
125
collected. I -Glucagon eluted from the column with the majority of
the radioactivity in one peak (Fig. 2.9). The main fractions were pooled
and urea was removed by gel chromatography using Sephadex G25 (fine grade)
in a 2.0 x 22 cm column, using 50 mM tris HC1 pH 7.4 containing 0.25%
gelatine for elution.
DEAE cellulose chromatography of an iodination mixture using equimolar
glucagon to iodide results in three peaks of eluted radioactivity
(Fig. 2.10). The second and third peaks indicate an increase in negative
charge on the protein thus requiring a higher ionic strength to elute
from the column. An increased negative charge on the protein is indicative
of multiple incorporation of iodine into tyrosine residues thus lowering
the pK of the amino acid from 9.11 to 6.48 (Weast 1977). It therefore
<3.
seems most likely that peaks 2 and 3 correspond to the di- and tri-
iodinated species of the hormone. The relative ratios of the three
iodinated species mono:di:tri are approximately 5:4:1 respectively.
Assuming 80% of total iodide is incorporated into protein the ratio of
mACT ION MM8I I
125
Fig. 2.9 Elution of I-glucagon from DEAE cellulose.
A 100 ml linear NaCl gradient up to 0.211 applied after fraction 6
and 2 ml fractions collected.
lodination reaction with glucagon:iodide ratio of 10:1.
125
Fig. 2.10 Elution of glucagon and " I glucagon from DEAE cellulose.
A lOO ml linear NaCl gradient up to 0.2M applied after fraction 10 and
2 ml fractions collected.
A sample of iodination mixture - with glucagon:iodide ratio of 1:1 was
added to a native glucagon solution and applied to the column.
Radioactivity (□-□) and absorbance at 280 nm (0-0) shown.
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iodinated to noniodinated hormone is approximately 1:1. The DEAE cellulose
purification procedure gives poor separation of the individual glucagon
species however and therefore when iodination reactions are carried out
using a 10:1 ratio of glucagon to iodide there must be a substantial,
but unknown amount of contamination of the monoiodoglucagon product by
the non-iodinated species. The non-iodinated glucagon that is still
present after removal of the urea on gel filtration columns thus lowers
the final specific activity of the iodinated glucagon from the theoretical
calculated value with one iodide atom per glucagon molecule. If high
specific activities of iodinated hormone are required for investigation
of very low levels of hormone binding then a much more effective separation
of the individual species is necessary.
c) Avian Pancreatic Polypeptide (APP)
Gel filtration. Carried out using Sephadex G25 (fine grade).
Procedure the same as with insulin and glucagon.
Adsorption columns. Although this hormone did adsorb to inert supports
(as do glucagon and insulin) there is no published method suggesting the
use of this technique as a purification procedure. As no biological
assay or radioimmunoassay was available to estimate the viability of the
iodinated hormone, this type of purification procedure was avoided.
d) Storage
Purified iodinated hormones were apportioned into small tubes and
kept at -20°C before use. Labelled insulin and APP retained the same
behaviour when subjected to chromatoelectrophoresis, acid precipitation,
dialysis and also gave similar binding responses to isolated cells,
for up to one month of storage apart from the reduction in specific activity
due to radioactive decay. However, by measurement of the same parameters,
labelled glucagon showed signs of damage after two weeks of storage at
-20°C. It is not known if this is due to some factor particular to the
iodinated glucagon molecule itself or to the high ethanol content of the
carrier buf fer .
6. Methods of Radio-ligand Assessment
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a) TCA or PCA precipitability for assessment of I bound to protein.
Aliquots of eluates from column purifications were diluted one hundred
fold with 50 mM phosphate buffer containing 1% BSA and were added to an
equal volume of 10% TCA or 6% PCA at 4°C. Samples were left for 15 min
and centrifuged (2750 g, 30 s). The supernatant was sampled for
radioactivity in order to assess the free iodide. This was routinely
less than 10% of the total radioactivity. However, using the same
125 -
buffer a variable percentage of a sample of I was also shown to
precipitate with PCA or TCA treatment. Sometimes as much as 20% of the
radioactive free iodide could be precipitated with the carrier BSA,
and less than half of this could be removed by extensive washing of the
denatured pellet with 50 mM phosphate buffer pH 7.4.
b) Dialysis. Eluted fractions were again diluted one hundred fold
by 50 mM phosphate buffer pH 7.4 containing 1% BSA. Samples were
o
extensively dialysed at 4 C against several changes of 50 mM phosphate
buffer. At least 95% of the radioactivity was retained by the dialysis
tubing. If BSA was omitted a significant proportion (up to 40% after
48 hr) of the radioactivity adsorbed irreversibly to the dialysis membrane.
c) Binding to talc. The percentage of the iodinated protein which
binds to talc gives an estimation of the viability of the tracer
(Cuatrecasas and Hollenberg 1975). Talc (25 mg) was added to 1 ml of a
suitably diluted protein sample. The bound radioactive count was
proportional to the viability of the radioactive tracer, as judged by
the other methods of assessment, but was also dependant on the concentration
of carrier BSA in the sample. An increase in carrier BSA concentration
reduced the total tracer bound to talc. Excessive amounts of talc
(up to 0.5 g) partially overcame the effect of BSA. Up to 70% of radio¬
active tracer would bind to talc (25 mg) on the presence of 0.25% BSA
in the diluent buffer.
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d) Paper chromatoelectrophoresis - Whatman 3MM filter strips (2.5
x 35 cm) were soaked in 30 mM barbitone buffer pH 8.6 and samples (10 yl)
of iodinated hormones applied to a pencil line drawn 5 cm from one end.
Strips were then placed in a Shandon chromatoelectrophoresis tank
containing the same barbitone buffer and electrophoresis was carried out
for 1 hour at 1.5 mAmp/strip (220-300 volts). Strips were then removed
dried in an oven and cut into 1 cm segments for assessment of radioactivity
in the Tracerlab gamma counter.
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e) Radioimmunoassay of I-insulin. Six different anti-sera for
insulin, raised in guinea pigs, were obtained from Wellcome Laboratories.
The double antibody technique (Yallow and Berson 1966) was used for dilution
titration of antiserum and subsequent determination of maximum percentage
binding of radioactive tracer.
Assay was carried out in Luckham LP3 tubes and using a 50 mM phosphate
buffer pH 7.4 containing 0.5% BSA (RIA grade) and 0.1% NaN^ as diluent.
A suitably diluted iodinated insulin sample (0.2 ml) was added to an
incubation medium containing guinea pig anti-insulin serum (AIS-GP
dilution 1:5000) and normal guinea pig serum (NGPS - diluted 1:500)
in a volume of 0.5 ml diluent buffer. Separate control tubes also
contained unlabelled hormone (5 yg/ml) to estimate non-specific binding.
o
Tubes were shaken and incubated for 24 hours at 4 C. Anti-guinea-pig
serum (AGPS) (0.3 ml) diluted 1:12 or 1:16 with diluent buffer was then
o
added and the tubes shaken and incubated for a further 18 hours at 4 c.
Antibody bound tracer was separated by filtration on Oxoid cellulose
125
filters pore size 0.45 ym. The percentage maximum binding of I-insulin
varied from 57 to 85% depending on which antibody was used.
7. Cell Incubations
Cell suspension prepared from liver perfusion (Chapter 3) was diluted
to give 5 to 20 x 10^ cells/ml in normal Krebs Ringer Bicarbonate buffer
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(KRB). When using the hepatocytes for cAMP or cGMP determinations the
cell suspension was preincubated for 15 minutes at 37°C with constant
gassing with 0 /CO in a circular shaking water bath. This allowed the
elevated cyclic nucleotide levels due to the extraction procedure to
stabilise. When the hepatocytes were used for all other parameters the
cell suspension was used immediately.
Cell suspension (0.5 ml) was added to a 7.6 x 2.5 cm plastic incubation
pot fitted with an air tight cap, containing 1 ml of KRB pre-equilibrated
with 95% 0^/5i CO^• If required, a concentrated hormone solution or
metabolic substrate was also previously added in a small volume (10-50 yl).
Pots were then gassed with 0^/C0^, caps fitted and incubated at 37°C in
a reciprocal shaking water bath for the desired time. After the incubation
period the pots were removed and immediately placed on ice for further
processing.
8. Glucose/Glycogen Determination
Cell suspension was centrifuged (2750 g, 30 s) and a sample of
supernatant (0.2-0.5 ml) removed for the determination of glucose by
the glucose oxidase method using 4-aminophenazone as the chromogenic oxygen
acceptor in place of o-dianisidine (Hugget and Nixon 1957). A stock
reagent mixture was made up containing 4-aminophenazone (0.3 mg/ml),
phenol (1.0 mg/ml), glucose oxidase (9 mg/lOO ml) and peroxidase
(3 mg/lOO ml) in 10 mM sodium phosphate buffer pH 7.4, which was stable
o
for up to 1 month when stored at 4 C. Aliquots of this reagent (2 ml)
were added to 0.2 to 0.5 ml of the unknown samples and a series of
suitably diluted glucose standards (0-100 yg/inl) , mixed thoroughly and
incubated at 37°C for 40 minutes to allow the colour to develop.
Absorption was read at 510 nm using a Cecil spectrophotometer. The absorbance
was linearly proportional to glucose concentration over the range used.
Deproteinisation of the unknown samples with TCA or PCA before glucose
estimation was not necessary.
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The glycogen content of the cells was determined by digesting the
remaining cell pellet with 1 ml 30% KOH for 30 minutes at 100°C. Samples
were allowed to cool to room temperature and 0.4 ml of 2% Na^SO^ followed
by 2.8 ml 96% ethanol were added. Samples were left overnight to allow
maximum precipitation of glycogen. The precipitate was washed twice in
70% ethanol, hydrolysed in 1 ml 1 MH^SO^ for 3 hr at 100°C, allowed to cool
and then neutralised by the addition of 1 ml 0.1M sodium phosphate
buffer pH 7.4 and 1 ml 2M NaOH. Aliquots of the digest (0.4-0.8 ml)
were used for glucose determination. The glycogen content of the cells
6
was expressed in yg glucose equivalents per 10 cells. Recovery of a
series of standard glycogen samples subjected to the above procedure was
nearly 100% and therefore freshly prepared glucose solutions were used
as standards.
9. Lipogenesis
Cell suspension was incubated with various acetate concentrations
r 14 ,
containing a tracer amount of[ CJacetate. After incubation, cell
suspension (1 ml) was removed and centrifuged (2750 g; 30 s) to sediment
cells. Lipid extraction of the pellet was by the method of Folch et_ al.
(1957). The pellet was resuspended in 5 ml 2:1 chloroform methanol
(v/v) and vigorously shaken. Material was centrifuged once more (2750 g;
1 min), pellet discarded and 1 ml of a 0.04% CaCl^ solution added to
the supernatant. After vigorous shaking the upper aqueous layer was
removed and the lower organic layer washed three times with 0.5 ml of
"pure solvents upper phase" (see below), discarding the aqueous layer each
time. The chloroform was then removed by evaporation and the triglyceride
pellet dissolved in 10 ml of scintillant (see method 14) for radioactive
determination of label incorporated. Lipogenic activity was then
6
expressed in ymole acetate incorporated per 10 cells.
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'Pure solvents upper phase' (PSUP) was prepared as described by
Folch et. al. (1957) . Chloroform, methanol and a 0.04% CaCl2 solution in
the proportions 8:4:3 respectively were mixed in a separating funnel by
vigorous shaking. The mixture was left to separate into two layers and
the upper layer removed for use in the assay.
10. DNA and Protein Determination
Cell suspension was centrifuged (250 g, 1 min) and pellet washed 3
times with, and finally resuspended to the original volume in isotonic
NaCl. Samples were frozen at -20°C for DNA and protein determinations.
Protein was measured by the method of Lowry et_ al_. (1951) and DNA
determined by the diphenylamine reaction of Burton (1956) .
11. Dry Weights
The dry weight of the cells was determined by pipetting triplicate
1 ml samples of cell suspension and of KRB buffer into tared vials.
Samples were dried to constant weight and weight of dried cells determined
by difference from the two groups of vials.
12. Oxygen Consumption
Oxygen consumption was measured at 37°c with a Clark type oxygen
electrode giving a direct readout to a Servoscribe chart recorder. The
recorder was calibrated with fully oxygenated KRB buffer and with buffer
deoxygenated by addition of sodium dithionite. Cell suspension (0.5 ml)
was added to 3.5 ml of gassed KRB buffer in the water jacketed vessel.
Suspension was stirred continuously by a small magnetic stirrer and the
oxygen content of the buffer monitored. At 37°c the maximum oxygen
content of KRB gassed with 95% 02/5% C02 is 1.071 mM. This figure is
calculated from the Bunsen coefficient (a), of 0.024 for a dilute salt
o
solution at 37 c (Dawson et al_. 1969) . Due to oxygen leakage from the
chamber a blank rate was also taken. Consumption of oxygen was
expressed as ymol/hr/10^ hepatocytes or ymol/hr/g dry weight.
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13. Electron Microscopy
Albumin was used as a carrier for fixing and embedding of the
isolated cells (Farrant and McLean 1969) .
A sample (5 ml) of concentrated cell suspension (20 x 10^ cells/ml)
was centrifuged (50 g; 1 min) and resuspended with 2 ml gassed KRB
buffer containing 10% BSA. A sample of this suspension (0.5 ml) was placed
on a microscope slide which had been previously silicone treated with
^t \N
Repelcote, and 170 yl of a 9% glutaraldehyde (v/v) solution in KRB
added and mixed thoroughly. The sample was allowed to stand at room
temperature for 5 minutes until gelling occurred and then cut into
approximately 1 mm squares. The diced sample was transferred to a vial
containing 3% glutaraldehyde (v/v) in KRB buffer and left for 1 hour at
4°C. The gel sections were then washed three times with ice cold 0.1M
sodium cacodylate buffer pH 7.4 and resuspended in 1% OsO^ (w/v) in
0.1M cacodylate buffer for 45 minutes at 4°C. The gel cubes were then
washed in four or five changes of cacodylate buffer prior to dehydration
in ethanol. Embedding, sectioning, lead citrate and uranyl acetate
staining was carried out by Mr. I.D. Sneddon, Department of Anatomy,
Royal (Dick) School of Veterinary Studies, Edinburgh.
14. Scintillant solutions
The following scintillant cocktails were universally used for all
14 3
C and H determinations. The scintillant cocktail for the phospho¬
diesterase assay comprised a mixture of toluene (625 ml) and 2-
methoxyethanol (375 ml) containing 4 g 2,5-diphenyloxazole (PPO) and
lOO mg 1,4-Di 2-(5-phenyloxazolyl) benzene (POPOP). All other assays
using scintillant used the same amounts of the fluors but in 1000 ml
toluene plus 300 ml 2-methoxyethanol or 2-ethoxyethanol.
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15. Sodium Dodecyl Sulphate (SDS) Polyacrylarniae Gel Electrophoresis of
Collagenase
SDS gel electrophoresis (Payne 1976 - review) was used to separate
the constituents present in the different batches of crude collagenase
obtained from Boehringer Ltd. 7.5% acrylamide 0.2% methylenebisacrylamide
cylindrical gels containing 0.1% SDS were made up in 75 mM tris-glycine
buffer pH 8.6. Gels were prerun in a Shandon electrophoresis tank for
1 hr at 2 mAmp/tube and then 20 jil of the prepared collagenase solution
containing 800 Jig was added. Gels were run for 3^ hours at 3 mAmp/tube
and then stained in Coomassie Brilliant Blue. Gels were scanned using a
Gilford gel scanner and the protein peaks recorded by Servoscribe recorder.
Sources of Materials Used
Except as indicated below, biochemicals were obtained from Sigma
(London) Ltd., laboratory reagents were of AnalaR quality (B.D.H., Ltd.),
enzymes were obtained from Boehringer Ltd. and radiochemicals from
The Radiochemical Centre.
Insulin, glucagon and calcium ionophore A23187 were obtained from
Eli Lilly & Co. Ltd., Indianapolis, U.S.A.,
Avian pancreatic polypeptide was a kind gift from Dr. J.R. Kimmel,
University of Kansas.
Boehringer collagenase - batch nos0used, 9, 13, 15, 17, 21, 25, 27,
29, 30.
Bovine serum albumin (fraction V) was obtained from Armour
Pharmaceutical Co., Eastbourne, Sussex.
CHAPTER 3
PREPARATION AND PROPERTIES OF ISOLATED
CHICKEN HEPATOCYTES
35.
Introduction - historical development of cell isolation
Early experimental techniques used to study the control of hepatic
metabolism employed the use of isolated perfused livers (Mortimore 1961;
Sokal et al. 1964; Hems et ad. 1966; Ross et ad. 1967; Exton and Park
1969; Exton et ad. 1971b)or liver slices (Ashmore 1964; Krebs et al.
1966; Miller et ad. 1974). Both systems remove the hepatic tissue from
the complex interactions between the different organs of the body, thus
allowing direct studies on liver metabolism to be made. Using the former
technique it was found that many of the metabolic characteristics found
in vivo were retained, including hormone sensitivity, adenylate and
potassium contents, cell-cell interactions and retention of cytosolic
enzymes. However using this method had several major disadvantages.
Due to the size, density and the high respiratory rate, it was very
difficult to keep the tissue adequately oxygenated and unless red blood
cells were also incorporated into the perfusion medium the tissue very
quickly became hypoxic, leading to cell deterioration induced by autolytic
digestion. Another disadvantage of this type of system was the few
experimental conditions which could be imposed on the liver during each
experiment. In order to study a variety of related effects or conditions
a large number of livers had to be isolated. Due to individual
variations between animals it was often difficult to correlate the
results using different livers. Liver slicing partially overcame the
disadvantages of perfused whole liver in that many different conditions
could be studied from tissue isolated from the same liver. Even allowing
for slight variations in composition between slices this method theoretically
allowed more accurate comparisons between effectors to be made. If slices
were cut thin enough (theoretically one cell thick) adequate oxygenation
could be supplied without the need for erythrocytes in the medium.
However the various experimental difficulties encountered with this method
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prevented its widescale use. Slicing the liver causes a great deal of
damage to cells resulting in the release of cellular constituents, including
the proteolytic enzymes. Slices could not be guaranteed of uniform
thickness and if too thick often the cells towards the interior of the
section became hypoxic and tissue degeneration quickly ensued. Metabolic
rates were found to be lower than in whole liver perfusion due to the
loss of essential cellular components on slicing (Ross et al. 1967;
Krebs 1970). Although tissue slicing resulted in a more versatile
method which allowed a more varied experimental approach, the quality
of the tissue was poor and often resulted in inaccurate measurement of
various parameters.
The difficulties found with liver slicing or whole liver perfusion
induced many workers to investigate complete tissue dispersion resulting
in the production of intact single cells. This type of system was much
more versatile than that of liver slicing but again the major problem was
in the difficulty of obtaining a technique which could assure the release
of large numbers of metabolically viable cells. Early methods were based
purely mechanical dispersion of cells by loose homogenizers (Potter and
Elvehjem 1936; Berry 1962; Howard and Green 1965) which resulted in
broken cell preparations. Pre-perfusion of the liver with calcium
chelating agents, which reduced intercellular adhesion, helped cell
recovery, but generally yields were very low with extensive damage to
the cells (Anderson 1953; Jacob and Bhargava 1962; Takeda 1964) .
The digestion of the extracellular connective tissue by the enzyme
collagenase was demonstrated in the first preparation of fat cells from
rat adipose tissue by Rodbell (1964a,b) . The isolated cells retained
their metabolic integrity with identical or increased hormone sensitivity
to that of the complete tissue. Enzymatic dispersion of the liver was
first demonstrated using the two enzymes collagenase and hyaluronidase
in a calcium free buffer (Howard et al_. 1967) . After the initial perfusion
of the liver with 10 ml ice cold enzyme solution tissue slices were then
incubated in the enzyme solution for 1 hour at 37°c. The original method
has since been modified resulting in improvements in cellular morphology
and metabolic activity (Howard and Pesch 1968; Howard et al_. 1973) but
still necessitates slicing of the liver before complete digestion of the
connective tissue. Although the damaged cells and other debris resulting
from the slicing can be removed after incubation by low speed centrifugation
procedures, the intact cells are still exposed for up to one hour at 37°C
to the proteolytic enzymes released from the large numbers of damaged
cells and thus not only is the cell yield low but the hormone sensitivity
of the isolated hepatocytes may be affected due to receptor degradation.
The liver perfusion system of Mortimore (1961) was used by Berry
and Friend (1969) for the first isolation of cells by a recirculating
type perfusion which did not necessitate liver slicing. This method
also reduced the length of time the liver was exposed to the digesting
enzymes. Rat liver was continually perfused in situ with the collagenase-
hyaluronidase enzyme solution and the perfusate was then returned to a
reservoir for reoxygenation before being used again. As a result,
high yields of metabolically active and hormonally sensitive cells were
produced. This method has now been universally accepted and used by
many other workers with only slight modifications to isolated hepatocytes
from various sources (Capuzzi et al. 1971; Seglen 1973; Capuzzi et al.
1974; Cornell et ad. 1974; Krebs et_ al. 1974; Arinze and Rowley 1975;
Staichfield and Yagar 1978; Goldfarb et al. 1978).
The preparation of isolated hepatocytes has many advantages over
the other methods used to study various aspects of liver metabolism
especially those under hormonal control. The isolation procedure purifies
the parenchymal cells from the erythrocytes and other sinusoidal cells
(non-parenchymal cells) and thus a direct study on the hepatocytes can
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be made. Other techniques have been developed from Berry and Friend's
perfusion method to preferentially isolate the Kupffer and other
sinusoidal cells such as endothelial cells, fat storing cells and pit
cells, while digesting the parenchymal cells with pronase (Knook et al.
1977; Wisse and Knook 1977). Therefore different populations of cells
within the liver are now accessible and can be purified from most other
cell types.
Isolated hepatocytes can be easily oxygenated and supplied with
metabolic precursors or hormones without the need for diffusion through
surrounding tissue. The ease of handling allows for a large number of
variables to be tested on the same preparation of cells and due to the
homogeneity of the suspensions very accurate comparisons can be made
between different conditions.
Viable hepatocytes can be kept in fortified media as non-profiterating
monolayer cultures for up to several days (Bissell et al. 1973; Laishes
and Williams 1976; Goodridge and Adelman 1976)
although after several weeks in culture cells show transformed
characteristics and columns of proliferating cells are formed (Borek
1972; Williams and Gunn 1974). Longer term experiments are therefore
possible for up to a few days after isolation of the cells.
The main disadvantage in cell isolation is the possible subtle damage
done to cell surface components which could lead to altered cell
interactions with solutes in the external medium. Gross morphological
damage to the cell is more easily recognised by various techniques
including trypan blue staining of damaged cell nuclei, leakage of
cytosolic enzymes, rates of endogenous oxygen consumption, ion and total
adenylate content as well as examination of intracellular fine structure
by electron microscopy. The extent of the more subtle damage to the
cell surface is more difficult to determine. Hormonal sensitivity is one
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possible method of estimating this type of damage and therefore gives a
reasonable indication of the viability of the hepatocyte. If the isolated
cells show the hormone sensitivity of the whole tissue to various
metabolic responses then this is reasonable evidence for little damage
to the external components of the plasma membrane and thus little damage
to the cell as a whole. Various other possible disadvantages using this
system are often overlooked. Hepatocytes isolated by this method are
now free of cell-cell contact which may be important in the intercellular
regulation of metabolism. The Kupffer and other liver sinusoidal cells
have been greatly reduced in number if not completely removed from cell
suspensions. It is unknown if they impose any regulatory effects on the
surrounding hepatocytes in the liver. Digestion of the hepatic tissue
with collagenase may select particular parenchymal cell populations within
the liver. Thus the isolated cells may be uncharacteristic of the
parenchymal cells as a whole. Certain specific cell receptors or carrier
proteins which are present in the plasma membrane may be more sensitive
to collagenase digestion than others, therefore imposing a regulatory
imbalance on metabolism when compared to whole tissue. The metabolic
shock suffered by the isolated hepatocytes by anoxia and loss of ion
gradients due to the harsh isolation procedures may have marked effects
on metabolism. Rat liver cells take up to 4 hours after isolation
before various physical and metabolic parameters stabilise (Goldfarb
'
£5. 1978) . It is possible to prepare non-proliferating monolayer
cultures of rat hepatocytes (Bissel et al_. 1973; Laishes and Williams
1976; Goldfarb et ad. 1978) and chicken hepatocytes (Tarlow et ad. 1977)
which allows longer term experiments of up to a few days to be carried
out. However these cultures cannot be maintained indefinitely and
the general metabolic functions of the cells are gradually lost. If and
when it becomes possible to culture colonies of replicating cells which
do not display any transformed characteristics many of these disadvantage
will not apply. The percentage of original cells isolated from the
liver will become increasingly small and therefore any irreversibly
modified characteristics induced by the tissue digestion will be diluted
out. With the growth of monolayer cultures cell-cell contact is
re-established and adequate oxygenation and accessibility to metabolites
maintained. Various liver sinusoidal cells can also be added back onto
the culture medium and their effects on parenchymal cell metabolism,
if any, noted.
Until it becomes possible to use untransformed hepatocyte cell
lines it is essential that the above mentioned factors are recognised
and must be considered when interpreting any results.
Preparation of Hepatocytes
During the period of study two different procedures were used to
isolate chicken hepatocytes. The initial method used (Method I) was
based on the procedure of Howard et al_. 1973 as modified for the chicken
(Dickson and Langslow 1975; Dickson 1977; Dickson et ad. 1978) .
This method was used for most of the experiments using caffeine and
theophylline as outlined in Chapter 6. All other experiments employed
the use of a recirculating type perfusion (Method II) modified from the
original procedure of Berry and Friend (1969) for use with the chicken.
Method I
Isolation of hepatocytes was carried out using 'method B' reported
by Dickson 1977. The chicken liver was perfused in situ with calcium
free Krebs-Ringer bicarbonate (KRB) buffer (Krebs and HenseLeit 1932) at
4°C using a reservoir of two 10 ml syringe bodies connected by a three
way tap and tubing to a number 19G syringe needle. The reservoir was
clamped at a height of 40 cm above the worktop and perfusion carried
out under gravity. The KRB buffer was fully oxygenated by equilibrating
with 95% 0^/5% C02 till pH 7.4. Bovine serum albumin (BSA) 1% (w/v) was
added to the buffer to protect the isolated cells by preventing clumping
and denaturation on the walls of the preparation vessels and to bind any
toxic substances released during the digest and purification procedures
(Krebs et aj . 19 74).
The chicken was killed by cervical dislocation. The skin was then
cut away at the inner top of both thighs and the legs dislocated and
restrained-. The skin was again cut near the pelvic region and stripped
forward exposing the sternum and surrounding musclature. An incision
was then made at the tip of the keel and the rib cage opened by cutting
down both sides to the backbone. The rib cage was then pulled upwards
to expose the liver. Holding the gall bladder with blunt forceps the
bile ducts were eased free from the portal vein and then cut. Still
holding the gall bladder the portal vein was eased up out of the body
cavity free of the surrounding connective tissue and fat depots by using
fine pointed forcepts. The needle of the perfusion apparatus was inserted
into the portal vein and the inferior vena cava cut. Immediately the
2+
liver was perfused in situ with 10 ml of ice cold Ca free KRB. Due to
the rapid clotting of chicken blood on some occasions portions of the
liver did not blanch with this initial flush through of buffer. Gentle
massaging of the liver sometimes succeeded in dispersing the blood clot.
The three way tap on the reservoir was then turned to allow perfusion to
2 +
continue by adding 50 ml of ice cold Ca free KRB buffer containing
collagenase (0.15-0.25 mg/ml) to the other syringe body. All perfusate
was allowed to run to waste after passing through the liver.
The liver was then excised free of the body cavity, the connective
tissue and liver capsule removed and then minced with scissors. The
2+
minced tissue was then incubated with 20 ml Ca free KRB buffer for
5 minutes at 40°C in a circular shaking water bath (100 cycles/min) with
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constant gassing with O^/CO^- The digest was then filtered through coarse
nylon mesh, returned to the shaking water bath for a further 2 min and
2 +
refiltered through fine nylon mesh into 30 ml of ice cold Ca free KRB.
The cell suspension was then centrifuged at 335 g for 5 minutes, the
pellet being resuspended in 20 ml of calcium free buffer by pasteur
pipette and recentrifuged at 60 g for 2 min. This procedure removes
nearly all of the non-parenchymal cells from the suspension but maintains
a good yield of hepatocytes (Dickson 1977). The final pellet was then
resuspended in the required volume of KRB buffer containing calcium.
A sample of cell suspension (0.2 ml) was diluted with 0.1% trypan blue
in isotonic KC1 (0.8 ml) and cell number and viability estimated using
a counting chamber. The remaining suspension was diluted accordingly
and used for experiments.
Method II
By use of a water jacketed reservoir and organ chamber (fig. 3.1)
all perfusion procedures were maintained at 37°C. All buffers used were
pre-equilibrated to this temperature beforehand. Subsequent isolation
and purification procedures were also carried out as close to 37°C as
possible although exposing the liver or liver digest to lower temperatures
was not detrimental to the isolation procedure.
With the clamp on the perfusion apparatus closed the reservoir was
2+
filled with 60 ml of Ca free KRB buffer and the 0^/C0^ gassing adjusted
to give a steady stream of bubbles. Overgassing resulted in frothing of
the BSA containing buffer and was therefore avoided. Initial stages of
the preparation were the same as with method I until the portal vein was
eased up free of the body cavity. A 25 cm length of silk suture
(Mersilis-Sutupak, Ethicon Ltd.) was placed under the portal vein ready
to tie in the needle. The needle was then inserted into the vein and
perfusion started immediately on cutting the inferior vena cava.
PERFUSION APPARATUS
As the liver was perfused in situ with 40 to 50 ml of the reservoir buffer
the needle was tied firmly in place with the suture. A good perfusion was
indicated by an even blanching of the liver as the blood was flushed out.
o
Since the perfusing buffer was close to 37 C the rate of blood clotting
was much quicker than with method I, but if the procedure was carried out
quickly enough the liver blanched evenly. Perfusion was then stopped
by closing the clamp on the perfusion apparatus. Due to the anatomical
features of the chicken it was very difficult to adopt the recirculating
perfusion method if the liver remained in_ situ and it was therefore
removed from the body cavity. To facilitate easy removal of the liver
a further excision was made through the backbone and skin allowing the
head and wings of the bird to be removed from the lower half of the body.
The liver, gall bladder and spleen were then carefully excised from the
body cavity and placed in the organ chamber and perfusion restarted.
Leakage of the perfusion buffer from the portal vein is usually sufficient
2+
to keep the exterior of the liver moist. If not a small amount of Ca
free KRB buffer was sprayed on the liver. After the remaining 10 to 15 ml
of buffer had passed through the liver and allowed to run to waste,
2+
50 ml of Ca free KRB buffer containing collagenase (0.2-0.3 mg/ml) was
added to the reservoir and the perfusate was then recycled to the
reservoir by means of a rotary pump (Watson-Marlow Ltd.). The height of
the reservoir above the organ chamber was adjusted to around 40 cm which
resulted in flow rates in the order of 15 to 25 ml/min through the liver.
The initial oxygen concentration of the gassed KRB buffer (1.071 mM)
was reduced to less than 5% after passing through a medium sized liver
of 8 g. After perfusion had been carried out for 10 minutes the oxygen
content of the buffer in the reservoir was in the region of 65-80% of the
original value. Increasing the height of the reservoir did not substantially
increase the flow rate through the liver, which was found to depend mainly
on the success of the initial wash out of blood. The buffer was not
pumped through the liver as the increase in pressure of the perfusate
within the liver itself could cause damage. Slight hypoxia for 10-15
minutes does not appreciably effect the quality of isolated hepatocytes
(Capuzzi et al. 1974). After 10 to 15 minutes of perfusion with
collagenase containing buffer the liver goes limp in the oxygen chamber.
Perfusion was then terminated and both spleen and gall bladder removed
from the liver. The liver capsule was stripped off and the digested
tissue was then broken up by gentle maceration with scissors and
2+
transferred to a weighed siliconised flask containing 20 ml Ca free
KRB. The flask was reweighed and incubated in the same procedure as
method I except that the orbital shaking bath was set at 80 cycles/min,
2+
the pellet was finally washed with 80 ml Ca free KRB and resuspension
of pellets was carried out by continual transfer of KRB buffer between
centrifuge tubes rather than by pasteur pipette.
For many preparations a Krebs Ringer bicarbonate buffer containing
a high potassium, low sodium content was used where the concentrations
of the two cations were interchanged. The normal high sodium buffer was
then used after cell isolation for all experimental purposes. The high
potassium medium inhibited the breakdown of intracellular glycogen in
the hepatocytes (Dickson 1977) possibly by inhibiting phosphorylase
activity (Hue et. a]^. 1975) . Preparing the cells using a high Na medium
greatly reduced the already low glycogen content of the cells thus
giving a false representation of the fed state. This could not be
overcome by using a glucose containing buffer during perfusion. The use
of the high K+ medium allowed studies to be carried out into the regulation
of glycogen breakdown by measurement of glucose release from cells isolated
+
from fed birds. The preparation of the cells in high K medium did not
alter any of the other parameters measured with the hepatocytes.
Hepatocytes could be isolated in 30 to 40 minutes ready for
experimentation by both methods.
All chickens used were males of the Thornber 909 breed and were
3 to 5 weeks old. All embryonic metabolic characteristics have been lost
but sexual development is still at a very early stage (Goodridge 1969).
The success rate of perfusion using both methods was found to be around
80% although often certain areas of the liver failed to blanch. After
collagenase treatment these unperfused areas were removed before
isolation of the hepatocytes. In some cases, particularly when using
method I and with livers from older chickens (5 to 6 weeks) low cell
yields were obtained due to excision of large portions of unperfused
liver. Livers of deep red colouration were more difficult to perfuse
than those of lighter colouration. In general, the older the bird used,
the deeper the colour of the liver and the lower the success rate of
the perfusion. Later it was found that the success rate of the perfusion
was dependent on breed of bird. Both the Shaver and Broiler breeds of
chicken, of ages 3 to 8 weeks, showed 100% success rates during perfusion
with complete blanching of the liver in all cases. The livers isolated
from these birds were all of a light colouration and no blood clotting
within the hepatic tissue was noted. The reasons for these variations
among breeds is unknown.
Assessment of Hepatocyte Viability
Various metabolic and physical parameters were measured in order to
assess the viability and stability of the hepatocytes isolated by the
two methods (Table 3.1). Cells were initially examined under the light
microscope and were found to consist of single cells or cells clumped in
small groups of up to 5 or 6. Contamination of parenchymal cells by other
cell types including red blood cells was always less than 5%. The
1956)


















































































































































































































































conveniently rapid and reasonably quantitative measure of gross morpholog¬
ical damage to the cell membrane (Howard et al. 1967; Berry 1974).
Fig. 3.2 shows the effect of incubation at 37°c on cell concentration
and percentage trypan blue staining. However other workers have questioned
the significance of trypan blue as a vital stain and suggest measurement
of enzyme leakage as a more accurate method. Determination of lactate
dehydrogenase activities are routinely used by some laboratories and may
well give a more accurate indication of gross structural damage to the
hepatocyte membrane. There is however reasonable correlation between
measurement of leakage of various cytosolic enzymes and extent of trypan
blue stained nuclei (Dickson 1977). A rapid test for intactness of the
hepatocytes using the oxygen electrode has been reported by Letko(1978).
Due to plasma membrane impermeability, the increase in
respiration rate on addition of succinate is used to estimate cell
viability. However such measures do not give any indication of other
signs of damage to the cell such as the irreversible loss of ion and
electrochemical gradients across the plasma membrane nor proteolytic
damage to surface components such as hormone receptors which are only
reflected in the metabolic competence of the cell. Both measurement of
enzyme leakage and trypan blue staining allow direct comparisons of
viability to be made between individual preparations of cells but they
only serve as a rough indication of metabolic integrity.
Although there were significant differences in the parameters
measured between the two methods only slight variations in characteristics
were noted when method II was routinely used. There was a correlation
between the success of the initial flushing of red blood cells and cell
yield and viability. Unlike that reported for method I (Dickson 1977)
there was no increase in trypan blue stained cells nor decrease in cell
yield when using livers from 24 hour starved birds. Different crude
40 80 120 100
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Fig. 3.2 Effect of incubation at 37 C on cell number (upper diagram)
and cells staining with trypan blue (lower diagram) for three individual
cell preparations A, □ and O.
collagenase batches obtained from Boehringer Corporation Ltd. gave
considerable variations in yield and percentage stained cells when
using method I (Dickson 1977). No such comparison could be made when
method II was adopted. It is not known if this is due to increased
consistency in batch preparation by the suppliers or to the different
methods used to isolate the cells. SDS polyacrylamide gel electrophoresis
of different collagenase batches resulted in variations in the amounts of
the individual protein components (fig. 3.3). In seven different
batches of collagenase used throughout the study there were no major
fluctuations in yield or percentage stained cells. However there were
marked differences in hormone sensitivity when studying the stimulation
of glucose release from the cells (Chapter 6). Cell sensitivity to
glucagon varied between 0.1 and 1.0 ng/ml with similar variations in
sensitivity to adrenaline. It is considered that hormonal sensitivity
gives the most accurate measure of cell viability.
Changes in the batch of bovine serum albumin used (Fraction V
Armour Pharmaceuticals) did not effect any of the basal nor hormone
stimulated parameters measured.
Cell yield varied considerably depending on the initial success of
perfusion. Yields ranged from 60 to 250 x 10^ cells/g wet of liver.
Using the conversion factor of wet to dry weights of 3.74 for chickens
hepatocytes (Dickson 1977) - 3.7 for rat hepatocytes (Krebs et al. 1974) -
this accounts for a 7 to 30% yield based on weight. Although this is
much lower than the 50% yield reported for rat hepatocytes (Berry and
Friend 1969; Krebs et al_. 1974) it compares favourably with other
1 9 74_;
workers isolating chicken hepatocytes (Capuzzi et al Dickson 1977).
Total adenylate contents for cells immediately after isolation by
method II were higher than those reported for method I and also higher
than the figures quoted for whole liver (Dickson 1977) (Table 3.1).
Fig.3.3SDSPolyacrylamidegelelectrophor sisofdiff rentBoehringerollagena ebatc . A.Batch17.25Ct9.
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However on incubation hepatocytes isolated by method I also showed higher
total adenylates than whole liver (Dickson 1977) . If adequate oxygenation
is not supplied during the isolation procedures the total adenylate
content of the cells falls to values as low as 2000 pmol/10^ hepatocytes.
The adenylate charge - the ratio of triphosphorylated adenylate to the
ATP
sum of mono- and di-phosphorylated ( ) in these conditions can^
ADP + AMP
approach zero despite the fact that the lower phosphorylated derivatives
of adenosine escape more easily from the cell than ATP. With adequate
oxygenation, adenylate content of the cells rises to around 5000 pmol/10^
cells. On incubation at 37°c there is a gradual increase in ATP content
of the cells at the expense initially of AMP and then ADP (fig. 3.4) .
With incubation the adenylate charge increases continually if adequate
oxygenation is given to the cell suspension. This was not found when
incubating cells prepared by method I (Dickson 1977). No adenylate
leakage could be demonstrated in cell suspension supernatants after
incubation periods of up to one hour. Similar findings were reported
for rat hepatocytes and perfused rat liver (Krebs et al_. 1974) .
Oxygen consumption rates of hepatocytes isolated by method II are
intermediate in value to those reported for chicken hepatocytes by Badenoch-
Jones and Buttery (1975) and Dickson (1977). The oxygen consumption of
certain cell preparations isolated from fed chickens could be stimulated
by adding sodium lactate to a concentration of 10 mM (fig. 3.5) but other
preparations showed no effect. The reason for this is not known. The
administration of caffeine or theophylline to cell suspensions at 10 mM
reduced the oxygen consumption rate by 13-25%. The effects of these two
methylxanthines is discussed in more detail in Chapter 6.
The morphological integrity of the hepatocytes was also examined by
the use of electron microscopy. Hepatocytes isolated from the livers of
both fed and 24 hour starved birds were processed. Hepatocytes from fed




Fig- 3.4 Effects of incubation at 37 c on cellular ATP (•-•), AD? (■-■),
AMP (A-A) and total adenylate contents
Cells prepared using method II.
TIME (minutes)
Fig. 3.5 Effect of incubation on respiration rate of cell suspensions.
O-O Normal cell suspension.
□ Cell suspension containing 10 mM lactate.
incubation (fig. 3.6 and 3.7). After this time, long processes of
cytoplasm attached to the main cell by plasma membrane were obvious
(fig. 3.8). A large proportion of the cells showed numerous vacuoles
throughout the cytoplasm with some containing more vacuoles than others
(fig. 3.9). These tended to merge together to form larger vacuoles when
incubated for longer periods of time. Vacuoles were not apparent in
hepatocytes isolated from 24 hour starved birds (fig. 3.10). It is not
known if these vacuoles are a result of some artefact of the preparation
procedures for the electron microscope or indeed if they are lipid
droplets associated with cell metabolism. Other workers have also
demonstrated the presence of large numbers of lipid droplets in isolated
chicken hepatocytes (Tarlow et al^. 1977) . Which ever is the case it is
obvious that there are certain definite populations of hepatocytes
isolated from fed birds which gave this appearance in the electron
microscope. Some parenchymal cells contain very few, if any vacuoles
whereas in others they constitute the majority of the cytoplasm. It is
not known if these are cells which aid not take up trypan blue but are
damaged during preparation for electron microscopy or indeed are cells
which have a high lipogenic activity or lipid storing capacity.
Although potassium contents and enzyme leakage from the cells were
not investigated, the parameters tested compare favourably with those
reported by others. It is therefore concluded that the recirculating type
perfusion (method II) provides a rapid and convenient method to isolate
large numbers of structurally and metabolically viable hepatocytes from
the livers of starved or fed chickens. These hepatocytes were then used
to examine the various aspects of chicken liver metabolism related to
the pancreatic polypeptide hormones which are presented in the following
chapters.
Fig. 3.6 Electron micrograph of hepatocyte - preincubated for 30 minutes
at 37 C - isolated from a fed chicken.
Magnification X 15,000.
Fig. 3.7 Electron micrograph of hepatocyte
at 37 C - isolated from a fed chicken.
Magnification X20,000.
- preincubated for 60 minutes
Fig. 3.8 Electron micrograph of hepatocyte - preincubated for
120 minutes at 37 C - isolated from a fed chicken.
Magnification XI5,000.
Fig. 3.9 Electron micrograph of hepatocytes - preincubated for
30 minutes at 37 c - isolated from a fed chicken.
Magnification X10,000.
Fig. 3.10 Electron micrograph of hepatocytes - preincubated for






It is now well accepted that there are components of the liver cell
plasma membrane (receptors) which specifically bind various polypeptide
hormones. This is the primary action in a series of related events which
lead to the alteration of various metabolic processes within the cell and
is therefore an important point at which to control the extent of hormonal
regulation. Metabolic rates within the liver cell are regulated by the
rate of release of the pancreatic hormones from islet tissue and also by
the hepatocytes' ability to recognise the presence of these hormone
signals carried in the blood via their specific receptors. The affinity
of the receptor for the hormone as well as receptor concentration on the
cell surface are the main initial factors which influence the sensitivity
of the cell to fluctuations in the circulating hormone concentration.
These hormone receptor interactions have been extensively studied in a
number of suitable preparations and many comprehensive reviews have been
published (Roth 1973; Kahn 1975; Cuatrecasas and Hollenberg 1976;
Freychet 1976; Kahn 1976).
Hormone-receptor interactions are monitored by incubating radioactively
125
labelled hormone ( I is the most universally used isotope) with a
suitable receptor preparation and affinity constants are determined by
kinetic or more often steady state binding experiments . Receptor bound
hormone can be separated from free hormone by centrifugation, filtration
or precipitation. Receptor affinity and specificity can be calculated
by the addition of various amounts of unlabelled hormone or related
agonists. Results are analysed by methods for competitive protein
binding assays, and thus quantitative measures of affinity and saturability
are obtained. Binding studies are mostly carried out at low temperatures
(usually room temperature or below) to minimise hormone and receptor
degradation which takes place during incubation. Methods and conditions
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used to study hormone binding and the various mathematical analyses of
results have been reviewed (Rodbard 1973; Kahn 1975; De Meyts 1976;
Cuatrecasas and Hollenberg 1976).
Apart from hormone recongition the receptor must also be capable of
transmitting the signal of hormone occupancy across the plasma membrane
to another membrane constituent or directly to the cell cytosol or both.
Many hormones, like glucagon act through their specific membrane receptor
by stimulating adenylate cyclase which is situated on the inner surface
of the plasma membrane ("for a review see Helmreich et al. 1976) but the
precise molecular mechanism by which this is carried out is unknown.
The mode of signal transfer by the insulin receptor is even less understood
although it is continually under investigation. Years of extensive
search for a second messenger such as cAMP for glucagon have so far been
unsuccessful, although a few candidates have been proposed. Many recent
reports on insulin degradation indicate the strong possibility of
receptor bound insulin "internalisation" into the cell which may explain
effects on intracellular processes (Goldfine 1977; Steiner 1977;
Bergeron et al. 1978, 1979).
Due to the relatively recent discovery of APP, very little is known
about its metabolic actions on the liver. APP has been reported to have
direct effects on adipose tissue (McCumbee and Hazelwood 1977) but it is
not known whether it affects the liver directly. Effects of whole body
carbohydrate and lipid metabolism have been reported (Hazelwood et_ al.
1973).
The Insulin Receptor
The interaction of insulin with a specific receptor has been investig¬
ated in a variety of tissues. The receptor has been isolated from fat
and liver cell membranes (Cuatrecasas 1972a,b; 1974) as well as lymphocytes
(Gavin et al. 1973) and avian erythrocytes (Ginsberg et al. 1976, 1977)
'<?
52.
by treatment with nonionic detergents. Similar, if not identical,
properties have been found for all preparations. The solubilised
receptor was found to be a glycoprotein with molecular weight about
300,000 and a Stokes radius, when complexed with detergent molecules,
o
of 70.7 A; this preparation still retains the ability to bind insulin
specifically. Insulin receptors from many other sources show identical
kinetic parameters to those of the major target tissues, liver and
adipose tissue, indicating that the receptor molecules are identical
or very similar in all preparations studied (Kahn 1976).
Some investigators studying the binding of radio iodinated insulin
have used small pieces of tissue, such as intact muscle, or tissue slices
as the receptor preparations (Stadie et al. 1953; Newerly and Berson
1957; Garrett 1966; Wohltmann and Narahara 1966; Lambert 1972).
Besides the obvious diffusion difficulties encountered, results were
often difficult'to interpret due to high non-specific binding and
degradation of the hormone. The development of cell isolation techniques
provided a more convenient receptor preparation since both the binding
of hormone and biological effect could in many cases be directly compared,
degradation rates could be controlled and non-specific adsorption of
tracer was greatly reduced. Cells isolated from the major target organs -
adipose tissue and liver - have been extensively used. Isolated fat
cells have been the main candidates when studying insulin binding with
numerous reports in the literature (Cuatrecasas 1971a,b; Cuatrecasas and
Illiano 1971; Freychet et al. 1971; Kono and Barham 1971; Bennet
and Cuatrecasas 1973; Gammeltoft and Gliemann 1973; Gliemann et al.1975;
Gliemann and Sonne 1978; Kahn and Baird 1978). Isolated rat hepatocytes
have also been successfully used under conditions which limit the high
rates of hormone degradation by this tissue (Kahn et _al. 1973; Freychet
et al. 1974; Olefsky et al. 1975; Terris and Steiner 1975; Gammeltoft
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et al. 1978). Insulin binding to chicken hepatocytes isolated by the
method of Capuzzi et ad. (1974) has also been recently reported (Simon
et ad. 1977a). Other receptor preparations studied include purified plasma
membrane fractions (Neville 1968) from rat (Freychet et al. 1971a,b;
Freychet et al. 1972a,b; Goldfine et al. 1973; Kahn et a^. 1973;
Freychet 1974; Kahn el: al_. 1974; Kahn 1975) and chicken liver (Simon
et ad. 1977a). Plasma membrane preparations from rat adipocytes
(Cuatrecasas 1971b; Freychet 1971b; Hammond et_ ad. 1972; Jarett and
Smith 1975) and rat and mouse cardiac muscle (Freychet and Forgue 1974;
Forgue and Freychet 1975) have also been investigated. All preparations
studied indicate the presence of a high affinity receptor for insulin
_10 _g
with dissociation constants in the range 10 to 10 M. Cuatrecasas
(1971a) reported the presence of a high affinity insulin receptor on the
rat adipocyte membrane with a dissociation constant (K^) of 6 x 10 "'""'"M.
This value compares well with the dose response curve of insulin stimulated
lipogenesis in the same tissue (Gliemann 1967; Crofford 1968; Kono and
Barham 1971) and thus binding and metabolic action curves are super-
imposable This implies that total receptor occupancy is required for
maximal metabolic effect. However much lower receptor affinities for the
rat adipocyte have been reported by others. Gammeltoft and Gliemann
-9
(1973) reported a K between 1 and 5 x 10 M, Kono and Barham (1971)
d
-9
found the K to be around 7 x 10 M whereas Hammond et_ a)L. (1975) found two
-10 -9
classes of binding sites with of 5 x 10 and 3 x 10 M. These
results suggest that the biological effect is maximum when only a small
fraction of the total cell receptors are occupied. This is consistent
with the 'spare receptor' theory (see Cuatrecasas and Hollenberg 1976)
where large numbers of receptors are present on the cell surface but
only a very small number need to be occupied to induce a maximum metabolic
effect.
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Various workers using rat liver cells found receptor affinities
similar to those found by Gammeltoft and Gliemann for the rat adipocyte
(Freychet et al_. 1974; Terris and Steiner 1975; Olefsky 1975). This
correlates well with the almost identical properties of the solubilised
receptors from the two tissues. Dissociation constants of the order of
-9
2 x 10 M have been reported for rat hepatocytes (Freychet et al. 1974;
-9
Freychet 1976) and 3 x 10 M for liver plasma membranes (Freychet et al.
-9
1974). Terris and Steiner also report a of 3.5 x 10 M for the high
affinity component of insulin binding to hepatocytes. Studies using
chicken hepatocytes and chicken liver plasma membranes isolated by the
-9
method of Neville (1968) showed dissociation constants of 1.3 x 10 M
-9
and 3.2 x 10 M respectively (Simon et al. 1977a}
Insulin receptors have been found in a number of tissues which are
not considered to be major target sites for the hormone, such as blood
mononuclear cells, thymic lymphocytes and placental tissue. Although
numerous studies have been carried out with receptor preparations from
these sources the reason for the existence of these specific binding sites
is not clear. Due to the ease of isolation and apparent stability,
human lymphocytes have been employed to study insulin binding interactions
(Gavin et ad. 1972; Archer et al. 1973; De Meyts et_ ad. 1973;
Gavin et ad. 1973; Gavin et ad. 1974; van Obberghen et_ ad. 1976).
These preparations show high affinity binding sites for insulin and have
been used to study the insulin-receptor interaction in a number of
pathological states including diabetes (Archer et_ al. 1973). An uneven
distribution of the insulin receptors within the lymphocyte preparation
has been reported. Using methods which preferentially isolate T type
lymphocytes from peripheral blood, workers have found no evidence for
high affinity insulin binding COlefsky and Reaven 1976; Krug, U. et ad.
1972) suggesting that the receptor population resides only in the B type
lymphocytes. Schwartz and co-workers (1975) however, report that the
blood monocyte contaminant of the lymphocyte preparation (approx. 10% of
total cell number) are the insulin binding cells. Other receptor
populations which have been investigated include human peripheral
granulocytes (Fussganger et_ al_. 1976) , animal placental tissue (Posner
1974; Cuatrecasas and Hollenberg 1975) mouse mammary cells (O'Keefe and
Cuatrecasas 1974) and rat (Goldfine £t al. 1972) mouse (Soli et al. 1974)
and chicken (Simon 1979) thymocytes.
Negative Co-operativity. Original measurements of kinetic and equilibrium
constants of the insulin-receptor interaction resulted j_nconflicting
reports. Although some workers found a homogeneous population of
receptors (Kono and Barham 1971; Cuatrecasas 1971a,b; Gammeltoft and
Gliemann 1973; Gammeltoft 1977; Pollet et al. 1977) other groups have
reported a heterogenous population of receptor sites (Hammond et al.
1972; Gavin et al. 1973; Kahn e_t ad. 1974; Posner 1974; Olefsky 1975) .
The latter workers reported that Scatchard analysis (Scatchard 1949)
of the insulin binding data revealed curvilinear plots which indicated
the presence of two or more distinct populations of insulin receptors
having different affinities for the hormone. These curvilinear plots
are often interpreted as resulting from two different receptor populations,
one of high affinity but low capacity, and the other of low affinity and
high capacity; equilibrium or dissociation constants are frequently
cited for both. These plots have also been interpreted as resulting from
ligand-ligand interactions with insulin dimerisation at high concentrations
inducing rapid dissociation from the receptor (Cuatrecasas and Hollenberg
1975) .
De Meyts and coworkers suggested that site-site interactions between
receptors may account for the steady state binding data (De Meyts et al.
1973; 1976; 1978). Kinetic studies using monocytes, lymphocytes and
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liver membranes showed that the dissociation rate of bound insulin from
its receptor was dependent on the fractional hormone occupancy of the
sites. It was postulated that high levels of receptor occupancy induced
receptor-receptor interactions of a negative co-operative type leading
to enhanced dissociation rates of the insulin-receptor complex, thus
lowering the average binding affinity. Similar reports of possible
negative co-operative interactions have been reported for human granulocytes
(Fussganger et al_. 1976) and adipocytes (Olefsky and Chang 1978) .
The solubilised receptor has been reported to retain negative co-operative
interactions and also to dissociate in a reversible manner into subunits
when incubated with insulin (Ginsberg et_ al_. 1976, 1977). It was
proposed that this insulin induced dissociation of a tetrameric receptor
complex was a possible mechanism for negative co-operativity. Recent
reports by De Meyts and co-workers indicate that a certain invariable
region of the insulin molecule is responsible for the induction of
receptor site co-operativity (De Meyts et al_. 1978) .
As stated previously, nearly all experimental incubations were
carried out below physiological temperature (30°C and below) to reduce
the amount of hormone and receptor degradation. Gammeltoft and co-workers,
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when investigating the dissociation of I-insulin from isolated rat
hepatocytes noted enhanced rates in the presence of native hormone at
o o
12 C but not at the physiological temperature of 37 C (Gammeltoft et al.
o
1978). Studies at 37 C revealed only a single class of insulin receptors
free of negative co-operative interactions with very high affinity (K.d
-10
4.0 x 10 M) and about 15,000 sites per cell. These results claim a
5 fold higher affinity and approximately a 7 fold decrease in receptor
number compared with previous studies of rat hepatocytes, when incubations
were carried out at lower temperatures. Dissociation experiments carried
out at 37°C by Olefsky and Chang (1978) using rat adipocytes showed
enhanced dissociation rates when incubations also contained native
hormone. Therefore, although the solubilized insulin receptors from liver
and adipose tissue are reported to be almost identical, there may be more
detailed differences between the two when they are incorporated in their
native membranes.
Insulin Degradation. Early experimental reports indicated that degradation
of insulin by the liver took place via some mechanism independent of
hormone binding to the receptor-effector system (Freychet et al. 1972;
Gammeltoft and Gliemann 1973; Le Cam et ad. 1974). However recent
evidence suggests that degradation of insulin by hepatocytes or adipocytes
requires prior association with receptor sites (Terris and Steiner 1975,
1975; Gliemann and Sonne 1978; Terris et al. 1979). It was found that
the degradation rate of insulin was dependent on the amount of insulin
bound to receptor at the steady state and unlike the earlier reports,
specificities of binding and degradation were the same. Prebinding of
insulin to receptor also increased the degradation rates. Since low
o
temperatures (below 20 C) and plant lectins or antimicrotubular agents
inhibit insulin degradation, Steiner and co-workers suggested that
certain populations of the insulin-receptor complex first aggregate on
the cell surface before being taken into the cell by absorptive pinocytosis
(Silverstein et al. 1977) followed by intralysosomal degradation
(Terris et al. 1979).
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I-insulin bound to rat adipocytes is rapidly altered or transferred
to some compartment less accessible to the external medium (Kahn and
Baird 1978). Autoradiographic analyses indicate a time and temperature
dependent incorporation of insulin into the intracellular environment of
human cultured lymphocytes (Goldfine et ad. 1978) or rat hepatocytes
(Gorden et al. 1978). Since impermeant sulphydryl blocking agents also
inhibit degradation and pinocytosis it is thought that an early degradative
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step takes place on the cell surface (Terris et_ al_. 1979) . This early
degradation may be the splitting of insulin into A and B chains by
glutathione-insulin transhydrogenase (Varandi et al_. 1972) which is found
in a few external microvillous projections of the hepatocyte (Varandi
et al. 1978). This may explain the two forms of the receptor previously
reported by others (Gliemann 1976; Krupp and Livingston 1978; Olefsky
and Chang 1978). Internalisation of the insulin-receptor complex gives
support to the finding of specific intracellular binding sites for this
hormone (Harvat et al. 1975; Forgue and Freychet 1975; Kahn 1976;
Goldfine and Smith 1976; Goldfine et. ad. 1977; Bergeron £t a^. 1977);
this intracellular bound insulin or some degradative product may be
responsible for initiating the intracellular effects associated with
this hormone.
Two mechanisms for insulin binding and action have been suggested
(as summarised by Steiner 1977); the 'receptor transducer' model in which
bound insulin remains in the extracellular environment and acts via the
production of some intracellular second messenger which influences
protein kinase or protein phosphatase activities, or the 'receptor
transducer internaliser' model which allows insulin bound to receptor
to enter the cell exposing it to the intracellular degrading system which
releases insulin or insulin fragments to regulate various metabolic
parameters. Although increasing evidence suggests insulin is internalised and
degraded, this process may be independent from the effector system;
in this case a second messenger must again be postulated. The second
model would also explain the phenomenon of down regulation of receptor
number by insulin (Gavin et al. 1974) as is also found for glucagon
(Soman and Felig 1978), growth hormone (Lesniack and Roth 1976) and
epidermal growth factor (Das and Fox 1978).
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The Glucagon Receptor
Rodbell and co-workers (1971a) indicated that glucagon bound
specifically to rat liver plasma membranes in a concentration range
identical to that observed for activation of adenylate cyclase.
Bataille et ad. (1974) also noted a close similarity between binding and
activation. Birnbaumer and Pohl (1973) however found maximum hormonal
effect on adenylate cyclase when only 10 to 20% of the receptors were
occupied and likewise Rosselin et al. (1974) and Sonne et al. (1978)
found full activation of the cyclase at low receptor occupancy.
The elucidation of the mode of action of the hormone was further
complicated by the discovery that physiological concentrations of
guanine nucleotides, particularly GTP, can influence both hormone
binding to receptor and hormone activation of adenylate cyclase in liver
membrane preparations and therefore may possibly have some regulatory
function on glucagonic responses (Rodbell 1971b,c; Lad etval. 1977;
Rendell et al_. 1977; Wei ton et al. 1977; Yamamura et al_. 1977) .
Using isolated rat liver membpane preparations major discrepancies were
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reported between the observed binding of I-glucagon and glucagon
stimulated cyclase activity in the presence of added GTP. The guanine
nucleotide decreased the apparent affinity of the receptor for the hormone
due to an increased dissociation rate of glucagon from receptor (Rodbell
et al. 1971b). However despite this decrease in affinity of the receptor,
GTP increases the affinity of glucagon for adenylate cyclase stimulation
and the apparent ED for glucagon action is decreased by approximately
50
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10 fold (values ranging from 2 x 10 M to 7 x 10 M were reduced to
values of 2.0 x 10 "*"°M to 5 x 10 "^M, Rodbell et al. (1974)) . The
increased dissociation rate of glucagon from its receptor was not related
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to cyclase activation. The kinetics of binding of I-glucagon to
receptor showed that the steady state is reached more slowly than would
be expected from the induction of hormone action (Rodbell et al. 1974)
indicating that some complex interaction between hormone receptor,
adenylate cyclase and GTP was necessary to explain the observed effects.
The binding site for GTP is distinct from the glucagon binding site
and is thought to have an allosteric action on the system (Rodbell et al.
1971b,c). Some evidence has been put forward for the possibility of
two distinct guanine nucleotide sites; one for regulation of receptor
binding and the other for cyclase activation (Lad et al. 1977).
Welton and co-workers (1977) have shown that solubilisation of liver
membrane preparations yields distinct receptor and cyclase populations
each having GTP regulatory sites. Another suggestion is that the
guanine nucleotide is required for coupling the receptor and cyclase
(Pecker and Hanoune 1977). The cyclase solubilised from pigeon erythrocytes
can be inactivated by dissociation into two protein fractions by GTP-
Sepharose affinity columns; only one protein retains the nucleotide
binding site (Pfeuffer 1977). Increasing evidence suggests that this
nucleotide binding protein regulates cyclase activation by both hormones
and fluoride (Rodbell 1978) . Work carried out on the solubilised
myocardial cyclase suggests that acid phospholipids play an important
role in coupling the receptor with catalytic units (Levey 1975;
Levey et al. 1975). It is not known if GTP has a role in this lipid
involvement although it has been shown that digestion of membranes with
phospholipase C (which cleaves acid phospholipids) abolishes the effect
of GTP on dissociation of glucagon and enhances cyclase activity (Rubaclava
and Rodbell 1973) . The system is further complicated by the discovery
of another GTP dependent site which in the presence of chelating or thiol
reducing agents inhibits cyclase activity without altering the stimulating
effects of GTP or hormones (Yamamura et al. 1977) .
61.
Glucagon Binding Sites
The majority of investigations into glucagon binding to its receptors
have been carried out using iodinated hormone as the tracer. Iodination
of the tyrosyl residues of glucagon produces two opposing biological
effects in the molecule. It has been reported that the covalent
insertion of an iodine atom increases the hydrophobic interaction of
the hormone with its receptor thus increasing the affinity, whereas the
lowered isoelectric point due to the inductive effect of the iodine atom
increases the proportion of ionised phenoxy groups, resulting in a
loss of binding capacity. Due to the heterogenous tracer population,
variations in pH can alter the overall biological affinity observed
(Rodbell et; al. 1976; Lin et_ al. 1976) , which will depend on the extent
of iodine incorporation into the hormone. A heterogenous tracer
population may also explain the anomalies between the kinetics of
r 3 n
binding and activation (Lin, MC et_ al_. 1977). When I-HJ-glucagon was
used in membrane preparations as the tracer it was possible to show
that only 90% of the receptor population had a reduced affinity in the
presence of GTP, with 10% remaining as high affinity receptors (Lin,MC
-9
et al. 1977). A sigmoidal affinity profile with K of 2 x 10 M was
changed into a complex binding curve composed of low and high affinity
sites in the presence of GTP. These high affinity receptors may be
responsible for the transmission of glucagon action with the low
affinity sites acting as spare receptors. Due to the low specific
activity of the tritiated hormone it was not possible to accurately
investigate the high affinity receptor.
Other workers have found variations in iodoglucagon affinity.
Bromer arid coworkers (1973) foundmonoiodoglucagon to be five times more
potent than native hormone and likewise, Desbuquois also noted an
increased ability of iodinated hormone to activate adenylate cyclase,
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and to a lesser extent, bind to receptor ( Desbuquois 1975, 1977).
A maximum adenylate cyclase stimulation of 5 fold was found with the
tetrasubstituted hormone and maximal increase in binding of 2 fold with
the trisubstituted. However Sonne et al. (1978), when using iodinated
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tracer preparations with 0.2 to 0.5 atoms of I per molecule of glucagon,
found no difference in the binding properties in isolated hepatocytes
at pH 6.5 or pH 7.4, indicating the tracer population behaved identically
irrespective of the percentage of ionisable tyrosines. Although similar
results were indicated at different pH's the tracer itself however may
not exhibit identical binding properties to the native hormone.
Sonne et al. (1978) found the receptor population to be a heterogenous
nature with both high affinity low capacity (K 7.0 x lO 20,000
-9
sites per cell) and low affinity high capacity (K, 13 x 10 M; 200,000d
sites per cell) components on Scatchard analysis. No evidence for
co-operativity between receptors was found although it was previously
reported that co-operative interactions may exist (Birnbaumer and Pohl
1973). Reports of glucagon-receptor affinity for rat liver membranes on
isolated hepatocytes are not as numerous as for insulin. Half-maximal
—9 —9
binding constants of 4 x lO M (Rodbell et_ aJL. 1971a) and 1.5 x 10 M
(Bataille et_ al. 1974) have been reported for rat liver membrane
-9
preparations and 3 x 10 M (Freychet et al. 1974) for rat hepatocytes.
Direct comparison with the values given by Sonne et al. are difficult
since the latter workers did not analyse the data for more than one
class of binding site. Freychet et al. (1974) reported a total of
110,000 binding sites per cell for glucagon but only around 11,000 need
be filled for half maximum activation of adenylate cyclase. Shaltz
and Marinetti (1972) using rat liver plasma membranes found two
relatively high dissociation constants of 1 x 10 "^M and 3 x 10
whereas Giorgio et al. (1974) reported that a purified Lubrol PX
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extract of liver membrane receptor had a high affinity for glucagon with
K, of 1 x 10 ^°M.
d
Although most workers report similar kinetic parameters the
conditions under which the various experiments were carried out must
be considered before valid comparisons can be made of the quantitative
results. In particular, variations in the specific radioactivities of
the tracer hormones makes detailed comparisons difficult.
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Reports on degradation of I-glucagon by the liver are relatively
scarce. Although liver membranes rapidly degrade glucagon (Rodbell
et al. 1971a) the inactivation of the hormone is thought to take place
at a site independent of adenylate cyclase activation (Pohl et al_. 1972) .
Desbuquois et al_. (1974) have shown that inhibitors of glucagon degradation
such as bacitracin can increase hormone binding by up to 80% and also
increase the apparent affinity for adenylate cyclase activation,again
suggesting independent sites for action and degradation. Since the liver
is considered to be the major site of glucagon clearance from the blood
(Buchanan et al. 1968) it has been suggested that the plasma membrane
fraction accounts for the most of this due to high rates of degradation
(Pohl et al. 1972). However, recent work using kidney membranes showed
that glucagon degrading activity per mg protein was 20-fold higher than
found in liver membranes, with an affinity of the degrading system
""6
(K 2.4 x 10 M) similar to that found for the liver (Duckworth 1978).
m
Therefore the extent the liver plays in glucagon degradation, and the
mechanism by which this is carried out, require more investigation.
Allowing for the observations reported on glucagon binding and
stimulation of adenylate cyclase with the requirements for GTP, and also
the poor evidence for the method of degradation, it is very difficult to
propose a model system which will allow for all possible modes of action
of the hormone. However various models have been proposed by some
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investigators to explain hormone binding and also activation of adenylate
cyclase with some models incorporating a role for GTP or analogues
(Rodbell 1973; Bennet et al_. 1975; Helmreich et; al. 1976; Cuatrecasas
and Hollenberg 1976; Rodbell 1978).
The APP Receptor
Investigations into the receptor binding properties of APP have been
confined to isolated chicken adipocytes (McCumbee and Hazelwood 1977).
The iodinated hormone was found to bind specifically to two classes of
-9
receptor site; a high affinity low capacity site (K = 5.6 x 10 M;
d
40,000 sites per cell) and a low affinity high capacity site (K^ =
-7
8.3 x 10 M; 190,000 sites per cell). Neither insulin nor glucagon
competed for the APP binding site. There have been no reports on APP
binding to chicken hepatocytes or chicken liver plasma membranes.
It is known that high intravenous concentrations of APP cause depletion
of liver glycogen and a decrease in plasma glycerol (Hazelwood et al.
1973). It is not yet known if these metabolic disturbances are due to a
direct effect of APP at the hepatic level or if indeed they are secondary
to another major effect of the hormone.
Experimental Approach
The binding of iodinated insulin, glucagon and APP to the chicken
hepatocyte preparation described in Chapter 3 was investigated.
Concomitantly, studies were performed of the metabolic effects of these
hormones; these are described in Chapters 5-6.
Method
Experimental Incubations. Cell suspensions were prepared using
either batch 17 or 25 collagenase. No significant variations in hormone
sensitivity were found in cells isolated using either collagenase batch,
therefore all results were used to calculate average affinity values.
Unless otherwise indicated all binding experiments using labelled insulin,
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glucagon or APP, were carried out using cell concentrations less than
10 x 106 cells/ml. Concentrated cell suspension was added to 1 ml
gassed KRB buffer containing tracer in 25 x 75mm plastic incubation pots.
The pots were then gassed with 95% 02/5% CO^ for approximately 20 seconds,
lids sealed ,and incubated for the desired time in a reciprocal shaking
water bath (120-140 strokes/min) at room temperature (22°C). A sample
of cell suspension (1 ml) was then removed and cells pelleted by
centrifugation in a Beckman microfuge B (10,000 rpm 7000 g) for 1 minute.
The supernatant was aspirated and 1 ml of ice cold KRB buffer added to
the tube without resuspension of the pellet. The tube was then recentri-
fuged as above for 30 seconds, supernatant aspirated and the tube allowed
to drain. The tip of the tube containing the cell pellet was excised
and radioactivity determined on a Tracerlab gamma counter.
Porcine insulin and glucagon and chicken pancreatic polypeptide




a) Tracer viability. Monocomponent porcine insulin was iodinated with
125
I by the chloramine-T method as described in Chapter 3. The quality
of the tracer was assessed by radioimmunoassay, paper chromato-
electrophoresis, TCA and PCA precipitability, binding to talc and
cellulose (for details of procedures and results see Chapter 3).
The cellulose column purification procedure removed all unreacted iodide
125
and nearly all damaged protein. However a large fraction of I-insulin
which was considered viable under conditions of chromatoelectrophoresis
and by binding to talc, did not adsorb to the column and was washed through
with the unwanted reaction products. Fig. 4.1 shows a typical paper
chromatographic separation of the reaction products before and after
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Fig. 4.1. Paper chromatoelectrophoretic pattern of iodinated insulin
from A. the iodination mixture, B. the 24% BSA eluate from cellulose
column and C. initial wash from cellulose column.
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the biological activity of the tracer since insulin was found to have
no metabolic effect on the chicken hepatocytes (see Chapters 5 and 6).
125 125
b) Time course of I-insulin binding. I-insulin (0.35 ng/ml) was
0
incubated with cell suspension (9.7 x 10 cells/ml) for various times
o o o
at either 10 C, 22 C or 40 C. Another series of pots containing tracer
plus 100 p.g/ml native insulin were also incubated under similar conditions
to estimate counts nonspecifically bound. Specific binding of tracer
was determined by subtraction of the counts bound in the presence of
the high native hormone concentration. The time course for specific
125
I-insulin binding is shown in Fig. 4.2. As expected binding was
much faster at 40°C, reaching a maximum at around 20 minutes. Total
binding at this temperature, however, only reached approximately 60%
of that at lower temperatures. The steady state binding level at 40°C
125
was also unstable and with prolonged incubations the binding of I-
insulin rapidly decreased. Although the binding rate was quicker at 22°c
than at 10°C, maximal binding was approximately the same and remained
relatively constant for 2 hours incubation. Cell suspensions were
regassed with 0^/C0^ after 60 minutes of incubation at these temperatures.
125
I-insulin binding therefore appears to reach a steady state after
45 minutes incubation at 22°C. Addition of small amounts of cold hormone
(2 ng/ml) or decreasing the cell suspension concentration to 5 x 10^
cells/ml did not markedly effect the rate of binding at 22°c. Binding
capacity was found to be linearly proportional to cell concentration
£
at least up to 14.0 x 10 cells/ml. Addition of glucagon or APP at
125
500 ng/ml did not effect the steady state binding level of I-insulin.
c) Effect of preincubation of cell suspension. Cell suspensions (10 to
12 x 106 cells/ml) after gassing with O^/CO^ were preincubated at 22°C,
32°C or 38°C for various periods of time before adding ~^^I-insulin








Fig. 4.2 Binding of I-insulin (0.35 ng/ml) to cells incubated at








Fig. 4.3 Effect of preincubation of cell suspensio25°C (□-□),
32 c (A-A) and 38 C (O-O) on subsequent binding of I-insulin
(0.35 ng/ml) at 22°c.
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Determination of specifically bound tracer was achieved by running
parallel incubations containing 10 jig/ml native hormone. Tracer binding
is shown in Fig. 4.3. Preincubation at higher temperatures results in
125
a progressive decrease in the amount of I-insulin bound. This does
not correlate with a decrease in cell number nor an increase in trypan
blue staining with time (see Chapter 3). After 2 hours incubation at
o o
38 C up to half the insulin binding capacity is lost whereas at 22 C
less than 20% of the insulin binding is affected after this time. After
incubation for 45 minutes at 22°c (the time used to attain steady state
binding) only approximately 10% of the binding capacity is lost.
125
d) Binding affinity. I-insulin (0.4 ng/ml) plus varying amounts of
native insulin (0.78 to 10,000 ng/ml) were incubated with cell suspension
(2.0 to 3.0 x 106 cells/ml) at 22°C for 45 minutes. Binding was assessed
by centrifugation as before, with radioactivity still bound in the presence
of 1 to 5 fig/ml native hormone taken to be non-specific binding.
Specifically bound hormone and free hormone was calculated and data
processed for Scatchard plot analysis (Scatchard 1949). Fig. 4.4
shows a typical curvilinear plot indicating the existance of more than
one class of binding site or negative co-operative interactions between
sites. The data were analysed as if they resulted from two distinct
classes of receptor. The linear portions of the extremities of the
plot were extrapolated to the axes and the binding contamination of the
high affinity sites by the low affinity sites was determined and
subtracted (see Fig. 4.4). The corrected data for the high affinity
component were replottea (Fig. 4.5) and the best straight line drawn
with weighting to the points of low receptor occupancy. Four individual
binding experiments were carried out using different cell preparations.
The results from these experiments are given in Table 4.1 with both
binding affinities and number of sites per cell reported. The high
2 > 4 S
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Fig. 4.4 Scatchard plot of specific insulin binding to cells.
Fig. 4.5 Scatchard replot of high affinity insulin binding sites
after subtraction of low affinity values.
Table 4.1: Insulin Binding - calculated affinity constants and binding
capacities from Scatchard analyses.

































Average = 3.0O x 10 -0,96 x 10 M (SD; n=4
Average binding capacity = 2178-816 (SD; n=4).
Low affinity site
-7+ -7
Average K, = 1.95 x 10 -1.40 x 10 M(SD; n=4)d
Average binding capacity = 713,000-180,000 (SD; n=4).
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affinity binding sites showed an averaged dissociation constant (KaV")
d
of 3.0O x 10 - 0.96 x 10 (S.D.) with approximately 2,000 receptor
sites per cell. The low affinity sites were much more variable with K
d
-7 -7
ranging from 0.3 x 10 M to 3.6 x 10 M and approximately 700,000
receptor sites per cell.
125
e) Dissociation of I-insulin from hepatocytes. Cell suspension
6 12 5
(5.0 to 8.0 x 10 cells/ml) was incubated with I-insulin (0.35 ng/ml)
o
for 45 minutes at 22 C. Cells were then pelleted at 60 g for 2 minutes
and resuspended to the same volume in fresh KRB buffer. Aliquots of
resuspended cell suspension were diluted ten fold with KRB buffer or
KRB buffer containing 1.0 pg/ml native insulin and further incubated for
various times at one of four temperatures - 10°C, 22°C, 30°C or 40°C.
After preset times,aliquots (1 ml) of suspension were removed and cell
bound radioactivity determined as before. Parallel initial incubations
were carried out in the presence of native insulin (5 pg/ml) to estimate
the extent of nonspecific binding. The results were all corrected and
reported as specific insulin binding. The rate of dissociation of
labelled insulin from hepatocytes was dependent on temperature (Fig. 4.6).
The presence of added native insulin to incubations after dilution
increased the dissociation rate at all temperatures used . The dissociation
rates in the presence or absence of native insulin were not linear
with the time and semi-logarithmic plots were also non-linear (Fig. 4.7).
125 125
f) I-insulin degradation by hepatocytes. I-insulin (0.5 ng/ml)
6 o
was added to cell suspension (9.0 x 10 cells/ml) and incubated at 37 c
for various times before the addition of an equal volume of ice cold
10% TCA. Samples were shaken, left at room temperature for 30 minutes
to allow maximum precipitation of protein and then centrifuged (2750 g;
1 minute). A sample of the supernatant was removed to determine the
amount of non-protein radioactivity remaining in the supernatant.
TIME (minltes)
Fig. 4.6 Dissociation of bound ^"^I-insulin from cells at A. 10°C,
B~! 22°c, c. 30°C or D. 40 C in the absence (0-0) and presence ( □-□ )





Pig. 4.7 Semi-logarithmic plot of I-insulin dissociation from cells
incubated at 22 C in the absence (0-0) and presence (□-□) of unlabelled
insulin (1 fig/ml) .
25 "I
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Time (minutes)
125
Fig. 4.3 Degradation of I-insulin in cell suspensions incubated at
37 C in the absence (0-0) and presence (□-□) of bacitracin (0.75 mg/ml) .
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Fig. 4.8 shows the increase in radioactivity in the supernatant with
time. Zero time soluble radioactivity (approximately 2 to 3% of total)
was subtracted from all other results obtained. Incubations containing
125
0.75 rag/ml bacitracin had an inhibitory effect on I-insulin degradation
but did not prevent degradation completely. The effect of cell
concentration on insulin degradation at 22°C is shown in Table 4.2.
Only very low levels of TCA soluble radioactivity are present after
45 minutes even with cell concentrations above 20 x 10 cells/ml.
"*"^^I-Glucagon-Receptor Interactions
a) Viability of tracer. For details of iodination and other aspects of
tracer preparation and viability see Chapter 3. Cellulose column
purification increased the proportion of viable iodinated hormone in
the sample. Results of typical chromatoelectrcphoretic patterns of
iodinated tracer solution before and after cellulose or urea-DEAE
125
column purification are shown in Figs. 4.9 and 4.10. In all I-glucagon
preparations purified by cellulose chromatography, 5 to 15% of the
total radioactivity of the tracer was not present as viable glucagon;
125
this was taken into consideration when calculating results. I-glucagon
purified by urea-DEAE cellulose column was not used in binding experiments.
125
The biological activity of I-glucagon was also examined.
Isolated chicken hepatocytes are very sensitive to glucagon with very low
concentrations inducing marked glycogenolysis (see Chapter 6).
125
The extent of induced glycogenolysis by various dilutions of I-glucagon
was compared to a standard dose response curve for native glucagon
125
(Fig. 4.11). Doubling the amount of I-glucagon added resulted in a
125
larger stimulation of glycogenolysis than was expected. i-glucagon
always showed an increased sensitivity over native glucagon. From the
results obtained in the glycogenolysis experiments the relative potencies
125
of I-glucagon and native glucagon were determined with the former
being approximately 150% as active as the latter.
Table 4.2: Effect of cell concentration on insulin degradation over
45 minutes at 22°C.
Cell concentration Percentage TCA
£







1 2 3 4 3 « 7 • 0 10 11 12 13 14 15 It 17 1» 1* 20
STRIP NUMBER
Fig. 4.9 Paper chromatoelectrophoretic pattern of I-glucagon from,
A. cellulose column purification; B. original iodination mixture.
100-1
STRIP NUMBER
Fig. 4.10 Paper chromatoelectrophoretic pattern of I-glucagon from,
A. original iodination mixture; B. urea-DEAE column purification
procedure.
[G Lie AGO\] ng/ml
Fig. 4.11 Glucagon dose respoj^g curve to cellular glucose release.
Unlj^glled glucagon (0-0) and I-glucagon (•) stimulated. Volumes




b) Time course of I-qlucaqon binding. Cell suspension (8.0 x 10
125
cells/ml) containing i-glucagon (0.22 ng/ml) was incubated at 22 C
for various times. Aliquots (1 ml) were then removed and radioactivity
bound to cells determined by centrifugation as in the insulin studies
(Fig. 4.12). Incubations were also carried out with native hormone at
10 yg/ml. Counts still bound in the presence of 10 yg/ml native glucagon
were taken to represent non-specific binding. At 22°C glucagon binding
reached a steady state equilibrium after 20 minutes. All future
incubations were carried out for 30 minutes to ensure steady state
binding. Addition of small amounts of native hormone or decreasing cell
concentration by half did not have a marked effect on the binding rate;
binding was proportional to the cell number. High concentrations of




c) Binding affinity. Cell suspensions (3.0 x 10 cells/ml and below)
were incubated for 30 minutes in the presence of tracer (0.2 ng/ml) with
native hormone at a range of concentrations (0.4 to 10,000 ng/ml). Dose
response binding curves showed a high proportion of low affinity specific
sites. High concentrations of native hormone (10 to 20 yg/ml) were
needed to successfully reduce tracer binding by 80 to 90% (Fig. 4.13) .
Radioactivity bound to cells in the presence of 10 yg/ml native hormone
was considered non-specific although increasing the native hormone
concentration to 20 yg/ml consistently removed another 3 to 5% of the
bound radioactivity. Scatchard plots again revealed more than one class
of binding site, but the analysis of the data was very difficult due to
the high levels of low affinity sites (Fig. 4.14). Like that of insulin,
the results were processed as if resulting from two classes of sites.
Extrapolation and subtraction of the high values for the low affinity
component from the values for the high affinity component unavoidably
TIME ( m i antes]
125
Fig. 4.12 Time course of I-glucagon (0.22 ng/ml) binding in the
absence (•-•) and the presence (■-■) of unlabelled glucagon (10 yg/ml) .
[ (. I. I ( \ (i O N ] jig/ml
125
Fig . 4.13 Reduction in I-glucagon (0.2 ng/ir.1) bound to cells
increasing unlabelled glucagon. B-radioactivity bound
B - radioactivity bound on the absence of unlabelled glucagon.
•( GLUCAGON BOl'SO
PK (.LIC\(iON BOl ND
Fig. 4.15 Scatchard replot of high affinity binding to cells.
Low affinity component subtracted from all high affinity values.
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resulted in large errors. Fig. 4.15 shows a Scatchard plot of the
recalculated high affinity values for one experiment. Affinity constants
and number of binding sites were determined for the high affinity sites
only,by using the values found for the slope and intercept of the
replotted data and are given in Table 4.3. Values for the low affinity
site proved difficult to estimate but generally resulted in a K^ of
4 x 10 or higher and around 1,500,000 sites/cell. The average
av -9 + -9
affinity of the glucagon receptor was calculated K^ 9.4 x lO - 3.1 x 10 M
(SD - five observations) and the number of binding sites found to be in
the order of 13,000 sites per cell. ,
125 125
d) I-glucagon dissociation. I-glucagon (0.2 ng/ml) was preincubated
with cell suspension (3.5 x 10^ cells/ml) for 30 minutes at 22°C. Cells
were pelleted by centrifugation (60 g: 2 min) and resuspended to the
original volume with fresh KRB buffer. The suspension was diluted ten
fold with KRB buffer or KRB buffer containing 2 )ig/ml native glucagon and
o
incubated for the times indicated at 37 c (Fig. 4.16). Only 50% of the
125
total I-glucagon bound was released after incubations for up to
90 minutes in duration with the majority of the tracer (approx. 40%) having
dissociated within the first 20 minutes. The presence of native glucagon
decreased the amount bound by approximately another 10% after 90 minutes
but did not increase the initial rate of dissociation. Semi-logarithmic
plots of the dissociation figures still were non-linear (Fig. 4.17).
125
e) I-glucagon degradation. Degradation was again judged by the
appearance of radioactivity in a TCA precipitated cell supernatant fraction.
Soluble counts at zero time (10% of total or less) have been subtracted
from all results. The effect of cell concentration on degradation of
tracer at 22°C and 37°c is shown in Fig. 4.18. At 22°C, concentrations of
3.0 x 10 cells per ml or below show the same proportion of tracer degradation
rate after 30 minutes incubation. Higher cell concentrations show
Table 4.3: Glucagon Binding - calculated affinity constants and binding

























Average = 9.4 x 10 -3.1 x 10 M (SD; n=5).











Fig. 4.15 Dissociation of bound I-glucagon from cells incubated in
the absence (0-0) or presence (□-□) of unlabelled glucagon (2 ]ig/nl) .
30 (0 *0
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125
Fig. 4.17 Semi-logarithmic plot of dissociation of bound I-glucagon
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Fig. 4.18 Effect of cell suspension concentration on the degradation
of i:^I-glucagon (0.2 ng/ml) after 30 minutes incubation at 37°C (0-0)
or 22 C (□-□).
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substantial increases in degradation especially at 37°C where a hyperbolic
relationship exists between cell concentration and fraction of hormone
degraded. The degradation rate of ^"'i-glucagon at 37°c was found to
vary considerably between individual cell preparations with degradation
rates of up to half that plotted in Fig. 4.18 being found. Bacitracin
125
(0.75 mg/ml) only slightly inhibited the degradation of I-glucagon
o
at 37 C (Fig. 4.19). At the low cell concentration and temperature
used for steady state binding studies the degradation of tracer is
approximately linear up to 1 hour with loss of only 2-3% of the tracer
in 30 minutes (Fig. 4.20).
125
I-APP-Receptor interactions
a) Tracer viability. As with insulin there was no biological assay
available to determine the viability of the iodinated hormone. Unlike
insulin however there was also no antibody to APP available to test the
immunological properties of the labelled hormone. The methods used to
estimate viability and the values obtained for acid precipitability and
binding to talc are given in Chapter 3. The chromatoelectrophoretic
pattern of iodinated products before and after gel column purification
are shown in Fig. 4.21.
125 125
b) Time course of I-APP binding. I-APP (0.5 ng/ml) was incubated
with cell suspension (6.0 x 10^ cells/ml) at 22°C for various times.
Radioactive bound tracer was determined as before. A parallel incubation
containing 2 pg/ml native APP was also carried out to estimate nonspecific
binding (Fig. 4.22). Binding of tracer reached a steady state after
40 minutes incubation. The high native APP concentration; although
successfully depressing the steady state binding by more than 50% failed
to completely inhibit specific binding.
125
c) Binding affinity. I-APP (0.5 ng/ml) and native hormone at various
concentrations (1.28 tolO,000 ng/ml) were incubated with cell suspension
TIME (minutts)
125
Fig. 4.19^, Degradation of I-glucagon (0.2 nn/ml) in cell suspension
(2.6 x 10 cells/ml) incubated at 37 C in the absence (•-•) or presence
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Fig. 4.20 Top - I-glucagon degradation rate at low concentration
of cell, suspension (less than 5 x 10 cells/ml) incubated at 22 C.




Fig. 4.21 Chromatoelectrophoretic pattern of I-APP.
A. sample of the iodination mixture. B. sample after




Fig. ^.22^_ Time course of I-APP ^0.5 ng/ml) binding to cell suspension
(6.0 x 10 cells/ml) incubated at 22 C in the absence (0-0) or presence
(□-□) of unlabelled APP (2 yg/ml) .
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(6.0 to 8.0 x 106 cells/ml) for 40 minutes at 22°C. The amount of radio¬
activity bound after incubation was determined by centrifugation. Counts
remaining bound in the presence of 10 jug/ml native hormone was taken as
nonspecific binding and data interpreted by Scatchard plot analysis.
Scatchard plots of the data resulted in only one class of binding site
(Fig. 4.23). Processing of the data revealed a very low affinity high
capacity binding site with K of approximately 2 x 10 with nearly
300,000 sites per cell.
125 125
d) Degradation of I-APP. Degradation of I-APP was estimated by
125 125
acid precipitation, using the same method as with I-insulin and I-
glucagon. A low rate of appearance of TCA soluble radioactivity indicated
a slow rate of APP degradation. Even at 37°C and at relatively high
cell concentrations (up to 16.0 x 10 cells/ml) less than 5% of the
total radioactivity was found in an acid soluble extract of suspension
after incubation for 40 minutes (Fig. 4.24).
Discussion
Before attempting to correlate the binding results obtained using
the three hormones, insulin, glucagon and APP, and comparing them with
the findings of other workers using chicken and rat hepatocytes it must
first be noted that all results obtained depend on the individual
characteristics of the iodinated hormones. Several workers have succeeded
in isolating the monoiodo-derivatives of insulin and glucagon from
iodination mixtures by DEAE cellulose or DEAE sephadex chromatography
(Freychet et al. 1971; Nottey and Rosselin 1971; Sodoyez et_ al_. 1975)
thus at least ensuring a homogeneous tracer population as well as a high
specific activity. Mono-iodoinsulin has been reported to have almost
identical biological activity to that of the native hormone (Bihler and
Morris 1972; Hamlin and Arquilla 1974; Sodoyez et a]^. 1975) whereas
mono-iodoglucagon has an enhanced binding affinity as well as enhanced
2-
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Fig. 4.23 Scatchard plot of APP binding to cells.
Fig. 4.24 Effect of cell concentration on the degradation of I-AP?
in suspensions incubated for 40 minutes at 37 C.
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biological potency (Desbuquois 1975). Assessing the biological potency
of the hormone as a guide to tracer viability may not give an accurate
assessment of binding affinity. Desbuquois (1975) has shown that when
using multi-iodinated derivates of glucagon,binding characteristics and
adenylate
potency of activating^cyclase are not directly proportional.
Although very few studies of APP have been made it has been found
125
that a I-APP preparation with iodide to protein ratios of 1.5 to 1
still retains biological activity in chicken adipocytes, although potency
is lower than that of the native hormone (McCumbee and Hazelwood 1977).
125
Therefore when calculating binding affinities using I-labelled
hormones it must be accepted that the values obtained for the dissociation
constants and rate constants etc., will only be as accurate as the tracer
allows. Because of this and due to the relatively large experimental
errors that accompany these type of radioactive experiments the binding
affinities obtained by mathematical treatment of the experimental results
given in this Chapter may only be accurate to within one order of magnitude.
However this may be sufficient for interesting comparisons to be made
with results obtained by other workers using rat and chicken hepatocytes.
Insulin Binding
Freychet and coworkers (Simon et al_. 1977a)recently reported that
there was a lower number of insulin receptor sites per cell, and indeed
per unit surface area of plasma membrane, in chicken hepatocytes than
in rat hepatocytes. Chicken hepatocytes isolated by the method of
Capuzzi et ad. (.1974) and chicken liver plasma membranes isolated by
the method of Neville (1958) showed half maximum binding constants of
-9 -9
1.3 x 10 M and 3.2 x 10 M respectively. This compares well with values
-9
obtained for rat hepatocytes and liver membranes of 2.0 x 10 M and
-9
3.0 x 10 M respectively, derived from experiments carried out under the
same conditions by the same group of workers (Freychet et ad. 1974).
75 .
Values found in the present work were of the order of 3 x 10 ^°M.
Gammeltoft et al. (1978) however,also found that the receptor on rat
hepatocytes had a higher affinity than that reported by Freychet's
group, steady state binding experiments giving dissociation constants of
-10
4-5 x 10 M.
There appears to be a great deal of variation between individual
workers on reported affinity constants for insulin binding to receptor.
Affinity values have been reported which vary over three orders of
—11 —8
magnitude with 'K' ranging from 5 x 10 M to 8 x 10 M. The maind
discrepancy seems to lie not with the individual tracer preparation or
receptor preparation or even variations in the experimental details such
as incubation temperatures, but in how individual workers interpret the
data obtained. Many investigators report figures that give half maximum
inhibition of tracer binding even although it is sometimes apparent that
a heterogenous population of receptor sites exists. The figures
derived by this method will obviously be dependent on the proportion of
the low affinity component as well as that of the high affinity component
and therefore intermediate binding constants are found. Examples of
this type of interpretation for rat hepatocytes include work by Freychet
-9
et al. (1974) and Freychet (1976) who report a of 2 x 10 M, Terris
—9 —9
and Steiner (1975) 3.5 x 10 M, Olefsky et ad. (1975) 4 x 10 M and
-9
also, for chicken hepatocytes, by Simon et al. (1977a)1.3 x 10 M.
Similar results are obtained when purified plasma membrane fractions are
used as the receptor preparation. Reports of half maximal inhibition
-9
constants for rat liver membranes of 3.0 x 10 M (Freychet 1974) and
-9
chicken liver membranes of 3.2 x 10 M (Simon £t a^. 1977a)have been
reported. However when binding data are analysed for the presence of
two or even three individual binding components much lower dissociation
constants are recorded for the higher affinity site. Reports of steady
state binding data analysed into separate components show high affinity
-10
dissociation constants, with of 4 x 10 M for rat hepatocytes
(Gamine 1 to ft et_ ah. 1978) and 5.0 x 10 for rat liver membranes (Kahn
et ah. 1974). Values obtained for insulin binding to chicken hepatocytes
as given in this work compare well with those of Gammeltoft et al. and
av -10
Kahn et al. with of 3.0 x 10 M.
Although there may be some discrepancy in the interpretation of
affinity values for insulin binding it appears that the receptors affinity
for the chicken liver insulin receptor is approximately the same as that
found in rat liver whether the data are treated as arising from single
or multicomponent sites. Half maximal binding constants although
reporting a much lower overall affinity also indicate that a similar
receptor population exists in rat and chicken liver (Simon et al. 1977a,b)
Reported binding capacities for the hormone are also dependent on
the treatment of the data, as well as temperature of incubation. In
general, low incubation temperatures result in higher binding capacities.
Results which have been analysed with respect to two classes of sites
yield binding capacities for rat hepatocytes of about 15,000 sites per
cell (Gammeltoft et al. 1978) and for rat liver membranes of 4 x lO^"0
sites per mg protein (Kahn et ad. 1974). Analyses in terms of a single
class of sites result in higher capacities being reported, with rat liver
having 80 to 90 x 103 sites per cell or around 160 x 10^° sites per mg
protein (Freychet et al. 1974; Freychet 1976) and chicken liver
4.6 x 103 sites per cell or 30 x lO"'"0 sites per mg protein (Simon et al.
1977ai Values found in the present study for chicken hepatocytes by
analysis of two individual sites indicate a binding capacity of the
higher affinity component of about x 10 sites per cell. This figure
is ten times lower than that reported by Gammeltoft and coworkers for
rat hepatocytes. If it is assumed that the rat and chicken hepatocytes
77.
are spherical with diameters of 24 pm and 12 pm respectively it can be
calculated that there is approximately a 2 to 3 fold decrease in receptor
density on the surface of the chicken hepatocytes compared to that of the
rat. Simon et al. (1977a)report a twenty fold difference in binding
capacity per cell between chicken and rat hepatocytes indicating an
approximate 5 fold decrease in receptor sites per unit surface area of
plasma membrane. Although the quantitative results of affinity and
receptor number reported vary considerably depending on the type of
mathematical treatment, the qualitative results between chicken and rat
hepatocytes are nearly identical. Ratios of receptor number between
chicken and rat liver membranes also appear reasonably similar no matter
which analysis is used. It must be added that direct comparison of
work in this respect to that of Gammeltoft must allow for the differences
in incubation temperature used (22°C compared to 37°C respectively)
thus slightly higher binding capacities will be reported for this work.
It therefore appears that the chicken liver insulin receptor has
approximately the same binding affinity as that found in rat liver but
the receptor number per unit area of the plasma membrane may be decreased
by 2 to 5 fold. Since chicken insulin has been reported to be about
twice as potent as mammalian insulins (Simon et al. 1977b) this apparent
decrease in receptor site number could well be counteracted by the
increased binding affinity of the chicken insulin.
2) Insulin-receptor dissociation
125
Dissociation rates of I-insulin from receptor were shown to be
non-linear (Figs. 4.6-4.7 ) indicating that the rate of dissociation from
receptors is not first order with respect to receptor occupancy. The slow
125
dissociation rate of a fraction of receptor bound I-insulin may be due
to site heterogeneity with the higher affinity sites releasing insulin at
a far slower rate (Gavin et al. 1973; Kahn et al. 1974); alternatively,
certain insulin-receptor complexes may eventually lead to insulin
78.
degradation (Terris and Steiner 1975; Gammeltoft et ad. 1978; Gliemann
and Sonne 1978) having different dissociation characteristics.
3) Glucagon Binding
The dissociation constant determined for the high affinity binding
125 av + -9
component of I-glucagon (K^ of 9.4 - 3.1 x 10 M) was 30 fold that
found for insulin, indicating a relatively lower affinity receptor for
this hormone. This value correlates well with reports of half maximal
-9 -9
binding constants of 4 x 10 M (Rodbell et al_. 1971a) and about 1.5 x 10 M
-9
(Bataille et al. 1973; 1974) for rat liver membranes and 3 x 10 M
(Freychet et al. 1974) for rat hepatocytes. Simon et al.(1977a)reported
125
binding curves for I-glucagon binding to chicken liver membranes and
although no figures were given it was concluded that specific glucagon
binding sites were less numerous in chicken membranes than in rat at low
glucagon concentrations (5 ng/ml) but more numerous at high concentrations
(lOO ng/ml). Sonne et ad. (1978), treating the binding data in terms of
two classes of receptor site, found the high affinity component of rat
liver membranes to have a K of 7.0 x 10 10M and a capacity of approximatelyd
20,000 sites per cell. The method of calculation of data is directly
comparable with that used in the present work using the chicken hepatocyte,
suggesting that there is approximately a 10 fold difference between
the binding affinities of the chicken and rat liver glucagon receptors.
This is similar to the conclusions of Simon et ad. referred to above.
The binding capacity of the chicken hepatocyte for the high affinity
site is approximately 13,000 sites per cell. Again assuming that both
rat and chicken hepatocytes are spherical with respective diameters of
24 pm and 12 pm there appears to be 2 to 3 times more glucagon receptors
per unit surface area of the chicken hepatocytes. However it must again
be stressed that due to the enhanced potency of various iodinated glucagon
preparations (Desbuquois 1975;Fig.4.11) large discrepancies can occur in
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the calculated affinity depending on the iodine to hormone ratio of the
tracer. Since iodination always increases the binding affinities of the
hormone at physiological pH, the calculated dissociation or half maximum
binding constants will always be too high since higher native glucagon
concentrations will be required to displace the more potent iodinated
species.
Chicken glucagon, although only differing from mammalian glucagons
at one position in the amino acid sequence, has been reported to have an
enhanced biological potency (Hazelwood 1976). It is not known if this
increased potency of the hormone or the reported increase in receptor
concentration on the cell surface will in some way compensate the apparent
low affinity of the receptor population.
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Dissociation of I-glucagon from the hepatocytes was not accelerated
by the presence of native glucagon (Fig. 4.16) thus indicating an absence'of
the apparent negative co-operative effect that is seen with the insulin
receptor. Sonne et 3^.(1978) also failed to note any evidence for negative
co-operativity of the glucagon receptor in rat hepatocytes. The
dissociation however did not show first order kinetics with respect to
receptor occupancy, indicating that more than one type of receptor
population was present. After prolonged incubation approximately 50% of
the bound tracer remained bound to the hepatocytes. This suggests that
a large fraction of glucagon bound to the hepatocytes at 37°c may be
altered in some way or transferred to some compartment which is less
accessible to the external medium. This process may be linked to the
high degradation rates observed with glucagon at 37°c (Fig. 4.19) .Hormone
degradation was found not to be linearly dependent on cell concentration
at this temperature and a hyperbolic response was found. This may be
due to the heterogeneity of the tracer population where highly iodinated,
highly potent glucagon molecules may be preferentially degraded by the
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hepatocytes. if heterogeneity of substrate is not responsible for this
response the increasing cell concentration must in some way regulate the
maximum degradation rate of the suspension as a whole. Even although a
large fraction of the iodinated tracer is degraded (up to 20%) this
decrease in substrate would not solely account for the lower degradative
capacity at higher cell concentrations.
4) APP Binding
In contrast to the findings of McCumbee and Hazelwood (1977) who
-9
demonstrated both high affinity (K = 5.6 x 10 M) low capacity (approx.d
3 -7
40 x 10 sites per cell) and low affinity (K^ = 8.3 x 10 M) high capacity
(approx. 19 x 10^ sites per cell) binding components for APP in chicken
adipocytes, only a low affinity binding site was found using chicken
hepatocytes. Values obtained for the affinity of the hepatic site were
two fold lower than the low affinity value reported for adipocytes with
Kj of about 2.0 x 10 however the capacities were similar
with approximately 300,000 sites per hepatocyte . Whether this low
affinity site has any biological significance is questionable.
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Hepatocytes were also found to degrade I-APP at a very slow rate
125 125
compared to equal concentrations of I-insulin or I-glucagon,indicat¬
ing the absence of a specific site for degradation of this hormone in
the liver (Fig. 4.24). Although it has been reported that APP lowers
liver glycogen content in vivo (Hazelwood et al_. 1973) it is very unlikely
that this effect is mediated through the low affinity binding site found
and is probably secondary to some major effect of the hormone acting
elsewhere in the body.
The physiological significance of the low affinity binding sites for
insulin and glucagon are also questionable since binding affinities are
much lower than the physiological concentrations of the hormones found
in the blood. Although individual cell preparations showed variations
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in the extent of low affinity binding for both insulin and glucagon,
the high affinity components showed remarkable consistency between
experiments. It is therefore suggested that the high affinity binding
sites are solely responsible for any hormone regulation of biological
effects in the chicken liver. Since no high affinity receptor was found
for APP it is concluded that this hormone has no direct biological action
in the chicken liver.
CHAPTER 5
'SECOND MESSENGERS' OF HORMONE ACTION
82.
Introduction
The regulation of many intracellular processes is dependent on
covalent modification of certain key enzymes. This modification leads
to altered activities of the rate controlling enzymes with a resulting
alteration in metabolic flux. The most common type of covalent modification
found in biological systems involves specific phosphorylation and
dephosphorylation processes. The earliest report of a reversible
phosphorylation of an enzyme leading to altered activity was in 1955 for
glycogen phosphorylase (Fischer and Krebs 1955). Since then over twenty
different enzymes have been found to be regulated by phosphorylation -
dephosphorylation mechanisms carried out by protein kinases and phospho-
protein phosphatases. The regulation and action of these kinases and
phosphatases has been the subject of recent review articles (Ruben and
Rosen 1975; Nimmo and Cohen 1977; Krebs and Beavo 1979).
Most of the evidence for the structure and function of protein kinases
and phosphoprotein phosphatases has been obtained from tissues other than
liver, particularly rabbit skeletal or cardiac muscle. Five different
classes of protein kinase have been reported which are regulated by
different factors (Krebs and Beavo 1979). Two cAMP dependent protein
kinases (type I and type II) and a single cGMP dependent protein kinase
have been found. Both cAMP dependent protein kinases comprise
two different subunits - a regulatory subunit which binds cAMP and a
catalytic subunit which dissociates on cAMP binding. The cGMP dependent
protein kinase contains two identical subunits which have both cGMP
binding and catalytic activity at two distinct functional sites on the
same molecule.
In addition two calcium dependent protein kinases have been found -
phosphorylase kinase and myosin light chain kinase. With myosin light
chain kinase the calcium sensitivity is induced by a calcium dependent
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molecular protein that is usually associated with activating cyclic
nucleotide phosphodiesterase (Dabrowski et al. 1928; Yagi et al. 1978;
Warsman et al. 1978). The same modulator protein may be responsible for
2+
inducing Ca sensitivity on phosphorylase kinase (Cohen et_ al_. 1978) .
It is therefore obvious that any fluctuations in basal intracellular
levels of cAMP or cGMP as well as those of free Ca^+ may activate a
particular protein kinase with resulting enzyme phosphorylation.
Depending on the specificities of individual protein kinases in the liver
cell, alterations in basal hepatic metabolism are possible. It is now
well established that activation of phosphorylase kinase by cAMP
dependent protein kinase leads to phosphorylase b to a_ conversion with
a resulting increase in the rate of glycogenolysis. The mechanism of the
glycogenolytic cascade effect has been reported in more detail by Nimmo
and Cohen (1977).
As mentioned above, phosphorylase kinase can also be directly
activated or deactivated by alterations in intracellular free calcium
levels (Heilmeyer et_ al. 1970). Therefore both cAMP and intracellular
calcium can regulate the glycogenolytic rate. Various models for the
interdependent actions of calcium and cAMP in different tissues have
been put forward by Berridge (1975).
Cyclic GMP protein kinase has been reported to have similar
specificity to the cAMP dependent enzyme. Both enzymes can phosphorylate
phosphorylase kinase, glycogen synthetase (Lincoln and Corbin 1977)
and pyruvate kinase (Lincoln and Corbin 1977; Ljungstrom and Ekmann
1977; Riou et al. 1978), as well as hormone sensitive lipase, cholesterol
esterase (Khoo et al. 1977) and fructose 1,6-diphosphatase (Riou et al.
1977). In view of their physical and biological similarities, it has
been suggested that cAMP and cGMP kinases may have evolved from a common
ancestral protein (Lincoln and Corbin 1977, 1978).
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Alteration of the basal intracellular levels of the two nucleotides
or calcium by extracellular hormone binding would be a possible mechanism
for hormonal regulation of metabolism. Both glucagon and adrenaline
stimulate liver adenylate cyclase with concomitant increases in intra¬
cellular cAMP resulting in activation of cAMP dependent protein kinase.
The hormone stimulation of cAMP in rat hepatocytes has been investigated
by several workers (Johnson et ad. 1972? Garrison and Haynes 1973?
Pilkis et al. 1975? Sonne et ad. 1978? Westwood and Siddle 1979).
Insulin has been reported to inhibit hormone stimulated cAMP levels
(Exton and Park 1972? Pilkis et al. 1975? Westwood and Siddle 1979).
Although some laboratories have reported a direct inactivation of
adenylate cyclase by insulin (Illiano and Cuatrecasas 1972? Hepp and
Renner 1972), other workers have found no effect (Pohl et a)L. 1971?
Thompson et_ al. 1973? Pilkis et a^. 1974).
Although adrenaline stimulates cAMP production in the rat hepatocyte,
recent evidence suggests that its effects on gluconeogenesis and
glycogenolysis are mediated through the cAMP independent a-receptor
(see Chapter 1). Binding studies indicate the presence of two a-adrenergic
binding sites in the liver plasma membrane with only one of these
believed to be physiologically important (El-Refai et ad. 1979).
Low levels of glucagon, insufficient to stimulate cAMP accumulation or
protein kinase activation, have been reported to activate liver
phosphorylase (Birnbaum and Fain 1977) , and Keppens et al_. (1977)
reported that calcium may be an additional messenger for glucagon,
besides cAMP. The same workers suggested that calcium may act by
activation of liver phosphorylase b kinase, in view of the well-
documented calcium dependence of the muscle enzyme (see review by Krebs
and Beavo 1979). Hughes and Coore (1978) reported diminished calcium
binding to rat liver plasma membranes after binding of glucagon.
They suggested that this may be part of the mechanism stimulating
adenylate cyclase. However this could also lead to increased intra¬
cellular calcium and activation of phosphorylase kinase at low glucagon
concentrations.
The relationship between guanylate cyclase, cGMP and the regulation
of metabolism has recently been reviewed (Goldberg and Haddox 1977;
Mittal and Murad 1977). The role of cGMP as a possible second messenger
for hormone action is rather obscure. Unlike adenylate cyclase and
cAMP there has been little conclusive evidence for hormone stimulation
of guanylate cyclase. Illiano et ad. (1973) reported that insulin and
cholinergic agents such as acetylcholine increased the intracellular
level of cGMP in isolated fat cells and in liver slices. Similarly
Pointer et al.(1976)reported increased levels of cGMP in isolated rat
hepatocytes exposed to the catecholamines, adrenaline, isoproterenol and
phenylephrine as well as carbachol, insulin, ionophore A23187 and to a
lesser extent glucagon. However cGMP levels did not correlate with the
observed biological effects of the various hormones. Both catecholamines
and insulin increased cGMP levels in the hepatocytes but had opposing
effects on glycogenolysis. Numerous other workers have failed to note
any effect of several hormones, including adrenaline, noradrenaline ,
insulin and glucagon, on cGMP accumulation (see Goldberg and Haddox
1977). Therefore the role of cGMP, if any, in hormone regulation
remains to be established.
The only means of removal of cAMP or cGMP from the cell cytoplasm
is by degradation by their specific cyclic nucleotide phosphodiesterases
to 5'AMP or 5'GMP. Alterations in cyclic nucleotide phosphodiesterase
activity would also serve as a control for nucleotide regulation.
The phosphodiesterases can be activated by calcium ions in the presence
of a heat stable protein modulator (Smoake et al. 1974; Kakiuchi et al.
1975). Two kinetic forms of both cAMP and cGMP phosphodiesterases have
been found in muscle, liver and nervous tissues from many different
animal species (Arch and Newsholme 1976) . Numerous workers have
reported activation of the particulate bound low K enzyme from adipose
m
tissue and intact adipocytes by insulin and adrenaline (Loten and Sneyd
1970; Manganiello and Vaughan 197 3; Paulson et_ al_. 1974; Kono et al.
1975; Zinman and Hollenberg 1974). This low K hormone-sensitive enzyme
m
has been successfully solubilised (Lovell-Smith et ah. 1977). Work by
Phelps and Varandi^197l)suggests that glutathione-insulin transhydrogenase-
catalysed sulphydryl-disulphideexchange with insulin may be a pre-requisite
for insulin stimulation of phosphodiesterase activity. This again
indicates that insulin degradation and internalisation, as postulated
with the liver (Terris et ah. 1979), may be necessary for intracellular
effects on metabolism.
Thompson et ah. (1973) reported that following injection of insulin
into rats, the liver high affinity cAMP phosphodiesterase exhibited
enhanced activity. Others have also reported an insulin sensitive
phosphodiesterase in rat liver (House et al. 1972; Tria et al. 1976) .
Glucagon has also been reported to stimulate the enzyme in the rat
hepatocytes (Allen and Sneyd 1975) . These reports have recently been
confirmed by Loten et al. (1978) who found stimulation of the low K
m
enzyme from liver by preincubating intact hepatocytes with insulin or
glucagon. The mechanisms of activation by the two hormones may be
different and the effect of glucagon could be responsible for the
failure to produce sustained increases in cAMP levels in rat hepatocytes.
Similar conclusions were reported when studying the effect of adrenaline
on cAMP production in rat adipocytes (Zinman and Hollenberg 1974).
Loten et ai. (1978) also suggested that the altered phosphodiesterase
activity may be a result of independent phosphorylations of the protein
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stimulated by glucagon- and insulin-induced specific protein kinases.
However, variations in free calcium could also effect the phosphodiesterase
activity by binding or dissociating from the modulator protein.
Nemecek (1978) recently reported that ionophore A23187 and calcium
stimulated cyclic nucleotide phosphodiesterase activity in isolated
hamster fat cells with no associated increase in cAMP.
To date, all investigations into possible intracellular mediators
of hormone action have been carried out using tissues isolated from
mammalian sources and no direct studies have been undertaken using
isolated chicken hepatocytes. It is not known if glucagon and adrenaline
have similar effects on intracellular cAMP levels in the chicken
2+
hepatocyte or indeed if cGMP, Ca and cAMP phosphodiesterase are also
involved in hormone control. Elucidation of these problems was the
objective of the work to be reported in this Chapter.
Methods
6
Concentrated cell suspension (0.5 ml of a 20 to 30 x 10 cell/ml
solution) was added to 25 mm x 75 mm plastic incubation pots containing
fresh KRB buffer (1 ml) equilibrated with 95% 0^/5% CO^ at 37°C and
containing any required effector. Pots were then gassed with 95% 0^/5%
CO^ for 10 to 15 seconds and lids sealed. All incubations were carried
out at 37°C in reciprocal shaking water baths (140 to 160 strokes/min).
Termination of cell incubations was carried out by
a) addition of a cell suspension sample (1 ml) to an equal volume of
ice cold 6% PCA (cAMP determinations) or ice cold 10% TCA (cGMP
determinations)for estimation of cyclic nucleotide content.
b) centrifugation (2750 g; 1 min) and resuspension of cell pellet in
10 mM tris-HCl buffer pH 7.4 by homogenisation (approximately 30 strokes
of the tight fitting pestle) for determination of adenylate cyclase
activity.
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c) centrifugation (2750 g; 1 min) and resuspension of cell pellet in
a 50 mM tris-HCl extraction buffer pH 7.4 by homogenisation (as above)
for determination of phosphodiesterase activity.
Complete details of these assay procedures are given in Chapter 2.
Results
1. Cyclic AMP
In comparing the experimental results in this section it will become
obvious that discrepancies exist between glucagon or adrenaline
concentrations and cAMP levels for different experiments. This problem
was introduced by the unavoidable changes in collagenase preparations
obtained from the Boehringer Corporation Ltd. Consistent results were
obtained when the same batch of collagenase was used to prepare the cells.
Discrepancies are presumably due to associated non-specific protease activity.
Time course experiments were carried out using batch number 17 collagenase
whereas dose response curves were carried out using batch 25 collagenase.
a) Basal Cellular cAMP Content. Immediately after isolation
concentrated cell suspensions (20-30 x 10^ cells/ml) were found to have
, 6
intracellular cAMP levels ranging from 1 to 4 pmols/lO cells.
Preincubation of the suspension for 15 minutes at 37°C with constant
gassing with O^/CO^ generally reduced the basal levels to a steady
/ ^
state around 1 pmol/10 cells. Fig. 5.1 shows a typical time course
o
of basal cAMP content of hepatocytes with incubation at 37 C. In all
other experiments reported the cell suspension was preincubated for
15 minutes at 37°c with constant gassing with t0 rec^uce kasal
levels to stable values. In some experiments however the basal levels
of cAMP did not fall to the values mentioned. Cells prepared by particular
batches of collagenase (25 or 27) consistently showed slightly
elevated cAMP levels which remained stable during incubations up to
40 minutes at 37°C. Centrifugation (50, 350 or 2750 g; 1 to 5 minutes)
TIME ( minutes 1
Fig. 5.1 Effect of incubation on basal cAflP content of the cells.
or rapid changes in medium temperature (addition of equal volume of
ice cold KRB) did not alter basal or hormone stimulated cAMP levels.
Therefore the physical procedures carried out during cell isolation were
not considered to be responsible for the elevated nucleotide levels,
b) Time course of Hormonal Effects on total cAMP. The time course of
cAMP accumulation in the suspensions in the presence of glucagon (25, 10
and 5 ng/ml) and adrenaline (1 jig/ml) are shown in Figs. 5.2 and 5.3
respectively. High concentrations of glucagon (100 or 25 ng/ml) produce
maximum levels of cAMP after approximately 5 to 10 minutes. The lower
glucagon concentrations (5 ng/ml) show maximum cAMP after only 1 or 2
minutes. After this peak,cAMP levels fall in a biphasic manner. Even
after 40 minutes incubation there is still a substantial elevation of
cAMP above basal levels. Cyclic AMP production in response to adrenaline
is similar to that of glucagon except that absolute levels of cAMP are
lower. Basal levels of cAMP remain relatively constant for the period
of incubation. Glucagon time courses in the presence of theophylline
(1 mM) show similar characteristics with the exception that cAMP levels
remain elevated for longer periods (Fig. 5.4). Basal levels of cAMP
were not elevated by the phosphodiesterase inhibitor. At the highest
glucagon concentration (50 ng/ml) cAMP did not decline at all but
remained constant for up to 60 minutes incubation.
Insulin (250, 10O or 25 ng/ml), APP (100, 25 or 6.25 ng/ml) and
calcium ionophore A23187 (5 or 1 jj.g/ml) failed to elevate basal cAMP
levels over a sixty minute time period whether 1 mM theophylline was
present in the incubation medium or not.
The distribution of hormone stimulated cAMP between intracellular
and extracellular compartments is shown in Figs. 5.5 and 5.6. Cell
o
suspension was incubated at 37 C for the times shown with or without
glucagon (12.5 or 25 ng/ml) and then samples (1 ml) were removed.
T I M E ( m i n m t • • )
Fig. 5.2 Time course profile of basal (•-•) and glucagon 25 (■-■),
10 (O-O) , 5 ng/ml (□-□), stimulated cAMP content.
TIME ( m inutes)
Fig. 5.3 Time course profile of basal (•-•) and adrenaline 1 yg/ml
(0-0) stimulated cAMP content.
TIME (m inutes)
Fig. 5.4 Time course profile of basal (□-□) and glucagon 50 (0-0),




EFFECT OF GLUCAGON (12.5 ng/ml) ON INTRACELLULAR (O 0)
EXTRACELLULAR ( A A) AND TOTAL ( □ □ ) cAfiP
10 20 30 40 50 60
minutes
EFFECT OF GLUCAGON (25 ng/ml) ON INTRACELLULAR (O—O)
EXTRACELLULAR (A A) AND TOTAL (□ O) CAMP
Fig. 5.6
The samples were either immediately added to an equal volume of ice cold
6% PCA to determine total cAMP in the suspension or centrifuged (2750 g;
30 seconds) at room temperature and a sample of supernatant added to an
equal volume of ice cold 5% PCA to estimate extracellular cAMP. Lower
centrifugation speeds (1400 g or 350 g; 30 sec) did not alter the
amount of cAMP found in the supernatant. Intracellular cAMP was
determined by difference. As shown in Figs. 5.5 and 5.6 there is a
rapid accumulation of intracellular cAMP which reaches a peak level
after 5 minutes for both glucagon concentrations used (12.5 and 25 ng/ml)
Intracellular cAMP quickly falls however presumably due to intracellular
degradation as well as loss to the external medium; even the highest
stimulated intracellular levels return to basal after 60 minutes
incubation. The nucleotide appears to be freely permeable through the
plasma membrane, escaping to the extracellular medium. However this
extracellular component of the total suspension cAMP is also degraded
by some mechanism as peak concentrations are reached after 20 and 30
minutes using glucagon concentrations of 12.5 and 25 ng/ml respectively.
This decrease in extracellular cAMP may be due to diesterases present in
the external medium and/or diffusion of the nucleotide back into the
cytoplasm for degradation by internal phosphodiesterase. At least 95%
of the basal cAMP at any time point was found to be of intracellular
origin.
In order to monitor the extracellular degradation of cAMP, a cell
6 o
suspension (20.5 x 10 cells/ml) was incubated for 60 minutes at 37 C
as previously described, the pots being regassed with O^/CO^ after 30
minutes. The suspension was then centrifuged once at 350 g for 2 minutes
and then the supernatant was centrifuged once more at 2750 g for 2 minute
The supernatant was then diluted with an equal volume of fresh KRB
buffer containing 200 pmol/ml cAMP. The diluted supernatant containing
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cAMP was then incubated for various times at 37°C in a reciprocal shaking
water bath and samples (1 ml) withdrawn for estimation of the cAMP
remaining. A parallel incubation of cAMP in fresh KRB buffer showed no
decrease in the level of the nucleotide. However, incubations with the
cell suspension supernatant resulted in marked degradation of cAMP
indicating the presence of extracellular diesterases (Fig. 5.7). Cell
suspensions did not show any marked signs of damage as judged by trypan
blue exclusion. Increase in the extracellular factor capable of
degrading cAMP was not associated with gross morphological damage to
the hepatocytes.
c) Effect of Insulin on Glucagon stimulated cAMP content. As reported
above insulin at any concentration failed to show an effect on basal cAMP
levels. However addition of pharmacologial levels of the hormone
(500 ng/ml) to subsaturating levels of glucagon (10 ng/ml) showed
reproducible changes in the time course of total cAMP production.
Fig. 5.8 shows the effect of the simultaneous addition of glucagon
(10 ng/ml) and insulin (500 ng/ml) or glucagon (10 ng/ml) alone, to cell
suspension at time zero. Initial rates of production of cAMP were
identical in both cases but the cAMP degradation rate was decreased
in the presence of insulin. Preincubation of the cell suspension for
10 or 20 minutes with insulin (500 ng/ml) before addition of glucagon
(10 ng/ml) consistently resulted in a slight decrease in the initial
rate of cAMP production as well as decreasing the cAMP degradation rate
(Fig. 5.9, 5.10). Preincubation also lowered the total amount of cAMP
produced on addition of glucagon. The addition of high insulin
concentrations failed to decrease the rate of glucagon (12.5 ng/ml)
elevated intracellular cAMP degradation as shown in Fig. 5.6.
Cell suspension was incubated in the presence of glucagon (12.5 ng/ml)
or glucagon (12.5 ng/ml) plus insulin (500 ng/ml) for 5 minutes at 37°C.
-I 1 1
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Fig. 5.7 Extracellular degradation of cAMP (100 pmol/ml).
activity in a cell suspension supernatant.
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c*»MP STIMULATION BV GLUCAGON (10 ng/ml) (O—-O) AMD GLUCAGON
(10 ng/nl) PLUS INSULIN (5O0 ng/ml) (□ □ )
Fig. 5.8
minutes
CAMP STIMULATION BY GLUCAGON (10 ng/ml) IN NORMAL CELL
SUSPENSION (O—O) AND SUSPENSION PRE INCUBATED FOR 10 min
IN PRESENCE OF INSULIN (500 ng/ml) (□ □)
Fig. 5.9
T I M E | minutes)
Fig. 5.10 cAM? stimulation by glucagon (10 ng/ml) in normal cell
suspension (O-O) and suspension preincubated for 20 minutes in the
presence of insulin (500 ng/ml) (□-□).
Cells were pelleted by centfifugation (350 g; 1 rtiin) and resuspended to
the same volume with fresh KRB buffer. The decrease in suspension cAMP
was observed with time (Fig. 5.11). There was no significant difference
in cAMP degradation rate between the two cell suspensions. Insulin
effect on total cAMP degradation was not observed at concentrations of
lOO ng/ml or below, even when lower glucagon concentrations (5 ng/ml)
were employed.
d) Effects of Glucagon plus Adrenaline. The maximum stimulation of cAMP
production by adrenaline (10 jug/ml) could be increased by up to 5 fold
by glucagon (100 ng/ml) but adrenaline could not potentiate maximum
effects by glucagon. In the presence of theophylline (1 mM) addition
of glucagon (100 ng/ml) after preincubation for 5 minutes with adrenaline
(10 jug/ml) induced only a slow increase in cAMP content (Fig. 5.12).
The production of cAMP in response to glucagon was much slower than
when fresh cells were exposed to glucagon alone.
e) Subsequent additions of Glucagon. Addition of glucagon in stages
resulted in additive effects and rapid responses were found with later
additions of glucagon. Fig. 5.13 shows the stimulation of total cAMP
by cell suspension treated with 200 ng/ml glucagon at zero time or
100 ng/ml glucagon at zero time followed by a further addition giving
200 ng/ml after 15 minutes of incubation. Glucagon concentrations
of 100 ng/ml appear to produce a maximum initial rate of cAMP production.
Higher concentrations maintain the level of cAMP for longer periods.
The further addition of glucagon after 15 minutes incubation giving
200 ng/ml produces a rapid increase in the declining cAMP level to
values similar to when glucagon at 200 ng/ml was administered at zero
time.
f) Effect of Bacitracin. The effect of the protease inhibitor bacitracin,










Fig. 5.11 Degradation of intracellular cAMP stimulated by glucagon
(12.5 ng/ml) (0-0) or glucagon (12.5 ng/ml) plus insulin (500 ng/ml)
(□-□).
Fig. 5.12 Cell suspension cAMP in response to adrenaline (10 yg/ml)
(0-0) and adrenaline (10 yg/ml) plus addition of glucagon (100 ng/ml) (□-□)
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Fig. 5.13 cAMP production in response to glucagon (200 ng/ml) (□-□
or 100 ng/ml (O-O). Also increasing glucagon concentration from 100
to 200 ng/ml after 15 minutes of incubation (•-•).
10
10 20 30 40
TIME (minutes)
Pic. 5.14 cAMP production in response to glucagon (10 ng/ml) (O-O)
or glucagon (10 ng/ml) in the presence of bacitracin (0.75 mg/ml)
(□-□).
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(0.75 mg/ml) into the incubation medium did not potentiate the effects
of subsaturating glucagon concentrations but in fact tended to depress
cAMP levels at all time points (Fig. 5.14).(Batch 25 collagenase used
to prepare cells for this experiment.)
g) Dose response for Glucagon and Adrenaline. Cell suspensions, prepared
using batch 25 collagenase, were incubated in the presence of varying
concentrations of glucagon or adrenaline as described previously.
o
After 2 minutes at 37 c, incubations were terminated by direct addition
of an equal volume of 6% PCA to the incubation pots. Samples were
processed for total cAMP content. The dose response curves of glucagon
and adrenaline are shown in Figs. 5.15 and 5.16 respectively. The first
significant increase in cAMP level was found with glucagon concentrations
of 10 ng/ml and at adrenaline concentrations of 50 ng/ml with half
maximum stimulations at approximately 45 ng/ml (13 nM)and 300 ng/ml
(1.7 |_iM) respectively. Maximum levels of adrenaline stimulated cAMP
were only one third of that produced by maximum glucagon concentrations.
Closer examination of cAMP levels at low glucagon concentrations is
6
shown in Fig. 5.17. Cell suspension (13.8 x 10 cells/ml) was incubated
for 2 minutes with various glucagon concentrations in the presence of
5 mM theophylline. Basal cAMP levels of 1.96 - 0.21 pmol/10^ cells were
elevated by approximately 30% to 2.51 - 0.35 pmol/10^ cells in the presence
of 0.31 ng/ml glucagon - the limits correspond to standard deviations
for three observations.
2) Cyclic GMP
Levels of cGMP tended to vary considerably between cell preparations.
Basal nucleotide values varied over a six fold range with values from
10 x 10 to 60 x 10 ^ mol/10^ cells. Average basal levels cGMP were
11 ■— 15 6
found to be 31.3 - 24.8 x 10 mol/lO cells (standard deviation - n = 4).









GLUCAGON LOSE RESPONSE ro*. cAMP PRODUCTION.
Fig. 5.15
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Fig. 5.16 Adrenaline dose response for cAMP production.
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Fig. 5.17 Glucagon dose response tor cAfl? production in cell
suspension containing 5 mM theophylline.
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values obtained from individual experiments from cells incubated under
identical conditions were also highly variable with values often
fluctuating by up to 25%. This suggested variability in the assay method
for cGMP,yet standard samples processed in an identical manner to the
unknowns showed remarkable consistency (see Fig. 2, Chapter 2). The
reasons for the observed variability are therefore unknown. The average
percentage changes noted with various effectors are shown in Table 5.1.
Values are calculated from experiments using four different ceil
preparations.
Due to the large fluctuations found when estimating cGMP levels
any small changes in the concentration of this nucleotide would not be
noticed under these conditions. It is however concluded that none of the
effectors used (insulin, glucagon, APP, ionophore A23187, adrenaline)
induced any large changes in total cGMP in the cell suspension comparable
with that found for maximum stimulation of cAMP by glucagon. After
centrifugation of the cell suspension less than 15% of the total cGMP
immunoreactivity was found in the supernatant.
3) Adenylate Cyclase Activity
Adenylate cyclase activity was measured in crude homogenates of
isolated cell suspension by the method outlined in Chapter 2. Activity
of the cyclase was found to be highly sensitive to cell homogenate
concentration and temperature. High concentrations of cell homogenate
(176 x 106 cells/ml) showed rapid inactivation of the cyclase during
incubations (Fig. 5.18). After 2 minutes there was a decrease in the
glucagon stimulated cyclase rate and the cAMP already produced was
rapidly lost even though the reaction medium contained 10 mM theophylline.
No significant stimulation of activity could be demonstrated with 10 mM
NaF using these high cell concentrations. Using lower cell homogenate
concentrations (26.8 and 13.4 x 10^ cells/ml), linear enzyme rates were
Table 5.1: Cell cGMP levels in cells incubated with various effectors.
cGMP x 10 15 mol/106 cells
Effector
Insulin (100 ng/ml)
Glucagon (100 ng/ml) 10






























Fig. 5.18 Time course of basal (A-A), glucagon (10 ng/ml) (•-•)
and sodium fluoride (10 mil) (0-0) stimulated adenylategCyclase
production of cAMP using a cell homogenate of 176 x 10 cells/ml.
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only found for the first 10 minutes of incubation after which activity
suddenly stopped (Fig. 5.19). Levels of cAMP in the medium remained
relatively constant indicating that theophylline was successfully
inhibiting the endogenous phosphodiesterase. Glucagon directly stimulated
adenylate cyclase by approximately 10 to 12 fold when added to these
homogenates. Basal rates of nucleotide production increased from an
6 6
average of 0.06 pmol/min/10 cells to 0.68 pmol/min/10 cells. Neither
insulin nor APP (both at 100 ng/ml) had any direct effect on basal or
glucagon stimulated cyclase activity under these conditions.
The rapid inactivation of the cyclase is shown in Fig. 5.20. Cell
homogenates were preincubated for various times at 30°C and then added
to the cyclase incubation medium containing glucagon (100 ng/ml).
Cyclic AMP production after 2, 5 and 10 minutes was determined. Only
the cell homogenate which was precincubated for one minute showed any
glucagon stimulated cyclase activity. Homogenates preincubated for 11,
21 and 31 minutes showed no cyclase activity. Basal cyclase activity
was also measured over 40 minutes of incubation. A low rate was noted
over the first 10 minutes incubation at 30°C but thereafter no increase
in medium cAMP was observed.
4) Phosphodiesterase Activity
High and low K phosphodiesterase activities were measured in crude
cell homogenates after preincubation of the cells for 20 minutes with or
without various effectors. Table 5.2 shows the result of changes in
cell homogenate concentration on low and high K phosphodiesterase
activities which were measured at cAMP concentrations of 5 and 250 pM
respectively. Cell homogenates ranging from 133 x 10^ cells/ml to
4.2 x 106 cells/ml were added to the assay medium and incubated for
o 6
1 hour at 37 C. Cell suspension homogenates of under 10 x 10 cells/ml










Fig. 5.19 Glucagon stimulated 26.S x 10 cells/ml; 13.4 x 10






Fig. 5.20 Inactivation of adenylate cyclase, basal (0-0) and glucagon
(inn ng/ml ) stimulated (□-□), on incubation of homogenates at 30 C.
Table 5.2: Effect of cell homogenate concentration on phosphodiesterase
activity.
Values given are averages of duplicate observations. High K enzyme
m
assayed at 250 11M cAMP; low enzyme assayed at 5 ]1M cAMP.
6
Homogenate concentration Enzyme activity pmol cAMP/min/10 cells











with or without insulin, glucagon, or APP (all at 100 ng/ml) for 20 minutes
at 37°C. Cells were pelleted by centrifugation (2750 g; 1 min) and
homogenised in extraction buffer as outlined in Chapter 2 and phospho¬
diesterase activity determined. Activities found for two different
experiments are shown in Table 5.3. The second experiment was carried
out using an extraction buffer containing 0.2% v/v triton X-lOO which
resulted in higher activities of both K enzymes. No significant increase
m
in high or low K activity was noted with any of the effectors used at
m
5 or 250 pM cAMP respectively. Activity of the low K enzyme was also
m
assayed using 0.5 pM cAMP as substrate after preincubation of the cells
with the hormones for either 10 or 40 minutes (Table 5.4). Again no
significant change in phosphodiesterase activity was found.
Discussion
The sensitivity of the cell preparations, with respect to cAMP
production, to low concentrations of glucagon was found to vary depending
on the particular batch of collagenase used to prepare the cells.
Initial experiments on time course of cAMP production were carried out
using cells prepared by batch 17 collagenase obtained from Boehringer
Corporation Ltd. and were found to show significant stimulations in basal
-9
cAMP levels at glucagon concentrations as low as 2.5 ng/ml (0.72 x 10 M) .
More recent experiments including the dose response curves were carried
out with cells isolated using batches 25 or 27 collagenase and consistently
yielded less sensitive cells. Concentrations of nearly 10 ng/ml
-9
(2.9 x 10 M) glucagon were required to produce measurable effects on
basal cAMP levels in the absence of theophylline, with half maximum
-9
stimulations obtained at approximately 45 ng/ml (12.9 x 10 M). These
hormone levels are higher than those reported for rat hepatocytes of
-9 -9
1.5 x 10 M (Pilkis et al. 1975),1 to 2x 10 M (Sonne et al. 1978) and
-9
6.0 x 10 M (Rosselin et al. 1974). However in the presence of 5mM
Table 5.3: Effect of Insulin, Glucagon and APP on cAMP phosphodiesterase
activity.
Activities of high and low K enzymes measured at 250 yM and 5 yM cAMP
respectively„ Cell suspension preincubated with effector for
20 minutes before assay of activity. Standard deviations given are
based on four observations.
Experiment A - normal extraction buffer
Effector Enzyme activity pmol cAMP/min/10^ cells
High K Low K
m m
6.75-0.59 2.43-0.19
Insulin (100 ng/ml) 6.49-0.21 2.58-0.12
Glucagon (100 ng/ml) 6.34-0.31 2.27-0.15
APP (100 ng/ml) 7.09-0.68 2.21^0.06
Experiment B - extraction buffer containing 0.2% v/v triton X-lOO
Effector Enzyme activity pmol cAMP/min/10^ cells
High K Low K
m m
11.19—O.57 3.58^0.13
Insulin (100 ng/ml) 11.82^1.02 3.60-0.10
Glucagon (100 ng/ml) 10.41-0.49 3.81-0.25
APP (lOO ng/ml) 12.15-0.60 3.57-0.10
Table 5.4: Effect of Insulin, Glucagon and APP on low K cAMP
m
phosphodiesterase activity.
Activity of the low K enzyme was measured using 0.5 l_iM cAMP as substrate
m
after preincubation of cell suspension for 10 or 40 minutes with effector.
Extraction buffer contained 0.2% v/v triton X-100. Standard deviations
based on four observations.
Effector Preincubation Enzyme activity
time (minutes) pmol cAMP/min/10 cells
10 0.759^0.052
40 0.734^0.058
Insulin (100 ng/ml) lO 0.758^0.013
40 0.770-0.016
Glucagon (100 ng/ml) 10 0.762^0.026
40 0.801-0.018
APP (100 ng/ml) lO 0.745^0.037
40 0.767-0.044
theophylline, substantial stimulation of basal cAMP (approximately 30%)
could be found with concentrations of 0.3 ng/ml (8.6 x 10 ^M) (cells
prepared with Batch 25 collagenase). These small increases in cAMP level
were not detected under the conditions used to monitor the larger
increases in the nucleotide level but are most likely to be more important
in the physiological control of metabolism. Due to this and the fact of
the reduced sensitivity found with batches 25 and 27 collagenase the
figure reported for half maximum responses will be overestimated.
Half maximal activation of the cyclase by adrenaline was found at about
—6
300 pg/ml (1.7 x 10 M) which again will be an overestimate of the true
value. This is almost identical to the half maximal value for adrenaline
stimulation of cAMP in rat hepatocytes (Tolbert et_ al_. 1973) .
Basal levels of the cyclic nucleotide varied considerably between
cell preparations isolated with different collagenase batches. High
levels of the nucleotide, 1 to 4 pmols cAMP/10^ cells, were found immediately
after the isolation procedure, but these generally stabilised to lower
values (0.5 to 1.5 pmols/10^ cells) within 10 to 15 minutes. Similar
nucleotide levels were found for rat hepatocytes by Rosselin et al.
(1974) (0.7 to 1.4 pmol/10^ cells). Assuming that the nucleotide is
evenly distributed throughout a hypothetically spherical cell, then the
chicken hepatocyte would contain approximately a 8 fold higher basal
concentration of cAMP than the rat (diameter of chicken and rat hepatocytes
are 12 )im and 24 pm respectively - Capuzzi et al. 1974, Dickson 1977) .
However Tolbert et ad. (1973) have reported basal levels of cAMP in rat
hepatocytes of 3 pmol/10^ cells;likewise Sonne et al. (1978) report basal
levels in the region of 5 pmol/10^ cells which correspond well with the
theoretical basal concentrations as found for the chicken hepatocyte.
Rosselin et; al_. (1974) also reported that basal levels of cAMP were
stimulated up to ten fold in the presence of (1 mM) theophylline alone.
However Pilkis et al_. (1975) found only minor increases in the basal
level with theophylline.
When preparing the hepatocytes using collagenase batches 25 and 27,
much higher basal levels of cAMP were noted with values ranging from
£
1.5 to sometimes 5 pmols/10 cells ,after preincubation of the cells for
up to 40 minutes. The increased basal concentration of the nucleotide
may be due to activation of adenylate cyclase by various contaminants
present in certain batches of collagenase. Hanoune et_ ad. (1977) have
previously shown that very low concentrations of crude collagenase are
capable of stimulating adenylate cyclase in rat liver plasma membranes.
The stimulatory factor was found to be a protein which could be separated
from the main collagenase component of the preparation and had a
molecular weight on gel chromatography of 30,000. The maintenance of
the elevated cAMP levels in the chicken hepatocytes is also consistant
with the apparently irreversible effect of this protein stimulator in the
rat liver plasma membranes. This activation may be due to certain
endogenous serine proteases in the crude collagenase preparation. Although
Rosselin et ad. (1974) reported no effect of trypsin on basal cAMP
concentrations other workers have reported that various serine proteases
like trypsin are capable of activating adenylate cyclase in cultured
fibroblasts (Wallach et ad. 1978) and in membrane fractions from rat ovary
(Richert and Ryan 1977). If collagenase contaminants are responsible
for these elevations in cAMP, direct comparison of basal and perhaps
hormone stimulated levels of the cyclic nucleotide will be critically
dependent on the extent of activator contamination of individual
collagenase preparations, the length of time and the concentration of
collagenase used during the perfusion. Even the lowest values found for
the chicken hepatocytes (0.5 to 1.5 pmoles/10^ cells) and indeed by other
workers using rat hepatocytes may be elevated above the natural basal
concentration due to the collagenase digest.
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Time courses of cAMP production stimulated by glucagon or adrenaline
resulted in an initial rapid accumulation of the nucleotide generally
reaching a peak between 2 (low hormone concentrations) and 10 minutes
(high hormone concentrations) of incubation. The nucleotide was rapidly
lost to the external medium and was degraded in both intracellular and
extracellular compartments. Similar time course profiles have been
reported for rat hepatocytes (Pilkis et ad. 1975) . After the initial
rapid accumulation of cAMP, levels quickly (low hormone concentrations)
or gradually (high hormone concentrations) returned to basal values.
The brief increase in production of cAMP must be controlled mainly by
the cyclase and not the cAMP phosphodiesterase since inhibition of the
latter with theophylline or caffeine does not prevent the abrupt
termination of nucleotide production although degradation is inhibited.
Maximum stimulation of the cyclic nucleotide by glucagon varied from
10 to 50 fold and by adrenaline by 5 to 10 fold depending mostly on the
initial basal levels. Maximum stimulation by glucagon in the absence of
theophylline consistently yielded concentrations of 30 to 40 pmoles/10^
cells after 10 minutes of incubation. Theophylline did not increase
maximum content of the cells but maintained the cAMP level for longer
periods. Results reported for rat hepatocytes have shown considerable
variation. Rosselin et_ al_. (1974) reported maximum stimulated levels
of only 10 to 15 pmols/10^ cells for rat hepatocytes although this could
6
be increased to 50 to 90 pmols/lO cells in the presence of theophylline.
Pilkis et_ al^. (1975) reported a 10 fold increase in the nucleotide which
was doubled on addition of theophylline whereas Sonne et_ jal. (19 78)
found over a 40 fold stimulation with cAMP levels reaching 200 pmol/10^
cells. The maximum theoretical intracellular concentrations found in
chicken hepatocytes are very similar to those reported by Sonne et ad.
(1978) for the rat but the results obtained by Rosselin et al^. (1974)
would indicate an approximate two fold higher nucleotide level in the
hormone stimulated chicken hepatocyte compared with the rat hepatocyte.
These variations are most likely due to the use of different collagenase
types and methods to isolate the cells as explained previously, making
direct comparisons very difficult if not impossible.
Concentrations of glucagon well above those needed to produce maximum
effects are capable of maintaining the cAMP levels for longer periods
than lower hormone concentrations that also initially produce maximum
effect. This was also found with rat hepatocytes (Pilkis et al_. 1975) .
Decrease in the cAMP level on incubation must therefore be due to
hormone degradation. Hormone degradation is not accompanied by receptor
or cyclase degradation since after a fall in a once maximal cAMP level
the hepatocytes respond rapidly to further increases in glucagon
concentration although cAMP levels cannot be elevated above the initial
maximal values. High glucagon concentrations however only induce a
slow increase in intracellular cAMP in cells preincubated with adrenaline
suggesting the initial catecholamine enhanced nucleotide accumulation
antagonises further activation by glucagon.
Although insulin has been shown to considerably decrease submaximal
glucagon stimulated levels of cAMP in isolated rat hepatocytes (Pilkis
et al. 1975; Westwood and Siddle 1979) as well as perfused rat liver
(Exton and Park 1972) preincubation of chicken hepatocytes for 10 minutes
with pharmacological concentrations of insulin only slightly inhibited
the peak of cAMP production. Simultaneous addition of insulin and
glucagon to cell suspension failed to depress the peak of nucleotide
production. The reasons for this are unclear. In all cases however
high insulin concentrations markedly prevented total cAMP degradation in
the suspensions. This was only observed at pharmacological levels of the
hormone. This effect of insulin has also been reported for rat adipose
101.
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tissue. Concentrations of insulin above 10 M have been shown to
potentiate adrenaline stimulated cAMP and lipolysis in rat adipose tissue
(Desai et al. 1973; Hales et al. 1978). The reason for this response
was not known.
Intracellular cAMP degradation was not inhibited by insulin
suggesting that the rate of extracellular cAMP degradation must be
decreased. Extracellular degradation was due to a soluble factor and
was not associated with the exterior surface of the hepatocyte. The
method by which insulin suppresses the rate of cAMP degradation is not
known but may be due to one of the following:
1) Insulin, or a degradative product, directly inhibits the factor(s)
present in the extracellular medium which degrades cAMP.
2) Insulin, or a degradative product, binds extracellular cAMP preventing
degradation by the active factor(s).
3) Insulin inhibits the release of the degradative factor(s) from the
cell or plasma membrane.
4) Insulin inhibits re-entry of extracellular cAMP for degradation by
the intracellular phosphodiesterase.
Whatever the reason for the decreased cAMP loss from the suspension
it is unlikely that this phenomenon will have any physiological importance.
Neither APP nor ionophore A23187 when incubated with the hepatocytes
for varying periods, altered basal or hormone-stimulated cAMP levels.
This is in contrast to the decrease in glucagon stimulated cAMP response
by ionophore A23187 reported for rat hepatocytes (Westwood and Siddle
1979). It is possible that insulin lowering of cAMP levels in rat
hepatocytes involves increase in intracellular calcium and that some
component of the interdependent action of these two effectors is not
present in the chicken hepatocyte.
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Adenylate cyclase activity in cell homogenates was stimulated by
glucagon but no direct effect on the enzyme was noted on addition of
insulin or APP. This absence of a direct effect by insulin has been
reported by others (Pohl et al_. 1971; Thompson et ad. 1973; Pilkis
et al. 1974). The loss of cyclase activity during preincubation may be
as a result of endogenous GTP hydrolysis which is known to stimulate
the enzyme (Rodbell 1971b,c; Lad et. al^. 1977) .
Despite reports of insulin stimulated phosphodiesterase activity in
rat hepatocytes (Loten et ad. 1978) no effect was noted when using the
chicken hepatocytes. This was supported by the unchanged degradation
rates of intracellular cAMP in hepatocytes incubated with insulin.
Inconclusive results were obtained for the effects of the hormones
and ionophore A23187 on cellular cGMP. Due to the high variability
encountered in basal cGMP between and within individual experiments,
changes in cGMP concentration by up to 100% would not be detected.
However no gross changes in the basal nucleotide level similar to those
seen with cAMP were observed after incubation with various effectors
including insulin. A lack of effect by insulin on cGMP levels after
short (5 minutes) or long (60 minutes) term incubations was also
reported for rat hepatocytes (Flockhart and Siddle 1979) , with basal
concentrations of the guanine nucleotide in the rat of 20 pmol/g wet wt.
Summary
The chicken hepatocyte adenylate cyclase responds to glucagon with
up to ten fold lower sensitivity than that found with isolated rat
hepatocytes. Sensitivity to adrenaline, however, appears to be similar
to that reported for rat hepatocytes. Hepatocytes responded by large
increases in cellular cAMP of up to 60 times basal which are similar
if not higher in magnitude than those observed with rat hepatocytes.
As previously found for mammalian liver, saturating concentrations of
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adrenaline fail to activate the cyclase population to the extent of that
seen with saturating glucagon concentrations, resulting in lower cellular
cAMP levels. It appears that all the adenylate cyclase is activated by
glucagon, since adrenaline has no additional effect; presumably only a
small proportion of cyclase molecules is activated when all adrenaline
receptors are fully occupied. Insulin does not appear to significantly
lower submaximally stimulated cAMP levels as reported for rat hepatocytes.
Pharmacological insulin concentrations in some unknown way maintain the
level of extracellular cAMP for longer periods although this is not
thought to have any physiological importance. Insulin was also found
to have no effect on adenylate cyclase or phosphodiesterase activities.
Basal cGMP levels in the cell are approximately 100 fold lower than
those of cAMP and are not influenced by any of the hormones mentioned nor
by ionophore A23187.
CHAPTER 6




Both carbohydrate and lipid metabolism in the mammalian liver can
be directly regulated by the pancreatic hormones, insulin and glucagon
(Exton and Park 1972; McGarry et al. 1975). Great interest has been
shown in the antagonistic actions of insulin and glucagon on the rat
liver and hence a substantial literature has accumulated on this subject.
Although adrenaline is also capable of stimulating glucose release from
the liver in times of stress, glucagon is considered to be the most
physiologically important hormone for the production of glucose via
hepatic glycogenolysis and gluconeogenesis.
There have been many reports on the hormonal control of glycogeno¬
lysis and gluconeogenesis in rat hepatocytes (Johnson et al_. 1972;
Garrison and Haynes 1973; Tolbert and Fain 1974; Wagle 1975; Hue
et al. 1978; Pilkis et ad_. 1978) but studies of the control of lipid
metabolism in rat liver have been less frequent with fewer reports on
perfused rat liver, and liver slices (Meikle et_ ad. 1973; Raskin et al.
1974; Harris et_ al_. 1978) or hepatocytes ( Geelan and Gibson 1975).
Despite the lack of interest in lipogenesis in the rat hepatocyte
however, Goodridge and co-workers have carried out numerous investigations
into the high rates of lipid synthesis found in neonatal chicken
hepatocytes (Goodridge 1973, 1975; Goodridge et_ ad. 1974; Goodridge
and Adelman 1976); and it is only recently that any detailed study on
the hormonal control of carbohydrate metabolism in chicken hepatocytes
has been reported (Anderson and Langslow 1975; Dickson 1977? Dickson
et al. 1978; Dickson and Langslow 1978).
Both glucagon and adrenaline stimulate glucose release from rat
hepatocytes isolated from fed rats and also stimulate gluconeogenesis
from a number of different precursors in hepatocytes isolated from
starved rats (Johnson et al. 1972; Garrison and Haynes 1973; Tolbert
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and Fain 1974; Pilkis et_ al_. 1975) . Garrison and Haynes (1973) reported
half maximum stimulation of glucose production (ED^q) from rat hepatocytes
(glycogenolysis or gluconeogenesis) with glucagon concentrations around
-7
1.5 x 10 M. However if incubations were carried out for shorter time
intervals and if the oxidised $-chain of insulin was incorporated into
the medium as a protective agent against glucagon degradation, values
as low as 1.0 x 10 "*"°M were found. Even under the latter conditions the
glucagon dose response curve covered glucagon concentrations of over three
orders of magnitude. The lower value for half maximum stimulation
reported by Garrison and Haynes (1973) compares well with the figures
reported for glucagon infusion in the perfused rat liver where ED
-10 -9
values in the range 10 to 10 M were found (Exton and Park 1968;
Lewis et al. 1970; Exton et_ al. 1971a,b). Hue et al. (1978) reported
a half maximal stimulation of gluconeogenesis by glucagon in rat liver
-9
cells at 1 x 10 M with the dose response range over one order of
magnitude indicating a very sensitive cell preparation. Likewise Pilkis
et al. (1975) have reported ED values for gluconeogenesis from lactate
at glucagon concentrations of 3 x 10 10M. Again the dose response curve
covers a very narrow range of glucagon concentrations.
Adrenaline has a half maximal response in the perfused rat liver at
_8
concentrations around 10 M (Exton and Park 1968) with reported ED
-7
values for glucose release in rat hepatocytes varying from 2.0 x 10 M
_/r
(Tolbert et ad. 1973; Pilkis et ad. 1975) to 2.5 x 10 M (Garrison and
Haynes 1973). Again reported ED values for glycogenolysis and gluco¬
neogenesis are similar with values of 1.3 x 10 and 2.5 x 10
respectively (Garrison and Haynes 1973) . Reports by Pilkis et_ al_. (1975)
and Claus and Pilkis (1976) suggest that adrenaline is not capable of
stimulating gluconeogenesis to the same extent as glucagon in rat
hepatocytes. However this has not been found by others using perfused
rat liver (Exton and Park 1968; Exton et al. 1971a,b) or rat hepatocytes
(Garrison and Haynes 197 3) .
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Higher values reported for half maximum stimulation of glucose
release are probably induced by a loss in sensitivity due to the collagenase
digest (Garrison and Haynes 197 3; Pilkis et ad. 1975) . Generally the
effects of glucagon are noticeable at very low concentrations (10 and
below); however, the concentration of hormone needed to produce maximum
metabolic effect shows considerable variation. The higher the
concentration of hormone necessary to produce the maximum response the
higher the reported value for and the lower is the sensitivity of
the cell preparation.
Maximum stimulatory effects of glucagon and adrenaline on gluconeo-
genesis in rat hepatocytes have been reported to be additive (Tolbert
and Fain 1974) indicating two independent stimulatory mechanisms which
both fail to saturate the metabolic effect. However this finding has
not been supported by other workers using rat hepatocytes (Pilkis et al.
1975; Hue et al_. 1978) or chicken hepatocytes (Anderson and Langslow
1975), where the maximum effect by glucagon could not be potentiated by
addition of adrenaline. However it is becoming increasingly apparent
that the actions of the catecholamines on the liver takes place mainly
in the rat
via the cAMP-independent a-receptor^(see Chapter 1 and review by Pilkis
et al. 1978).
Chicken hepatocytes have been reported to show similar responses to
rat hepatocytes with respect to glucagon stimulated gluconeogenesis
(Dickson and Langslow 1978) and glycogenolysis (Dickson el: al_. 1978) .
Although the dose response range of glucagon in perfused rat liver and
isolated rat hepatocytes was found to be the same for both glycogenolysis
and gluconeogenesis with similar concentrations inducing half maximal
response (Lewis et al. 1970; Garrison and Haynes 1973), the ED values for
50
these metabolic pathways differ by an order of magnitude in chicken
-9
hepatocytes. A glucagon concentration of 9.0 x 10 M was required to
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produce half maximal stimulation of glycogenolysis with the effect
-7
saturating at 10 M (Dickson 1977; Dickson et al_. 1978) whereas glucagon
at 7.7 x 10 10M was sufficient to produce half maximal stimulation of
gluconeogenesis (Dickson 1977; Dickson and Langslow 1978). However, if
the stimulation of gluconeogenesis failed to reach saturation,a lower Ed^q
value would result. If indeed a difference in half maximal stimulation
does exist between the two pathways, this suggests that the rate limiting
step for stimulation of gluconeogenesis in chicken hepatocytes lies
beyond the level of the hormone receptor.
Dickson et_ al_. (1978) have also shown that adrenaline stimulates
-9
glycogenolysis in the chicken hepatocyte with an ED^q at 3.5 x lO M and
-7
saturation at 10 M. Low levels of adrenaline therefore appear to ,be
much more effective in chicken hepatocytes than in rat hepatocytes, with
-9
concentrations as low as 1 x 10 M showing a considerable stimulation
of glucose release.
Dibutyryl cAMP (Bt^cAMP) has been shown to stimulate glycogenolysis
-7 -7
and gluconeogenesis in rat hepatocytes (ed^q at 4.5 x 10 M and 7-.-0 x 10 M
respectively - Garrison and Haynes 1973) and chicken hepatocytes (ED^Q
approximately 2 x 10 - Dickson 1977) . In both systems the cyclic
nucleotide was capable of giving a maximum stimulation comparable with
glucagon. The dose response curves for Bt2CAMP are almost identical for
glycogenolysis or gluconeogenesis in the chicken hepatocyte (Dickson 1977)
in spite of their ten fold difference in sensitivity to glucagon as
reported above. This indicates that some other glucagon stimulated
factor besides cAMP may be responsible for the enhanced gluconeogenic
rate at low hormone concentrations.
Insulin antagonises the effects of glucagon and adrenaline on glyco¬
genolysis and gluconeogenesis in the rat liver (Exton and Park 1972) and
rat hepatocytes (Johnson et al. 1972; Wagle 1975; Hue et al. 1978).
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However insulin has been reported not to effect glycogen deposition nor
basal or hormone stimulated glucose release in hepatocytes isolated from
fed or starved chickens (Anderson and Langslow 1975). This lack of
effect of insulin on the hepatocyte is in agreement with the apparent
insensitivity of the chicken to intravenous injections of the hormone
(see Chapter 1) .
There have been numerous reports on the control of lipogenesis in
the chicken liver (Allred and Roehrig 1972; Goodridge 1973; 1975;
Capuzzi et al_. 1971; 1974; Watkins and Lane 1976) . Glucagon inhibits
-9
lipogenesis in the chicken hepatocyte with an of 2 x 10 M (Goodridge
-4
1973) as does Bt^cAMP with an of 1 x 10 M (Capuzzi et_ al_. 1974) .
Watkins and Lane (1976) suggested that the inhibition of lipogenesis by
glucagon or Bt^cAMP was due to a decrease in intracellular citrate,
the allosteric activator of acetylCoA carboxylase. These workers concluded
that the actions of glucagon and Bt^cAMP were due to inhibition of the
glycolytic pathway resulting in a decrease by up to 90% in the intra¬
cellular citrate concentration.
Insulin has been reported to increase basal lipid synthesis by
approximately 15% in chicken hepatocytes and also to depress the inhibition
imposed by cAMP (Capuzzi et al. 1971) . This appears to be the only
report suggesting a direct action of insulin on the isolated chicken
hepatocyte.
Methods
Hepatocytes isolated from fed chickens were used in investigations
of glycogenolysis and lipogenesis. Hepatocytes isolated from 24 hour
starved birds were used in the gluconeogenesis experiments. All isolations
were carried out using a high potassium content KRB buffer (see Chapter 3)
to prevent glycogenolysis and loss of glucose during preparation
(Dickson 1977).
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Immediately after isolation, the cell suspension was diluted with
fresh normal KRB buffer to give concentrations in the range 6 to 10 x 10^
cells/ml, and dispensed into plastic incubation pots (25 x 75 mm).
If required, hormones or effectors/ere added to the pots in small volumes
(10 to 25 fj.1) before addition of the cell suspension. Pots were gassed
for 10 to 20 seconds with 95% 0^/5% CO^ and incubated at 37°c in a
reciprocal shaking waterbath (120-140 strokes/minute). After the
required incubation times cells were pelleted by centrifugation (2750 g;
1 min) and processed for the determination of glycogen or incorporation
of j^cj-acetate into lipid as outlined in Chapter 2. The supernatant
was also sampled for estimations of glucose released to the external
medium (see Chapter 2).
Results
1) Glycogenolysis
As reported in the results for glucagon induced cAMP accumulation
in hepatocyte suspensions (Chapter 5), the sensitivity of the cell
suspension was dependent on which batch of collagenase was used to
prepare the cells. However only slight variations in the concentration
range of hormone stimulation was found using cells prepared using the
same batch of collagenase with dose response curves giving virtually
identical plots. Batch 17 collagenase again produced the most sensitive
cell preparation compared to the other batches tested (25, 29 and 30).
a) Time course of glucose release. The average glycogen content of
hepatocytes isolated from fed birds was 30.32 - 5.02 pg glucose
equivalents/10^ cells (standard deviation: n = 7). The basal rate of
glucose release and glycogen content of the hepatocytes is shown in
Fig. 6.1. An approximately linear rate of glucose accumulation in the
6
external medium was found with about 13 jog glucose released per 10 cells
per hour. This was accompanied by a parallel linear decrease in glycogen
12 24 31 41 M
TIME (minutas)
6-1 Basal glucose release (□-□), glycogen content (A-A) and
total carbohydrate (0-0) in cell suspensions incubated at 37°c.
TIME (minut«s)
Fig. 6.2 Glucagon (10 ng/ml) stimulated glucose release (□-□) with
resulting glycogen content (A-A) and total carbohydrate (0-0) in cell
suspensions incubated at 37°c.
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content of the cells although nearly 20 jag of glycogen, measured as
glucose equivalents (see Chapter 2) was lost in one hour.
In the presence of saturating concentrations of glucagon (10 ng/ml;
-9
2.9 x 10 M) the rate of accumulation of glucose in the external medium
was approximately doubled and loss of cellular glycogen was greatly
accelerated (Fig. 6.2). After only 20 minutes incubation, 13 pg of
6
glucose was released per 10 cells, and within 30 minutes the glycogen
content was depleted to the same level found for one hours incubation
in the absence of glucagon. In the presence of glucagon the total
carbohydrate content (glucose plus glycogen) of the cell suspension
remained relatively constant for 60 minutes. Although there was an
initial decrease in total carbohydrate content up to 10 minutes of
incubation this was gradually replenished with longer incubation,
b) Glucagon dose response curve for glucose release. As mentioned above,
the sensitivity of the cells varied depending on the batch of collagenase
used during the initial preparative stages of isolation. The most
sensitive preparations were consistently found using batch 17. Fig. 6.3
shows the release of glucose and loss of glycogen from cells incubated
in the presence of varying concentrations of glucagon for 30 minutes
at 37°c. Concentrations of glucagon at 0.15 ng/ml (4.4 x 10 ^M) showed
significant elevations in glucose release and glycogen breakdown. Half
maximal effect was found with glucagon concentrations of 0.6 ng/ml
-10 -9
(1.7 x 10 M) and maximum effects with 5 ng/ml (1.44 x 10 M). However
all the later batches of collagenase used (25, 29 and 30) showed much
lower sensitivities (Figs. 6.4, 6.5 and 6.6 respectively). Half maximal
stimulations were found at concentrations of 2.6 ng/ml (7.5 x 10 ^°M) -
-9 -9
batch 29; 3.8 ng/ml (1.09 x 10 M) - batch 25; and 9.6 ng/ml (2.8 x 10 M)
- batch 30. Values reported are averages for two experiments using
individual cell preparations isolated with the same batch of collagenase.
10
Fig. 6.3 Glucagon dose response for glucose release (•-•) and glycogen
loss (0-0) from cell suspensions incubated for 30 minutes at 37 c.
Values obtained in the absence of hormone subtracted from all points.
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Fig. 6.4 Glucagon dose response for glucose release. Cells prepared
using batch 25 collagenase.
<i
01 1 It 100
[GLUCAGON] ng/ml
Fig. 6.5 Glucagon dose response for glucose release. Cells prepared
using batch 29 collagenase.
[GLUCAGON] ng/ml
Fig. 6.6 Glucagon dose response fa:" glucose release. Cells prepared
by batch 30 collagenase incubated with (A-A) or without (•-•) Bt cGMP
(0.2 yM).
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Incorporation of soya bean trypsin inhibitor (20 pg/ml) throughout
the preparative stages of cell isolation did not increase cell sensitivity.
Fig. 6.7 shows the glucagon dose response curve for glucose release using
cells prepared by batch 25 collagenase with added trypsin inhibitor.
Half maximal effect was found at 3.2 ng/ml(9.1 x 10 ^°M)which compares
well with cell preparations without the inhibitor. The inhibitor did
not effect cell yield nor the percentage of cells which stained with
trypan blue.
Addition of bacitracin (0.5 mg/ml) to the 30 minute incubations with
glucagon did not alter the shape or position of the dose response curve
(Fig. 6.7). Half maximum stimulations of glucose release were found at
the same glucagon concentration and low concentrations of the hormone
produced identical effects under both conditions.
Addition of Bt cGMP (0.2 pM) induced a slight increase in basal or
submaximally glucagon stimulated glucose release (Fig. 6.6).
c) Adrenaline dose response. The chicken hepatocyte also showed a high
affinity for adrenaline. Cells prepared by batch 17 collagenase produced
half maximal stimulation with adrenaline concentrations of 17.4 ng/ml
—8
(9.5 x 10 M) with maximal effect at concentrations at 100 ng/ml
(5.3 x 10 *^M) or above (Fig. 6.9) . Using batch 25 collagenase to prepare
the cells the dose response curve was not as symmetrical and half maximal
stimulation was found at adrenaline concentrations of approximately
"7 —^
25 ng/ml (1.36 x 10 M) with maximum effect at lOOO ng/ml (5.5 x 10 M)
(Fig. 6.8) .
d) Glucagon-adrenaline relationship (Table 6.1). Maximal effects of
glucagon and adrenaline on glucose release were not additive. Adrenaline
(1 pg/ml) was capable of producing a maximum stimulation of glucose
release from the hepatocytes similar to that found using saturating
glucagon concentrations.
0-1 1 1t 1*0
[G LUCAGON] ng/ml
Fig. 6.7 Glucagon dose response for. glucose release. Cells prepared
using batch 25 collagenase containing added soya bean trypsin inhibitor.
Cells incubated with (□-□) or without (•-•) bacitracin (0.5 mg/ml) .
[ADRENAL I NE] no/ml
Fig. 6.8 Adrenaline dose response for glucose release,
by batch 25 collagenase.
Cells prepared
[ADRENAL INE] no/ml
Fig. 6.9 Adrenaline dose response for glucose release. Cells
prepared by batch 17 collagenase. Glucose release in absence of
hormone subtracted from all points.
Table 6.1: Glucose release - Effect of maximum concentrations of
Glucagon and Adrenaline.
Cell suspension incubated for 30 minutes at 37°C with or without hormone
and glucose release determined. Batch 17 collagenase used to prepare
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e) Insulin, APP and ionophore A23187. Neither porcine or chicken
insulin (10 or 500 ng/ml) nor APP (10 or 500 ng/ml) showed any significant
effect on basal glucose release from hepatocytes from fed birds
(Figs. 5.10 and 5.11). However ionophore A23187 (5 yg/ml) showed a
substantial increase in glucose accumulation in the medium (Fig. 6.10).
Although insulin (10, 100 or 500 ng/ml) again showed no significant
effect on submaximally stimulated glucagon levels, increasing APP
concentrations (10 to 500 ng/ml) resulted in a small progressive increase
in glucose release. Ionophore A23187 exhibited a biphasic effect on
hormone stimulated glucose release. Low concentrations of ionophore
(0.1 and 0.5 yg/ml) showed significant inhibition of glucose release
whereas high concentrations (1 or 5 yg/ml) gave marked stimulations
(Figs. 6.10 and 6.11). However, higher concentrations of the ionophore
(10 yg/ml) produced a marked inhibition in glucose release. The inhibition
at lower concentrations is most probably due to the ethanol in which
the stock ionophore is dissolved. Fig. 6.12 shows the inhibition of
glucose release by various ethanol concentrations. The ethanol content
at different ionophore concentrations is also given and it can be seen
that glucose release is inhibited to approximately the same extent at
nearly all ethanol concentrations.
Incubation of cells results in a progressive decrease in glycogen
content (Fig. 6.1). Addition of physiological glucose concentrations
(15 mM) to cell incubations reduced the glycogen loss after one hour
by 25 to 30%. Further addition of either porcine or chicken insulin
(0.001 to 100 ng/ml) to the medium did not increase glycogen content of
the cells. Incubation of cells with increasing APP concentrations
showed a slight preservation of glycogen content although glucose output
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Fig. 6.10 Effect of insulin, AP? and ionophore A23187 on basal and
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Fig. 6.11 Effect of ionophore A23187 and APP on basal glucose release
and glycogen content after 30 minutes incubation. (•) denotes the
values in the absence of effector.
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Fig. 6.12 Inhibition of basal glucose release in the presence of
ethanol-Ionophore concentrations in cell suspensions necessitated
the following ethanol concentrations.








f) Cyclic AMP and Dibutyryl cAMP. Cyclic AMP and the synthetic derivative
dibutyryl cAMP (Bt2cAMP) also stimulated glucose release (Figs. 6.13 and
6.14 respectively). Bt^cAMP was much more effective with a maximum
stimulation of glucose release over basal of over 200% at a concentration
of 5 x 10 ~*M. Half maximal response was found at 1.58 x 10 ^M.
Relatively higher concentrations of cAMP were required to produce similar
effects on glucose release. Half maximal stimulation was found at
-5 -4
5.0 x 10 M with minimum response at 6.0 x 10 M. Cyclic AMP also failed
to stimulate glucose release to the same extent as Bt^cAMP with only a
170% stimulation being found.
2) Gluconeogenesis
The control of gluconeogenesis was studied by monitoring the rate
of incorporation of lactate into glucose in hepatocytes isolated from
24 hour starved birds. The glycogen content of these hepatocytes was
always below measurable amounts under the conditions used (less than
6
0.5 jig glucose equivalentsylO cells).
a) Time course. Fig.6.15 shows the time course of glucose output of the
cells incubated in the presence of lactate (1.25 or 2.5 mM) with or
without glucagon (100 ng/ml). Only small stimulations of glucose
release were found which were more apparent at shorter time intervals.
b) Dose response to lactate. Fig. 6.16 shows the production of glucose
after 30 minutes incubation with various lactate concentrations.
A linear response was only found with concentrations up to 1.5 mM.
Higher concentrations, up to 10 mM, gradually saturated the rate of
production of glucose from lactate resulting in maximum rates around
10 jug glucose per 10^ cells per 30 minutes.
c) Glucagon and adrenaline. Cell suspensions prepared using batch 25
collagenase, were incubated in the presence of 1.5 mM lactate for
20 minutes in the presence of varying concentrations of glucagon (Fig. 6.17)
or adrenaline (Fig. 6.18). Both hormones induced maximal increases of
around 30% over basal. Half maximum activation of gluconeogenesis under
[ c A M p] y M
Fig. 6.13 cAMP dose response for glucose release.
1
T
,■ 1 1 > i
,-i i '•
[ Btj c AMP ] fiM




Fig. 6.15 Gluconeogenesis from lactate in the absence, 1.25 mil;
0-0 2.5 mM; or the presence 1.25 mM, 2.5 mil, of glucagon (100 ng/
ml). Glucose release in the absence of lactate subtracted from all
points.
[lactate] mm
Fig. 6.16 Gluconeogenesis - glucose production from cells incubated
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STIMULATION OF GLUCONEOGENESIS FROM LACTATE ( 1-5 mM ) 3Y ADRENALINE.
Fig. 6.18
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these conditions was found at concentrations of 1.68 ng/ml (4.8 x 10 ^°M)
_ s
glucagon and 3.8 ng/ml (2.08 x 10 M) adrenaline. High concentrations
of adrenaline (100 ng/ml) but not glucagon resulted in a slight reduction
in the stimulation of gluconeogenesis (Fig. 6.18).
d) APP (10 or 100 ng/ml) did not effect basal or hormone stimulated
gluconeogenesis from lactate (1.5 mM) under the conditions mentioned above.
3) Lipogenesis
Lipogenesis was studied by the incorporation of acetate into tri¬
glyceride using cell suspensions prepared using batch 25 collagenase.
Hepatocytes isolated from fed birds were used in all experiments.
a) Time course. Fig. 6.19 shows the time course of acetate incorporation
into cellular triglyceride. 1 CJ-Acetate (2.5 mM) was incubated in the
presence of cell suspension with or without insulin (lOO ng/ml) and/or
glucagon (5 ng/ml). Cells were reoxygenated after one hour's incubation.
Linear rates of tracer incorporation into triglyceride were found with
up to 90 minutes of incubation. Glucagon markedly decreased the rate of
incorporation whereas insulin had no effect on basal or glucagon reduced
rates.
b) Glucagon and adrenaline. Cells were incubated for one hour with 2.5 mM
acetate with or without various concentrations of glucagon or adrenaline
(Figs. 6.20 and 6.21). Basal rates of acetate incorporation under these
conditions was generally in the range 20 to 25 nmol acetate incorporated
per 106 cells per hour. Although both glucagon and adrenaline were
capable of reducing acetate incorporation into triglyceride by as much as
90%, neither hormone induced complete inhibition of lipogenesis. Half
maximum effect of glucagon ranged from 3.5 to 3.8 ng/ml(1.00 to 1.09 x
-9 -9
10 M) with maximum effect around 12 ng/ml (3.4 x 10 M). Adrenaline
_8
was half maximally effective at 12.6 ng/ml (6.9 x 10 M) with maximum
-7
effect at 30 ng/ml (1.6 x 10 M).
Fig. 6.19 Incorporation of acetate (2.5 mM) into cellular triglyceride
in the absence of effector (O-O) or in the presence of glucagon
(5 ng/ml) (□-□); insulin (500 ng/ml) (•-•) or insulin (500 ng/ml)
plus glucagon (5 ng/ml) (■-■).
Fig. 6.20 Glucagon dose response for triglyceride synthesis from acetate
mM) (•-•). A indicates the effect of theophylline (10 mM) on basal(2.5
triglyceride synthesis.
-1 — ? ! I
0-1 1 10 100 1000
[ADRENALINE] ng/ml
Fig. 6.21 Adrenaline dose response for triglyceride synthesis from
acetate (2.5 mM).
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c) APP. Basal or glucagon inhibited lipogenesis was not effected by
APP (1 to 1000 ng/ml).
4) Effects of Caffeine and Theophylline
Cells isolated by method A (see Chapter 3) were used for the majority
of the experiments incorporating these phosphodiesterase inhibitors.
However similar if not identical characteristics were found when using
cells prepared by method B (see Chapter 3). Although theophylline
successfully maintained hormone stimulated intracellular cAMP levels in
the hepatocytes (see Chapter 4), a wide range of concentrations of
theophylline and caffeine inhibited glycogenolysis from hepatocytes
isolated from fed birds (Figs. 6.22 and 6.23) and gluconeogenesis from
lactate in hepatocytes isolated from starved birds (Fig. 6.24).
The methylxanthines (10 rnM) were found to inhibit basal, hormone or
Bt^cAMP stimulated gluconeogenesis from lactate (2.5 mM) or fructose
(2.5 mM) by 40 to 70% (Table 6.2). Incubation of cell suspension in the
presence of theophylline or caffeine did not increase the percentage of
cells which stained with trypan blue. The effects of the methylxanthines
on glucose release could be reversed by washing the cells by three
repetitive centrifugations (50 g; 2 min) and resuspension in fresh KRB.
These cell^ which were relieved of the inhibition by washing were still
sensitive to the re-addition of caffeine or theophylline. Theophylline
also decreased lipogenesis from acetate by 50% (Fig. 6.20) and decreased
intracellular ATP content by nearly 30% (Fig. 6.25).
Discussion
The main difficulty in quantitatively assessing the results obtained
in this work and the comparison with figures reported by others, has with
the variability in cell sensitivity to the hormone studied. The apparent
sensitivity does not only depend on the individual method used during the
preparative procedure but is also dependent on the quality of collagenase




Fig. 6.22 Effect of caffeine on basal (•-•) and glucagon stimulated
(10 ng/ml) (■-■) glucose release after 30 minutes incubation at 37°C.
[THEOPHYLLINE] mM
Fig. 6.23 Effect of theophylline on basal glucose release
after 30 minutes incubation at 37 c.
It
[CAFFEINE] mM
Fig. 6.24 Effect of caffeine on basal and glucagon (10 ng/nl)


















































































initial ■After 30 minutes incubation-
Fig. 6.25 Effect of caffeine on cellular ATP content. Error bars
indicate standard deviation of 4 estimates from one representative
experiment.
116.
induced marked variations in the sensitivity of the isolated cells,
therefore direct quantitative comparisons could only be made with cells
prepared using the same collagenase batch number.
Cells isolated from fed birds contained glycogen stores comparable
with those reported by Dickson (1977) . Incubation of cells resulted
in a gradual decrease in total carbohydrate in the cell suspension.
Cellular glycogen was continually degraded to glucose and then either
released to the external medium or, presumably, used for cell respiration.
In the presence of glucagon, however, the total carbohydrate content of
the cell suspension was conserved indicating that the hepatocytes were
using some other energy source (protein and/or lipid deposits) for
respiration: in the presence of glucagon total cell suspension carbohydrate
was initially reduced and then re-elevated but never exceeded the initial
glycogen content of the cells. This suggests that gluconeogenesis from
various endogenous precursors is activated by glucagon to maintain the
carbohydrate store of the cell.
Due to the difficulties in maintaining cell sensitivity as mentioned
above, the affinity for glucagon varied over a ten fold range. The most
sensitive preparations, with half maximum effect of glucagon on glyco-
— 10 —8
genolysis at 1.7 x 10 M and adrenaline at 9.5 x 10 M probably gives
the closest reflection of the in vivo sensitivity of the liver cell to
the hormones. Immunoreactive glucagon present in peripheral blood of
starved chickens has been reported to be up to 3 or 4 x 10 (Samols
et al. 1969; Krug et al. 1976) and presumably the glucagon immunoreactivity
in the portal blood will be considerably higher. However, after
pancreatectomy approximately half of the glucagon immunoreactivity still
remains in the blood which indicates that only 50% of the circulating
glucagon estimated by radioimmunoassay is derived from the pancreas
(Krug et al. 1976). The extra pancreatic source of this glucagon-like
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immunoreactivity (GLI) is the ileum and jejunum of the gut. Gut GLI has
been suggested not to be active in carbohydrate metabolism in the chicken
liver (Krug and Miahle 1971) suggesting that the liver is exposed only
to low concentrations of active pancreatic glucagon (1 to 2 x 10 ^°M).
Obviously the extent of the pancreatectomy is very important (see Chapter 1).
Although the sensitivity to glucagon was over fifty fold greater than
-9
reported by Dickson et_ al_. (1978) (ED5q of 9.3 x 10 M) the sensitivity
of the cells to adrenaline was over one order of magnitude lower. Since
no reports were made of different batches of collagenase being used to
prepare the cells during their studies, it must be assumed that different
hormone-effector systems are not desensitised to the same extent during
cell isolation and that different types of collagenase may specifically
affect certain hormone receptor systems to a greater extent than others.
Both glucagon and adrenaline stimulated glycogenolysis by nearly 200%
and gluconeogenesis from lactate by 30%. These values are slightly lower
than those reported for rat hepatocytes (Garrison and Haynes 1973) and
perfused rat liver (Exton and Park 1968) but compare well with previous
reports using chicken hepatocytes (Dickson 1977; Dickson et al. 1978).
Using cell preparations with lower affinity, half maximum stimulation
of gluconeogenesis was found with much lower concentrations of glucagon
and adrenaline than needed to produce half maximal stimulation of glyco¬
genolysis. Glucagon produced an ED^0 at 9.1 x 10 "^°M for glycogenolysis
and 4.8 x 10 for gluconeogenesis (both batch 25 collagenase). Likewise
-7
adrenaline produced an ED at 1.36 x 10 M for glycogenolysis and
_g
2.08 x 10 M for gluconeogenesis (again batch 25 collagenase). Although
no differences in estimated ED_ values have been found for hormone
50
stimulated glycogenolysis or gluconeogenesis in the rat (Garrison
and Haynes 1973; Lewis et al_. 1970) other workers using chicken
hepatocytes also report similar variations in ED,_0 values for the two
pathways (Dickson 1977; Dickson et al^. 1978; Dickson and Langslow 1978).
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Dibutyryl cAMP and cAMP produced similar stimulations of glycogenolysis
to glucagon or adrenaline, indicating that both hormones stimulate this
process via the cyclic nucleotide. Bt^cAMP is much more effective at
lower concentrations and also produces a slightly greater stimulation
than cAMP, which is possibly due to both its enhanced solubility in the
plasma membrane and a relatively lower affinity for phosphodiesterase.
Concentrations producing half maximum stimulation of glycogenolysis
(1.5 x 10 ^M) are almost identical to those reported for chicken hepatocytes
"~6
by Dickson (1977) (2.0 x 10 M). Since Bt^cGMP showed a small increase
in basal or submaximally hormone stimulated values it is unlikely that
this intracellular nucleotide is responsible for the antagonistic effects
of insulin as found in the rat (Exton and Park 1972; Wagle 1975).
APP was found to have no effect on gluconeogenesis from lactate or
lipogenesis from acetate. However weak reproducible effects were noted
on glucagon stimulated glycogenolysis where APP slightly potentiated
glucose release. This may be due to the protection of glucagon from
degradation since APP alone had no effect on glucose release. However
addition of bacitracin; a potent inhibitor of glucagon degradation, did
not potentiate the glucagon response. There was also a small decrease
in the basal rates of glycogen breakdown in the presence of APP but
there was no simultaneous effect on glucose release. A more detailed
study of these effects would have to be carried out before any valid
conclusion could be made. However APP does not directly enhance glycogen
breakdown or inhibit lipogenesis in the liver cell suggesting that the
effects in vivo of this hormone (Chapter 1; Hazelwood et al. 1973) are
not due to a direct action on the liver. McCumbee and Hazelwood (1976)
have also reported a lack of effect of APP on isolated chicken hepatocytes
but found that APP was capable of inhibiting lipolysis in chicken
adipocytes.
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The different ED^Q values reported in this work were not due to a shift
in .the entire dose response curve to lower concentrations but mainly to
a saturation of response at lower hormone concentrations. Therefore the
hormonal effects on gluconeogenesis saturate at lower levels of hormone
occupancy than are necessary to fully stimulate glycogenolysis.
Using batch 25 collagenase, half maximum inhibition of lipogenesis
-9
occurs with glucagon and adrenaline concentrations of 1.04 x 10 M and
_ 8
6.9 x 10 M respectively. The dose response to glucagon compares well
with that found for stimulation of glycogenolysis. However the
concentration of adrenaline which induces half maximal inhibition of
lipogenesis is intermediate between values obtained for gluconeogenesis
and glycogenolysis. The low value reported for gluconeogenesis is again
due to the effect saturating at low concentrations of adrenaline and
not due to increased sensitivity at low hormone concentrations. The
apparently high concentration of adrenaline necessary to half maximally
stimulate glycogenolysis is due to the assymetric shape of the dose
response curve (Fig. 6.8) which fails to completely saturate the effect
at high hormone concentrations. Although the reason for this shape of
the curve is unknown, it may result from altered adrenaline binding to
the a and/or 3 type receptors induced by proteases in batch 25 collagenase.
This skewed curve is not observed when studying inhibition of lipogenesis.
This may be due to the hormonal effect being mediated by a different
receptor population than that for glycogenolysis. The 90% maximum
inhibition of lipogenesis by either glucagon or adrenaline compares well
with the reported 90% maximum reduction in intracellular citrate
concentrations in the presence of these hormones (Watkins and Lane 1976).
This work therefore generally supports the theory that hormonal inhibition
of lipogenesis is due to a decrease in intracellular citrate.
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Insulin (porcine or chicken) was found to have no effect on glyco-
genolysis, glycogen synthesis or lipogenesis, alone or in the presence
of glucagon. A lack of effect of insulin on glycogenolysis in the
chicken hepatocyte had been previously reported (Anderson and Langslow
1975). The stimulation of hepatic lipogenesis reported by Capuzzi et al.
(1971) could not be repeated. It is therefore concluded that under the
conditions used, insulin has no direct biological effect on carbohydrate
and lipid metabolism in the chicken hepatocyte.
The complex effect of ionophore A23187 on glycogenolysis was due
both to the carrier ethanol and the ionophore itself. Ethanol reduces
glucose output from hepatocytes isolated from fed birds by 20 to 30%
over a wide range of concentrations. Similar reductions in gluconeogenesis
in the presence of ethanol have been found previously (Dickson 1977).
The ionophore however succeeds in stimulating glucose output in the
presence of ethanol with a corresponding decrease in glycogen content.
This glycogenolytic effect of the ionophore has been reported by others
using rat hepatocytes (Westwood and Siddle 1979).
Theophylline and caffeine are both potent inhibitors of cAMP phospho¬
diesterase and have been widely used to potentiate the actions of
glucagon on cAMP accumulation. Theophylline maintained hormone stimulated
levels of cAMP in the chicken hepatocytes (see Chapter 4) and also
potentiated glucagons effect in rat hepatocytes (Pilkis et al. 1975;
Sonne et al. 1977; Westwood and Siddle 1979). However these methylxan-
thines were found to inhibit basal or glucagon stimulated effects on
cell metabolism. Miller et al_. (1974) have reported an inhibition of
glycogen phosphorylase activity by theophylline which reduces basal or
glucagon stimulated glucose release from rat liver slices. This would
explain the decrease in glycogenolysis found in hepatocytes isolated
from fed birds but would not however account for the decrease observed
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in gluconeogenesis or lipogenesis. No gross morphological damage to the
hepatocytes was detected and this was supported by the ease in reversing
the effects of the methylxanthines by simply washing the cells. It is
concluded that the methylxanthines, besides inhibiting phosphodiesterase,
also markedly decrease the metabolic flux through the major carbohydrate
and lipid pathways of the chicken liver. The method by which this is
carried out is uncertain but may be due to a general decrease in cellular
respiration since both ATP content and oxygen consumption of the cells is
lowered (see Chapter 3). The site of action of the methylxanthines is
unknown.
Summary
Both glucagon and adrenaline were capable of producing identical
stimulations of glycogenolysis and gluconeogenesis while inhibiting
lipogenesis in chicken hepatocytes. Concentrations of the hormones which
induced these effects were similar to the physiological levels in the
blood. Although insulin failed to show any direct effects on lipid or
carbohydrate metabolism on the hepatocytes, APP tended to maintain the
glycogen content of the cells during incubation and high concentrations
slightly potentiated glucagon action on glucose release in hepatocytes
isolated from fed birds. It is not known if this is of any physiological
importance or if the effects reported are secondary to some non-
physiological effect of the hormone. Ionophore A23187 is also capable
of stimulating glycogenolysis in the hepatocytes although the effects
were antagonised by the carrier ethanol. This suggests that increasing
2+
intracellular Ca levels can also stimulate glycogen breakdown probably
via direct activation of phosphorylase kinase (see Chapter 5). The
methylxanthines although potentiating the actions of glucagon on cAMP
production inhibit basal or hormone stimulated glucose release from
glycogenolysis or gluconeogenesis and also inhibit lipogenesis in the
122.
chicken hepatocyte. It is suggested that as well as inhibiting phospho¬
diesterase the methylxanthines also have an unknown non-specific
inhibitory effect on cell metabolism leading to lowered cell respiration,




Hepatocytes isolated from the liver of the domestic fowl have been
used to study the direct effects of the pancreatic hormones. With
incubation at 37°c, cells isolated using the recirculating perfusion
method retained their cellular viability in cell suspensions for at least
one (hepatocytes isolated from starved birds) to three hours (hepatocytes
isolated from fed birds), provided the medium was adequately oxygenated.
Preparation of cell suspensions at 37°C increased the likelihood of
anoxia during isolation procedures, resulting in lower intracellular ATP
and glycogen contents. However, the hepatocytes quickly recovered and
displayed biological and physical characteristics similar to, if not
better than, the original isolation method (see Chapter 3; Dickson 1977;
Dickson et_ ad. 1978). Although cell sensitivity to the pancreatic
hormones and adrenaline was highly dependent on the extent of an endogenous
protease contaminant of the collagenase, physiological concentrations
of the hormones were shown to be effective in receptor binding and/or
inducing a metabolic response.
Therefore the isolated chicken hepatocyte proved to be the ideal
model for the study of the short term hormonal control of carbohydrate
and lipid metabolism in the chicken liver and allowed a direct comparison
to be made with the rat hepatocyte and also with the previous reports
of studies in_ vivo carried out with the chicken. It must however be
accepted that in preparation of the isolated hepatocytes it is possible
to induce major changes in cell structure which ultimately may lead to
an altered metabolic balance within the cell. Results which do not
parallel well established responses in vivo must be carefully analysed
and interpreted with respect to the conditions used for the study.
Birds show a relative imbalance in the sensitivities shown to intra¬
venous injections of glucagon and insulin compared to the rat and most
other mammals. In mammals, insulin is the most potent hormone,
physiologically regulating carbohydrate and lipid homeostasis. However
in the bird, although insulin circulates in the blood at similar
concentrations to those found in the mammal, glucagon is the most
important pancreatic hormone. This imbalance is reflected in the
apparent hyposensitivity in vivo to insulin and hypersensitivity to
glucagon, which may be partially or entirely responsible for the higher
blood glucose levels found in the bird even after prolonged starvation.
The hypersensitivity to glucagon found in vivo in the bird was also
reflected in the response found with the isolated hepatocyte. Glucagon
which circulates in the peripheral avian blood at concentrations up to
4 x 10 "^M in the starved state , binds specifically to a receptor
molecule present in the isolated hepatocyte which has a dissociation
-9
constant for the hormone of 9.44 x lO M. Even assuming there is a ten
fold increase in glucagon concentration in the portal blood only a
small population of the total receptor number would be occupied under
the highest possible physiological concentrations of the hormone.
Glucagon also stimulated adenylate cyclase with a resultant increase
in intracellular cAMP. Induction of this second messenger showed half
-9
maximal stimulation at a glucagon concentration of 13 x 10 M which
compares favourably with the value found for the dissociation constant
reported for hormone binding. A parallel relationship appears to exist
between hormone binding and induction of cAMP accumulation suggesting
that the high affinity glucagon receptor:adenylate cyclase ratio is
approximately one to one. The degree of cAMP accumulation and the steady
state occupancy of glucagon binding sites has also been shown to be near
identical in rat hepatocytes (Soman and Felig 1978; Sonne et al. 1978).
Others have not found a parallel relationship between cyclase activation
and steady state binding (Birnbaumer and Pohl 1973; Rosselin et al.
1974). These latter workers however did not analyse the binding data
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in terms of two components, therefore obtaining high values for K
d
(see Chapter 4) . Sonne et al_. (1978) , although finding that the dissociation
constant for receptor binding to a high affinity component at the steady
state (7.0 x 10 ^°M) was almost identical to the value for cyclase
activity after 3 minutes, the occupancy of glucagon binding within
3 minutes did not coincide with cyclase activation. Glucagon
—8
concentrations of 3 x 10 M was required to half saturate binding after
-9
3 minutes whereas ED for cyclase activation was about 1 x 10 M.
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If one relates my results to physiological levels of circulating
glucagon, it appears that relatively small increases in the intracellular
cAMP must be responsible for initiation of the metabolic effects of
glucagon. Under optimum experimental conditions, hormone concentrations
of 3 x 10 ^"°m (near physiological levels) induced an increase of
t0
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approximately 30% in basal levels (jaround 2 pmols cAMP/lO cells) .
Presumably these small increases in the cyclic nucleotide level are
responsible for initiating the metabolic response. However, it was
found that during a small number of cell isolations (less than 10%)
the intracellular concentration of the nucleotide was elevated by as
much as five fold during preparation, and this did not always decay back
to basal levels on incubation. In fact, nearly all cell preparations
showed a slight increase in cAMP immediately after isolation which
decayed back to basal levels in ten to fifteen minutes. Assuming that
this effect is not due to experimental artefacts, it must be accepted
that varying degrees of nonspecific stimulation of the intracellular
cyclic nucleotide pool failed to induce similar stimulations of metabolic
responses to those observed with glucagon. If the cyclic nucleotide is
evenly distributed throughout a spherical hepatocyte of 12 pm in diameter
then basal intracellular cAMP concentrations immediately after isolation
range from 5 to 30 x lO ^M. Minimum glucagon stimulation of glycogenolysis
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occurs at concentrations which elevate intracellular cAMP by a further
—6
5 to 10 x 10 M over basal, with maximal stimulation at concentrations
which elevate intracellular cAMP by only a further 50 to 100 x 10 ^M.
Theoretically, it would seem that cells isolated with a cAMP content of
-6
30 x 10 M should show a higher rate of glycogenolysis than cells with
levels of 5 x 10 ^M. However this is not the case. Addition of extra¬
cellular Bt^cAMP at around 50 x 10 saturates the glycogenolytic
-6
effect as does cAMP at 150 x 10 M. These figures compare well with
the calculated intracellular levels of the nucleotide found after a
hormone stimulation which just saturates the metabolic response.
Therefore although the dose response range of the cyclic nucleotide is
similar whether cells are incubated with glucagon or by direct addition
of cAMP or Bt^cAMP, the apparent basal nucleotide levels show substantial
variation without altering metabolic effect. Various other reports
of basal nucleotide levels found in rat hepatocytes also show similar
variations. The reason for this is unknown; however the explanation
may lie in cAMP compartmentation within the cells which prevents
activation of the protein kinase. As cAMP is generally considered to
be uniformly distributed throughout the cell cytosol, compartmentation
could be achieved by the presence of intracellular cAMP binding proteins
other than the specific protein kinase. A closer investigation is
required before any satisfactory conclusion can be reached.
The effects of glucagon on carbohydrate and lipid metabolism appear
to be closely correlated with the physiological levels of the circulating
hormone. Using cell preparations of high hormone sensitivity isolated
by a collagenase batch containing little damaging proteolytic activity,
half maximal effects of glucagon on glycogenolysis were found at
1.7 x 10 10M with the smallest noticeable effect occurring at 4.4 x 10 ^M.
These values are in the same concentration range as reported for glucagon
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in the peripheral blood of starved chickens. Since portal blood glucagon
concentrations will be elevated over values in peripheral blood the results
suggest that glycogenolysis will be nearly maximally activated in the
chicken liver, during starvation. Direct comparisons with the figures
already mentioned for binding and second messenger stimulation however
must be made with lower affinity values due to the low sensitivity of
the cells found with other batches of collagenase. Half maximum
effective values for glucagon were found at 9.1 x 10 for glycogenolysis;
-10 -9
4.8 x 10 M for gluconeogenesis and 1.05 x 10 M for lipogenesis.
Both inhibition of lipogenesis and stimulation of glycogenolysis appear
to have parallel dose response curves where effects on metabolism
appear to saturate with approximately 10% of the total receptor sites
occupied (1300 sites per cell) and 10% of the total possible cAMP
produced (3 to 4 pmol/10 cells). The dose response to gluconeogenesis
is over a much narrower range with the effect saturating at around half
the values reported above for glycogenolysis.
adenylate
Table 7.1 summarises the results for binding,^cyclase activation and
glycogenolytic effect to allow direct comparisons to be made. Clearly
there are a large number of 'spare' glucagon receptors present on
the chicken hepatocyte all of which appear to be associated with adenylate
cyclase. Only a small fraction of these receptor sites needs to be
occupied for maximal effect of the hormone on the carbohydrate and lipid
pathways mentioned. This supports the concept of the spare receptor
theory found with mammalian tissues and may well increase the sensitivity
of the chicken hepatocyte to small changes in circulating hormone
concentration. It is also suggested that the calculated values reported
for binding and adenylate cyclase activation (Table 7.1) will almost
certainly be of lower affinity than found in whole tissue due to the
proteolytic degradation on cell isolation. One particular batch of
Table 7.1: Summary of results obtained for binding, cyclase activation
and metabolic effect.
Binding results obtained using batch 17 or 25 collagenase. Adenylate
cyclase activation results obtained using batch 25 collagenase.
Effect on carbohydrate and lipid metabolism using batch 17, 25, 29
or 30 collagenase. Average values given for all parameters.
Parameter
1) Binding affinity (M)
a) high affinity site
b) low affinity site
2) Binding capacity
(sites per cell)
a) high affinity site






































collagenase produced isolated hepatocytes with a five fold higher
glycogenolytic sensitivity to the hormone and it is likely that similar
increases in cell sensitivity to binding and cyclase activation would
be found.
A high affinity receptor for insulin was found on the isolated
hepatocyte with a dissociation constant of approximately 3 x 10 ^°M.
Physiological levels of insulin circulate in the peripheral blood
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within the range 8 x 10 M to 2 x 10 M and higher levels of the hormone
are obviously found in the portal blood. Since the true affinity of the
liver in vivo may be much higher, due to the possibility of partial
degradation of the receptor on cell isolation and the relatively higher
affinity of chicken insulin compared to the porcine insulin used in this
study, it would appear that even at the lowest physiological levels of
the circulatory hormone a large proportion of the insulin receptors would
be occupied. Although this high affinity receptor is present on the
chicken hepatocyte the binding of hormone failed to induce any measurable
biological effect at physiological concentrations of the hormone.
_ q
Pharmacological levels of the hormone (10 M) reduced the cAMP degradation
rate in the external medium, but since this was only effective at
concentrations well above those required to saturate all high affinity
binding sites it is considered not to be of any physiological importance
nor is it expected to illuminate the mode of hormone action in chicken
liver.
Therefore in the chicken hepatocyte the receptor system for insulin
remains intact although the effector system appears to be lacking.
However an insulin requirement in the chicken has been shown in_ vivo.
Insulin is capable of slightly lowering circulating glucose levels in
the blood. Therefore, either the effect of insulin on the hepatocyte
is lost on cell isolation or, more likely, insulin's regulatory effect
129.
on circulating glucose levels in the bird is due to action on some other
tissue, possibly muscle. Therefore it is suggested that the lack of
sensitivity found in vivo to intravenous insulin is due to a lack of
hormone effector system in the liver cell and that the low hypoglycaemic
effect found, results from hormone stimulating glucose uptake in tissues
other than the liver.
The third pancreatic hormone to be investigated, APP, induced only
minor changes in carbohydrate metabolism. However one can only speculate
if the effects noted are of any physiological significance and indeed if
they are a direct result of hormone action. APP does not regulate basal
or hormone stimulated cAMP levels which suggests that if the observed
metabolic effects are a direct result of classical hormone action, some
other intracellular mediator must be involved. The main factor against
the direct action of APP on the liver cells was the failure to find a
high affinity specific receptor on the hepatocyte plasma membrane.
Even though APP circulates in peripheral blood at relatively high
-9
concentrations (1 to 3 x 10 M) compared to the other pancreatic hormones
(and its levels are probably much higher in portal blood) it is unlikely
that the low affinity receptors found in hepatocyte suspensions (K about
2 x 10 ^M) would be of any physiological importance. Although it is
very unlikely it cannot be completely discounted that a small finite
number of higher affinity sites are present on the liver cell which were
not detected under the conditions used. Until further studies are
carried out the only hypothesis that can be drawn is that APP does not
bind to hepatocyte plasma membranes and the minor effects noted in
carbohydrate flux are probably due to some nonspecific action of APP
or a contaminating protein. This implies that the effects of APP found
in vivo must result from actions on other tissues.
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Although no binding studies were carried out using adrenaline it is
obvious that high affinity receptors must exist for the catecholamine.
Discussion of actions between a and B receptors as reported with various
mammalian tissues cannot be made in this study. However since adrenaline
elevated intracellular cAMP levels above that needed to induce maximum
metabolic effect and was also capable of stimulating glycogenolysis to
the same extent as glucagon, Bt^cAMP or cAMP it is suggested that the
catecholamine may act predominantly through a $ type receptor mechanism
in the chicken hepatocyte in contrast to the predominant a type effect
found for carbohydrate metabolism in rat hepatocytes. However it will
be necessary to investigate catecholamine action further using pure a or
B agonists and antagonists before any conclusive results can be obtained.
Since adrenaline fails to elevate maximally glucagon stimulated cAMP
levels it appears that there is no excess of adenylate cyclase molecules
over glucagon receptors in the chicken hepatocyte and that adrenaline
and glucagon receptors both share the cyclase population when activated
by their respective hormones.
In summary, the isolated chicken hepatocyte proved to be a valuable
model for analysing pancreatic polypeptide hormone action in the chicken
liver. Glucagon appears to be the most important of the pancreatic
hormones with respect to regulation of intracellular carbohydrate and
lipid metabolism. Insulin, despite circulating in chicken blood at
concentrations similar to those found in mammals and having a specific
high affinity receptor present on the liver cell membrane does not have
a biological action in the chicken hepatocyte suggesting a lack of the
effector system that must be present in the mammalian hepatocyte. This
apparent lack of the effector of hormone action could result in the chicken
hepatocyte being the ideal model to study the mode of insulin action in
the liver. Incorporation of various components of the rat liver cell
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into the chicken hepatocyte may help to elucidate the membrane bound
and/or intracellular factor(s) which mediate the hormone response in the
mammal.
APP appears to be devoid of any effect on the chicken hepatocyte
indicating that the site of action of this hormone lies elsewhere.
Under times of stress adrenaline can induce metabolic actions
identical to those found with glucagon on carbohydrate and lipid
metabolism in the hepatocyte. The high activities found with the
catabolic hormones (glucagon and adrenaline) and the lack of effect of
insulin in the chicken hepatocyte are consistant with the in_ vivo
findings concerning these hormones in birds. However it has yet to be
determined how avian carbohydrate and lipid metabolism can be so
carefully regulated without the antagonistic actions of glucagon and
insulin on the liver which is of paramount importance in the mammal.
REFERENCES
132.
Abel, J.J. (1926) Proc. Nat. Acad. Sci. 12, 132-136.
Adam, H. (1965) in Methods of Enzymatic Analysis 2, 573-577, 1st Edition,
H.U. Bergmeyer, ed. Academic Press.
Allen, E.H. and Sneyd, J.G. (1975) Biochem. Biophys. Res. Comm. 62,
594-601.
Allred, J.B. and Roehrig, K.L. (1972) Biochem. Biophys. Res. Comm. 46,
1135-1139.
Amer, M.S. (1974) Gastroenterology 67_, 333-337.
Anderson, N.G. (1973) Science 117, 627-628.
Anderson, C.E. and Langslow, D.R. (1975) Biochem. Soc. Trans. 3_, 1037-
1039.
Aquilar-Parada, E., Eisentraut, A.M. and Unger, R.H. (1969) Diabetes 18,
717-723.
Arch, J.R.S. and Newsholme, E.A. (1976) Biochem. J. 158, 603-622.
Archer, J.A., Gorden, P., Gavin, J.R., Lesniak, M.A. and Roth, J. (1973)
J. Clin. Endocrinol. Metab. _36, 627-633.
Arinze, I.J. and Rowley, D.L. (1975) Biochem. J. 152, 393-399.
Ashmore, J., Wagle, S.R. and Uete, T. (1964) Adv. Enz. Reg. 2_, 101-114.
Assan, R. (1972) in Glucagon, Molecular Physiology, Clinical and
Therapeutic Implications, 151-173. P.J. Lefebvre and R.H. Unger,
eds. Pergamon Press.
Assimacopoulos-Jeannet, F.D., Blackmore, P.F. and Exton, J.H. (1977)
J. Biol. Chem. 252, 2662-2669.
Avruch, J., Carter, J.R. and Martin, D.B. (1972) in Handbook of Physiology,
Section 7, Endocrinology, Vol. 1, 545-562. R.O. Greep and
E.B. Astwood, eds. Waverly Press Inc., Baltimore.
Badenoch-Jones, P. and Buttery, P.J. (1975) Int. J. Biochem . 6_, 387-392.
Banting, F.G. and Best, C.H. (1922) J. Lab. Clin. Med. 7_, 251-266.
Bataille, D.P. Freychet, P., Kitabgi, P.E. and Rosselin, G.E. (1973)
FEBS Lett. 30, 215-218.
133.
Bataille, D., Freychet, P. and Rosselin, G.E. (1974) Endocrinology 95,
713-721.
Battaglia, F.C. and Randle, P.J. (1960) Biochem. J. 75_, 408-416.
Bennett, V. and Cuatrecasas, P. (1973) Biochim. Biophys. Acta 311, 362-
380.
Bennett, V. , O'Keefe, E. and Cuatrecasas, P. (1975) Proc. Nat. Acad. Sci.
7_2, 33-37.
Bergeron, J.J.M., Evans, W.H. and Geschwind, I.I. (1973) J. Cell. Biol.
59, 771-776.
Bergeron, J.J.M., Posner, B.I., Josefsberg, Z. and Sikstrom, R. (1978)
J. Biol. Chem. 253, 4058-4066.
Bergeron, J.J.M., Sikstrom, R., Hand, A.R. and Posner, B.I. (1979)
J. Cell. Biol. 80, 427-443.
Bernard, C. (1856) as sited by Koppanyi, T., Ivy, A.C., Tatum, A.L. and
Jung, F.T. (1926) Amer. J. Physiol. 78_, 666-674.
Berridge, M.J. (1975) Adv. Cyclic Nuc. Res. 6_, 1-98.
Berry, M.N. (1962) J. Cell. Biol. 1_5, 1-8.
Berry, M.N. (1974) Methods in Enzymol. 32.' 625-632.
Berry, M.N. and Friend, D.S. (1969) J. Cell. Biol. 4_3, 506-520.
Bierman, E.L. and Dole, V.P. (1957) Fed. Proc. 16_, 11 (Abs.) .
Bierman, E.L., Schwartz, I.L. and Dole, V.P. (1957) Amer. J. Physiol.
191, 359-362.
Bihler, I. and Jeanrenaud, B. (1970) Biochim. Biophys. Acta 202, 496-506.
Bilhar, D.A. and Morris, J.W.S. (1972) Biochem. J. 130, 321-324.
Birnbaum, M.J. and Fain, J.N. (1977) J. Biol. Chem. 252, 528-535.
Birnbaumer, L. and Pohl, S.L. (1973) J. Biol. Chem. 248, 2056-2061.
Birnbaumer, L., Pohl, S.L. and Rodbell, M. (1971) J. Biol. Chem. 246,
1857-1860.
Bissell, D.M. Hammaker, L.E. and Meyer, U.A. (1973) J. Cell. Biol. 59,
722-734.
134.
Blackmore, P.F., Brumley, F.T., Marks, J.L. and Exton, J.H. (1978) J.
Biol. Chem. 253, 4851-4858.
Blem, C.R. (1976) Am. Zool. 16_, 671-684.
Bondareva, V.M. (1970) Dokl. Akad. Nauk. SSSR 19_, 247-249.
Borek, C. (1972) Proc. Nat. Acad. Sci. 69_, 956-959.
Bromer, W.W. (1972a) in Handbook of Physiology, Section 7, Endocrinology,
Vol. 1, 133-138. R.O. Greep and E.B. Astwood, eds. Waverly
Press Inc., Baltimore.
Bromer, W.W. (1972b) in Glucagon; Molecular Physiology, Clinical and
Therapeutic Implications, 27-30. P.J. Lefebvre and R.H. Unger,
eds. Pergamon Press.
Bromer, W.W., Boucher, M.E. and Koffenberger, J.E., Jr. (1971)
J. Biol. Chem. 246, 2822-2827.
Bromer, W.W., Boucher, M.E. and Patterson, J.M. (1973) Biochem. Biophys.
Res. Commun. 53_, 134-139.
Buchanan, K.D., Solomon, S.S., Vance, J.E., Porter, H.P. and Williams,
R.H. (1968) Proc. Soc. Exp. Biol. Med. 128, 620-623.
Burger, M. and Brandt, W. (1935) Zeit. Ges. Exp. Med. 96_, 375-397.
Burns, T.W. and Langley, P.E. (1968) J. Lab. Clin. Med. 7_2, 813-823.
Burton, K. (1956) Biochem. J. 62_, 315-323.
Capuzzi, D.M., Rothman, V. and Margolis, S. (1971) Biochem. Biophys.
Res. Commun. 4_5, 421-429.
Capuzzi, D.M., Rothman, V. and Margolis, S. (1974) J. Biol. Chem. 249,
1286-1294.
Carlson, L.A., Liljedahl, S., Verdy, M. and Wirsen, C. (1964) Metabolism
13, 227-231.
Catt, K.J. and Dufau, M.L. (1976) Biol. Reprod. 14_, 1-15.
Cesari, E. and Luft, R. (1969) Horm. Metab. Res. 1_, 221-223.
Chambers, J.V. and Bass, A.D. (1970) Fed. Proc. 29, 616 (Abs.).
135.
Chan, T.M. and Exton, J.H. (1977) J. Biol. Chem. 252_, 8645-8651.
Chen, K.K., Anderson, R.C. and Maze, N. (1945) J. Pharm. Exp. Therap.
84, 74-77.
Cherrington, A.D., Assimacopoulos, F.D., Harper, S.C., Corbin, J.D.,
Park, C.R. and Exton, J.H. (1976) J. Biol. Chem. 251, 5209-5218.
Chlouverakis, C. (1967) Endocrinol. 81, 521-526.
Claus, T.H. and Pilkis, S.J. (1976) Biochim. Biophys. Acta 421, 246-262.
Cohen, P., Birchell, A., Foulkes, J.G., Cohen, P.T.W., Vanaman, T.C. and
Nairn, A.C. (1978) FEBS Lett. 92, 287-293.
Colca, J.R. and Hazelwood, R.L. (1976) Gen. Comp. Endoc. 28, 151-162.
Coore, H.G., Denton, R.M., Martin, B.R. and Randle, P.J. (1971)
Biochem. J. 125, 115-127.
Corbin, J.D., Reemann, E.M., Walsh, D.A. and Krebs, E.G. (1970) J. Biol.
Chem. 245, 4849-4851.
Cornell, N.W., Lund, P. and Krebs, H.A. (1974) Biochem. J. 142, 327-337.
Crofford, O.B. (1968) J. Biol. Chem. 243, 362-369.
Crofford, O.B. and Renold, A.E. (1965) J. Biol. Chem. 240, 3237-3244.
Cuatrecasas, P. (1969) Proc. Nat. Acad. Sci. 63, 450-457.
Cuatrecasas, P. (1971a) Proc. Nat. Acad. Sci. 68_, 1264-1268.
Cuatrecasas, P. (1971b) J. Biol. Chem. 246, 6532-6542.
Cuatrecasas, P. (1972a) Diabetes 2]^, 396-402.
Cuatrecasas, P. (1972b) Proc. Nat. Acad. Sci. 69_, 318-322.
Cuatrecasas, P. (1972c) J. Biol. Chem. 247, 1980-1991.
Cuatrecasas, P. (1974) Ann. Rev. Biochem. 43^, 169-214.
Cuatrecasas, P. and Illiano, G. (1971) J. Biol. Chem. 246, 4938-4946.
Cuatrecasas, P. and Hollenberg, M.D. (1975) Biochem. Biophys. Res. Commun.
62, 31-41.
Cuatrecasas, P. and Hollenberg, M.D. (1976) Adv. Prot. Chem. 30, 251-451.
136.
Dabrowska, R., Sherry, J.M.F. Aromatorio, D.K. and Hartshorne, D.J.
(1978) Biochem. 17, 253-258.
Das, M. and Fox, C.F. (1978) Proc. Nat. Acad. Sci. 75, 2644-2648.
and
Dawson, R.M.C., Elliot, D., Elliot, W.H.^ Jones, K.M. (1969) eds.
Data for Biochemical Research, 2nd Edition, p. 609. Claredon Press.
DeBodo, R.C., Steele, R., Altszuler, N., Dunn, A. and Bishop, J.S. (1963)
Rec. Prog. Horm. Res. 19_, 445-488.
DeMeyts, P. (1976)in Methods in Receptor Research, Part I, 301-383.
M. Blecher, ed. Dekker, New York.
DeMeyts, P., Roth, J., Neville, D.M., Jr., Gavin, J.R. Ill and
Lesniak, M.A. (1973) Biochem. Biophys. Res. Commun. 55_, 154-161.
DeMeyts, P., Bianco, A.R. and Roth, J. (1976) J. Biol. Chem. 251, 1877-
1888.
DeMeyts, P., van Obberghen, E., Roth, J., Wollmer, A. and Brandenburg, D.
(1978) Nature 273, 504-509.
DePlaen, J. and Galansino, G. (1966) Proc. Soc. Exp. Biol. Med. 121,
501-504.
Desai, K.S., Li, K.C. and Angel, A. (1973) J. Lipid Res. 14_, 647-655.
Desbals, P., Mialhe, P. and Desbals, B. (1970) Diabetologia 6_, 625 (Abs.).
Desbuquois, B. (1975) Eur. J. Biochem. 5_3, 569-580.
Desbuquois, B. (1977) in First International Symposium on Hormonal
Receptors in Digestive Tract, Physiology 127-140. S. Bonfils, ed.
Elsevier/North Holland.
Desbuquois, B., Krug, F. and Cuatrecasas, P. (1974) Biochim. Biophys.
Acta 343, 101-120.
Dickson, A.J. (1977) Ph.D. Thesis, University of Edinburgh.
Dickson, A.J. and Langslow, D.R. (1975) Biochem. Soc. Trans. _3, 1034-
1037.
Dickson, A.J. and Pogson, C.I. (1977) FEBS Lett. 83_, 27-32.
137.
Dickson, A.J. and Langslow, D.R. (1978) Mol. Cell Biochem. 22_, 167-181.
Dickson, A.J., Anderson, C.A. and Langslow, D.R. (1978) Mol. Cell. Biochem.
19, 81-92.
Dole, V.P. (1956) J. Clin. Invest. J5, 150-154.
Duckworth, W.C. (1978) Endocrinology 102, 1766-1774.
El-Refai, M.F., Blackmore, P.F. and Exton, J.H. (1979) J. Biol. Chem.
254, 4375-4386.
Exton, J.H. and Park, C.R. (1968) Adv. Enz. Reg. 6_, 391-407.
Exton, J.H. and Park, C.R. (1969) J. Biol. Chem. 244, 1424-1433.
Exton, J.H. and Park, C.R. (1972) in Handbook of Physiology, Section 7,
Endocrinology, Vol. 1, 437-455. R.O. Greep and E.B. Astwood, eds.
Waverly Press Inc., Baltimore.
Exton, J.H., Jefferson, L.S., Jr., Butcher, R.W. and Park, C.R. (1966)
Am. J. Med. 40, 709-715.
Exton, J.H., Lewis, S.B. Ho, R.J., Robison, G.A. and Park, C.R. (1971a)
Ann. N.Y. Acad. Sci. 185, 85-100.
Exton, J.H., Robison, G.A., Sutherland, E.W. and Park, C.R. (1971b)
J. Biol. Chem. 246, 6166-6177.
Exton, J.H., Robison, G.A. and Sutherland, E.W. (1972) in Handbook of
Physiology, Section 7, Endocrinology, Vol. 1, 425-436. R.O. Greep
and E.B. Astwood, eds. Waverly Press Inc., Baltimore.
Fain, J.N. (1967) Ann. N.Y. Acad. Sci. 139, 879-890.
Fain, J.N. and Butcher, F.R. (1976) J. Cyclic Nuc. Res. 2_, 71-78.
Fain, J.N., Kovacev, V.P. and Scow, R.O. (1966) Endocrinology 1Q_> 773-
778.
Farrant, J.L. and McLean, J.D. (1969) in Proceedings of the Electron
Microscopy Society of America, 27th Meeting, p. 422.
C.J. Arceneaux, ed.
138.
Favarger, P. (1965) in Handbook of Physiology, Section 5, Adipose Tissue,
19-23. A.E. Renold and G.F. Cahill, Jnr., eds. Waverly Press Inc.,
Baltimore.
Fischer, E.H. and Krebs, E.G. (1955) J. Biol. Chem. 216, 121-132.
Flawia, M.M. and Torres, H.N. (1973) FEBS Lett. 30, 74-78.
Fleming, G.B. (1919) J. Physiol. 53_, 236-246.
Flockhart, D.A. and Siddle, K. (1979) Biochem. Soc. Trans. 7_, 1033-1035.
Floyd, J.C., Jr., Fajans, S.S., Pek, S. and Chance, R.E. (1977) Rec.
Prog. Horm. Res. _33_, 519-570.
Folch, J., Lees, M. and Stanley, G.H.S. (1957) J. Biol. Chem. 226,
497-509.
Forgue, M.E. and Freychet, P. (1975) Diabetes 24_, 715-723.
Freychet, P. (1974) J. Clin. Invest. 54_, 1020-1031.
Freychet, P. (1976a) in Methods in Receptor Research, Part II, 1_2, 385-
428. M. Blecher, ed. Dekker, New York.
Freychet, P. (1976b) Diabetologia 1_2_, 83-100.
Freychet, P. and Forgue, M.E. (1974) Diabetes 23 (Suppl.), 354 (Abs.).
Freychet, P., Roth, J. and Neville, D.M., Jr. (1971a) Proc. Nat. Acad.
Sci. 68, 1833-1837.
Freychet, P., Roth, J., Neville, D.M., Jr. (1971b) Biochem. Biophys.
Res. Commun. 43_, 400-408.
Freychet, P., Kahn, R., Roth, J. and Neville, D.M., Jr. (1972a) J. Biol.
Chem. 247, 3953-3961.
Freychet, P., Laudat, M.H., Laudat, P., Rosselin, G., Kahn, C.R.,
Gorden, P. and Roth, J. (1972b) FEBS Lett. 25_, 339-342.'
Freychet, P., Brandenburg, D. and Wollmer, A. (1974) Diabetologia 10, 1-5.
Freychet, P., Rosselin, G., Rancon, F., Fouchereau, M. and Broer, Y.
(1974) Horm. Metab. Res. _5 (Suppl.), 72-78.
Friedman, N. and Park, C.R. (1968) Proc. Nat. Acad. Sci. 61, 504-508.
139.
Froesch, E.R., Burgi, H., Bally, P. and Labhart, A. (1965) Mol. Pharmacol.
1_, 280-296.
Fussganger, R.D., Kahn, C.R., Roth, J. and DeMeyts, P. (1976) J. Biol.
Chem. 251, 2761-2769.
Gammeltoft, S. and Gliemann, J. (1973) Biochim. Biophys. Acta 320, 16-32.
Gammeltoft, S., Kristensen, L.O. and Sestoft, L. (1978) J. Biol. Chem.
253, 8406-8413.
Garrison, J.C. and Haynes, R.C. Jr. (1973) J. Biol. Chem. 248, 5333-5343.
Garratt, C.J., Jarrett, R.J. and Keen, H. (1966) Biochim. Biophys. Acta
121, 143-150.
Gavin, J.R. Ill, Roth, J., Jen, P. and Freychet, P. (1972) Proc. Nat.
Acad. Sci. 69_, 747-751.
Gavin, J.R. Ill, Gorden, P., Roth, J., Archer, J.A. and Buell, D.N.
(1973) J. Biol. Chem. 248, 2202-2207.
Gavin, J.R. Ill, Roth, J., Neville, D.M., Jr., DeMeyts, P. and Buell, D.N.
(1974) Proc. Nat. Acad. Sci. 71_, 84-88.
Geelan, M.J.H. and Gibson, D.M. (1975) FEBS Lett. 58_, 334-339.
Giaja, J. (1912) C.R. Soc. Biol. 73_, 102-104.
Ginsberg, B.H., Kahn, C.R. and Roth, J. (1976) Biochim. Biophys. Acta
443, 227-246.
Ginsberg, B.H., Kahn, C.R. and Roth, J. (1977) Endocrinology lOO, 82-90.
Giorgio, N.A., Johnson, C.B., Blecher, M. (1974) J. Biol. Chem. 249,
428-437.
Gliemann, J. (1967) Diabetologia 3_, 382-388.
Gliemann, J. (1976) Diabetologia 12_, 393 (Abs.) .
Gliemann, J. and Sonne, O. (1978) J. Biol. Chem. 253, 7857-7863.
Gliemann, J., Gammeltoft, S. and Vinten, J. (1975) in Contemporary
Topics in the Study of Diabetes and Metabolic Endocrinology,
130-137. E. Shafrir, ed. Academic Press, New York.
140.
Goldberg, N.D. and Haddox, M.K. (1977) Ann. Rev. Biochem. 46, 823-896.
Goldfarb, S., Barber, T.A., Pariza, M.W. and Pugh, T.D. (1978) Exp.
Cell. Res. 117, 39-46.
Goldfine, I.D. (1977) Diabetes 26_, 148-155.
Goldfine, I.D. and Smith, G.J. (1976) Proc. Nat. Acad. Sci. 73, 1427-
1431.
Goldfine, I.D., Gardner, J.D. and Neville, D.M. Jr. (1972) J. Biol. Chem.
247, 6919-6926.
Goldfine, I.D., Kahn, C.R., Neville, D.M. Jr., Roth, J., Garrison, M.M.
and Bates, R.W. (1973) Biochem. Biophys. Res. Commun. 5_3, 852-857.
Goldfine, I.D., Smith, G.J., Wong, K.Y. and Jones, A.C. (1977) Proc.
Nat. Acad. Sci. 74_, 1368-1372.
Goldfine, I.D., Jones, A.L., Hradek, G.T., Wong, K.Y. and Mooney, J.S.
(1978) Science 202, 760-763.
Goodner, C.J. and Porte, D. Jr. (1972) in Handbook of Physiology,
Section 7, Endocrinology, Vol. 1, 597-609. R.O. Greep and
E.B. Astwood, eds. Waverly Press Inc., Baltimore.
Goodridge, A.G. (1964) Comp. Biochem. Physiol. 13_, 1-26.
Goodridge, A.G. (1968a) Biochem. J. 108, 655-661.
Goodridge, A.G. (1968b) Am. J. Physiol. 214, 897-901.
Goodridge, A.G. (1969) Can. J. Biochem. 47, 743-746.
Goodridge, A.G. (1973) J. Biol. Chem. 248, 1924-1931.
Goodridge, A.G. (1975) Fed. Proc. 34_, 117-123.
Goodridge, A.G. and Ball, E.G. (1965) Comp. Biochem. Physiol. 1(5, 367-381.
Goodridge, A.G. and Ball,E.G.(1967)Am.J. Physiol. 213, 245-249.
Goodridge, A.G. and Adelman, T.G. (1976) J. Biol. Chem. 251, 3027-3032.
Goodridge, A.G., Garay, A. and Silpananth, P. (1974) J. Biol. Chem.
249, 1469-1475.
141.
Gorden, P., Carpentier, J.L., Freychet, P., Le Cam, A. and Orci, L. (1978)
Science 200, 782-785.
Gordon, R.S. Jr. and Cherkes, A. (1956) J. Clin. Invest. 3_5' 206-212.
Grande, F. and Prigge, W.F. (1970) Am. J. Physiol. 218, 1406-1411.
Greenwood, F.C. (1971) in Principles of Competitive Protein Binding Assays,
288-312. W.D. Odell and W.M. Daughaday, eds. Lippincott,
Philadelphia.
Greenwood, F.C., Hunt, W.M. and Glover, J.S. (1963) Biochem. J. 89_, 114-
123.
Hales, C.N., Luzio, J.P. and Siddle, K. (1978) Biochem. Soc. Symp. 43,
97-135.
Hamlin, J.L. and Arquilla, E.R. (1974) J. Biol. Chem. 249, 21-32.
Hammond, J.M., Jarett, L., Mariz, I.K. and Daughaday, W.H. (1972) Biochem.
Biophys. Res. Commun. 49_, 1122-1128.
Hanoune, J., Feldman, G., Stengel, D., Lancombe, M-L. and Coudrier, E.
(1977) J. Biol. Chem. 252, 2039-2045.
Harris, R.A., Mapes, J.P.,0chs, R.S., Crabb, D.W. and Stropes, L. (1978)
Adv. Exp. Med. Biol. Ill, 17-42.
Havrankova, J. and Roth, J. (1978) Nature 272, 827-829.
Hazelwood, R.L. (1958) Endocrinology 63_, 611-618.
Hazelwood, R.L. (1972) in Avian Biology, Vol. II, 471-526. D.S. Farner
and J.R. King, eds. Academic Press, London.
Hazelwood, R.L. (1976) in Avian Physiology, 210-232. P.D. Sturkie, ed.
3rd Edition. Springer-Verlag, New York.
Hazelwood, R.L. and Lorenz, F.W. (1959) Am. J. Physiol. 197, 47-51.
Hazelwood, R.L. and Langslow, D.R. (1978) J. Endocrinol. 76_, 449-459.
Hazelwood, R.L., Kimmel, J.R. and Pollock, H.G. (1968) Endocrinology 83,
1331-1336.
Hazelwood, R.L., Kimmel, J.R. and Pollock, H.G. (1971) Comp. Biochem.
Physiol. 39B, 267-278.
142.
Hazelwood, R.L., Turner, S.D., Kimmel, J.R. and Pollock, H.G. (1973) Gen.
Comp. Endocrinol. 21_, 485-497.
Heald, P.J., McLachlan, P.M. and Rookledge, K.A. (1965) J. Endocrinol.
33, 83-95.
Heilmeyer, L.M.G., Meyer, F., Haschke, R.H. and Fischer, E.H. (1970)
J. Biol. Chem. 245, 6649-6656.
Helmreich, E.J.M. (1976) FEBS Lett. £31, 1-5.
Helmreich, E.J.M., Zenner, H.P., Pfeuffer, T. and Cori, C.F. (1978)
Curr. Topics Ce.. Reg. 10, 41-87.
Hems, R., Ross, B.D., Berry, M.N. and Krebs, H.A. (1966) Biochem. J.
101, 284-292.
Hepp, D., Challoner, D.R. and Williams, R.H. (1968) J. Biol. Chem. 243,
4020-4026.
Hepp, K.D. and Renner, R. (1972) FEBS Lett. 20, 191-194.
Hickie, R.A. (1976) Biochem. J. 157, 705-712.
Hoskins, J.N., Meynell, G.G. and Sanders, F.K. (1956) Exp. Cell. Res.
Ill, 297-305.
House, P.D.R., Poulis, P. and Weidemann, M.J. (1972) Eur. J. Biochem.
24, 429-437.
Howard, R.B. and Green, C. (1965) Biochem. J. 9<5, 33P.
Howard, R.B. and Pesch, L.A. (1968) J. Biol. Chem. 243, 3105-3109.
Howard, R.B. and Widder, D.J. (1976) Biochem. Biophys. Res. Commun. 68,
262-269.
Howard, R.B., Christensen, A.K. , Gibbs, F.A. and Pesch, L.A. (1967)
J. Cell. Biol. 35, 675-684.
Howard, R.B., Lee, J.C. and Pesch, L.A. (1973) J. Cell. Biol. 57_, 642-658.
Hue, L., Bontemps, F. and Hers, H-G. (1975) Biochem. J. 152, 105-114.
Hue, L., Feliu, J.E. and Hers, H-G. (1978) Biochem. J. 176, 791-797.
Hugget, A.St.G. and Nixon, D.A. (1957) Biochem. J. £36, 12P.
Hughes, W.A. and Coore, H.G. (1978) Int. J. Biochem. 9, 751-755.
143.
Humbel, R.E., Bosshard, H.R. and Zahn, H. (1972) in Handbook of Physiology,
Section 7, Endocrinology, Vol. 1, 111-132. R.O. Greep and E.B.
Astwood, eds. Waverly Press Inc., Baltimore.
Hunter, W.M. and Greenwood, F.C. (1962) Nature 194, 495-496.
Hutson, N.J., Brumley, F.T., Assimacopoulos, F.D., Harper,S.C.and
Exton, J.H. (1976) J. Biol. Chem. 251, 5200-5208.
Illiano, G. and Cuatrecasas, P. (1972) Science 175, 906-908.
Illiano, G., Tell, G.P.E., Siegel, M.I. and Cuatrecasas, P. (1973)
Proc. Nat. Acad. Sci. 22/ 2443-2447.
Jacob, S.T. and Bhargava, P.M. (1962) Exp. Cell. Res. 2J_, 453-467.
Jarret, L. and Smith, R.M. (1975) Proc. Nat. Acad. Sci. 72, 3526-3530.
Jaworek, D., Gruber, W., Bergmeyer, H.U. (1974) in Methods of Enzymatic
Analysis 4_, 2127-2131, 2nd Edition. H.U. Bergmeyer, ed.
Academic Press, New York and London.
Jefferson, L.S., Exton, J.H., Butcher, R.W., Sutherland, E.W. and Park, C.R.
(1968) J. Biol. Chem. 243, 1031-1038.
Johnson, M.E.M., Das, N.M., Butcher, F.R. and Fain, J.W. (1972) J. Biol.
Chem. 247, 3229-3235.
Jungas, R.L. and Ball, E.G. (1963) Biochem. 2_, 383-388.
Jungas, R.L. and Taylor, S.I. (1972) in Insulin Action, 369-413.
J.B. Fritz, ed. Academic Press, New York and London.
Kahn, C.R. (1975) in Membrane Receptors for Polypeptide Hormones, 81-146.
E.D. Korn, ed. Plenum Press, New York.
Kahn, C.R. and Baird, K. (1978) J. Biol. Chem. 253, 4900-4906.
Kahn, C.R., Neville, D.M. Jr. and Roth, J. (1973) J. Biol. Chem. 248,
244-250.
Kahn, C.R., Freychet, P., Roth, J. and Neville, D.M. Jr. (1974) J. Biol.
Chem. 249, 2249-2257.
Kakiuchi, S., Yamazaki, R., Teshima, Y., Uenishi, K. and Miyamoto, E.
(1975) Biochem. J. 146, 109-120.
144.
Katzen, H.M. and Vlahakes, G.J. (1973) Science 179, 1142-1143.
Kausch, W. (1896) Arch, ftir Exp. Path. u. Pharm. 37, 274-289.
Keppens, S.S., Vandenheede, J.R. and DeWulf, H. (1977) Biochim. Biophys.
Acta 496, 448-457.
Khoo, J.C., Steinberg, D., Thompson, B. and Mayer, S.E. (1973) J. Biol.
Chem. 248, 3823-3830.
Khoo, J.C., Sperry, P.J., Gill, G.N. and Steinberg, D. (1977) Proc. Nat.
Acad. Sci. 74_, 484 3-4847..
Kimball, C.P. and Murlin, J.R. (1923) J. Biol. Chem. 58_, 337-346.
Kimmel, J.R., Pollock, H.G. and Hazelwood, R.L. (1968) Endocrinology 83,
1323-1330.
Kimmel, J.R., Pollock, H.G. and Hazelwood, R.L. (1971) Fed. Proc. 30,
1318 (Abs.).
Kimmel, J.R., Hayden, L.J. and Pollock, H.G. (1975) J. Biol. Chem. 250,
9369-9376.
Kimmich, G.A., Randies, J. and Brand, J.S. (1975) Anal. Biochem. 69,
187-206.
Kimura, H. and Murad, F. (1975) J. Biol. Chem. 250, 4810-4817.
Kleiner, I.S. (1919) J. Biol. Chem. 40, 153-170.
Koike, T., Nalbandov, A., Dimick, M., Matsumura, Y. and Lepkovsky, S.
(1964) Endocrinology 74_, 944-948.
Kono, T. (1969) J. Biol. Chem. 244, 1772-1778.
Kono, T. and Barham, F.W. (1971) J. Biol. Chem. 246, 6210-6216.
Kono, T., Robinson, F.W. and Sarver, J.B. (1975) J. Biol. Chem. 250,
7826-7835.
Koppanyi, T., Ivy, A.C., Tatum, A.L. and Jung, F.T. (1926) Am. J. Physiol.
78, 666-674.
Krebs, E.G. (1972a) Curr. Topics Cell. Reg. 5, 99-133.
145.
Krebs, E.G. (1972b) in Endocrinology, Proceedings of the 4th International
Congress, Ser. No. 273, Amsterdam, 17-29. Excerpta-Medica,
Amsterdam.
Krebs, E.G. and Beavo, J.A. (1979) Ann. Rev. Biochem. 44_, 923-959.
Krebs, H.A. (1970) Adv. Enz. Reg. 8_, 335-353. G. Weber, ed. Pergamon
Pre ss.
Krebs, H.A. and Hens&eit, K. (1932) Hoppe-Seyler's Z. Physiol. Chem.
210, 33-66.
Krebs, H.A., Notton, B.M. and Hems, R. (1966) Biochem. J. 101, 607-617.
Krebs, H.A., Cornell, N.W., Lund, P. and Hems, R. (1974) in Alfred
Benzon Symposium VI, 718-743. Munksgaard, Copenhagen.
Krug, E. and Mialhe, P. (1971) Horm. Metab. Res. _3, 24-27.
Krug, E., Gross, R. and Mialhe, P. (1976) Horm. Metab. Res. 8_, 345-350.
Krug, U., Krug, F. and Cuatrecasas, P. (1972) Proc. Nat. Acad. Sci.
69, 26O4-2608.
Krupp, M.N. and Livingston, J.N. (1978) Proc. Nat. Acad. Sci. 75_, 2593-
2597.
Kuo, J.F. and Greengard, P. (1969) Proc. Nat. Acad. Sci. 64, 1349-1355.
Lad, P.M., Welton, A.F. and Rodbell, M. (1977) J. Biol. Chem. 252,
5942-5946.
Laishes, B.A. and Williams, G.M. (1976) In vitro 12_, 521-532.
Lambert, B., Sutter, B.Ch.J. and Jacquemin, CI. (1972) Horm. Metab. Res.
_4, 149-151.
Langendorff, 0. (1879) Arch, ftir Anat. u. Physiol., 1-35.
Langan, T.A. (1973) Adv. Cyclic Nuc. Res. 3_, 99-153. P. Greengard and
G.A. Robison, eds. Raven Press, New York.
Langslow, D.R. (1969) Ph.D. Thesis, University of Cambridge.
Langslow, D.R. (1976) Gen. Comp. Endocrinol. 29_, 423-425.
Langslow, D.R. and Hales, C.N. (1969) J. Endocrinol. 43_, 285-294.
146.
Langslow, D.R. and Hales, C.N. (1970) Lancet _i, 1151-1152.
Langslow, D.R. and Hales, C.N. (1971) in Physiology and Biochemistry of
the Domestic Fowl, 521-547. D.J. Bell and B.M. Freeman, eds.
Academic Press, New York and London.
Langslow, D.R., Butler, E.J., Hales, C.N. and Pearson, A.W. (1970)
J. Endocrinol. 46_, 243-260.
Langslow, D.R., Kimmel, J.R. and Pollock, H.G. (1973) Endocrinol. 93,
558-565.
Larsson, L.I., Sundler, F., Hakanson, R., Pollock, H.G. and Kimmel, J.R
(1974) Histochem. 42_, 377-382.
Lawrence, A.M. (1966) Proc. Nat. Acad. Sci. 55, 316-320.
LeCam, A. and Freychet, P. (1978) Endocrinology 102, 379-385.
Letko, G. (1978) Acta Biol. Med. Germ. 37_, 663-665.
Lepkovsky, S., Nalbandov, A.V., Dimmick, M.K., McFarland, L.Z. and
Penchatz, R. (1964) Endocrinology 74_, 207-211.
Lepkovsky, S., Dimmick, M.K., Furuta, F., Snapir, N., Park, R., Narita,
and Komatsu, K. (1967) Endocrinology 81_, 1001-1006.
Lesniak, M.A. and Roth, J. (1976) J. Biol. Chem. 251, 3720-3729.
Leveille, G.A. (1967) Proc. Soc. Exp. Biol. Med. 125, 85-88.
Levey, G.S. (1975) Metabolism 24_, 301-310.
Levey, G.S., Fletcher, M.A. and Klein, I. (1975) Adv. Cyclic Nuc. Res.
53-65.
Lewis, S.B., Exton, J.H., Ho, R.S. and Park, C.R. (1970) Fed. Proc. 29,
379 (Abs.).
Lin, M.C., Nicosia, S., Lad, P.M. and Rodbell, M. (1977) J. Biol. Chem.
252, 2790-2792.
Lin, T.C., Pettit, F.H., Hucho, F. and Reed, L.J. (1969) Proc. Nat.
Acad. Sci. 64, 227-234.
147.
Lin, T.C., Pettit, F.H. and Reed, L.J. (1969) Proc. Nat. Acad. Sci.
62, 234-241.
Lin, T.M. and Chance, R.E. (1972) Gastroenterology (52, 852 (Abs.).
Lin, T.M. and Chance, R.E. (1974) Gastroenterology 67_, 730-755.
Lin, T.M., Chance, R.E. and Evans, D. (1973) Gastroenterology 64, 865
(Abs.).
Lin, T.M., Evans, D.C., Chance, R.E. and Spray, G.F. (1977) Am. J.
Physiol. E311-315.
Lincoln, T.M. and Corbin, J.D. (1977) Proc. Nat. Acad. Sci. 74_, 3239-
3243.
Lincoln, T.M. and Corbin, J.D. (1978) J. Cyclic Nuc. Res. £, 3-14.
Linde, S. and Hansen, B.A. (1974) Int. J. Pept. Prot. Res. 6_, 157-163.
Ljungstrom, 0. and Ekman, P. (1977) Biochem. Biophys. Res. Commun. 78,
1147-1155.
Loten, E.G. and Sneyd, J.G.T. (1970) Biochem. J. 120, 187-193.
Loten, E.G., Assimacopoulos-Jeannet, F.D., Exton, J.H. and Park, C.R.
(1978) J. Biol. Chem. 253, 746-757.
Lovell-Smith, C.J., Manganiello, V.C. and Vaughan, M. (1977) Biochim.
Biophys. Acta 497, 447-458.
Lowry, O.H., Rosebrough, N.J., Farr, A.L. and Randall, R.J. (1951)
J. Biol. Chem. 193, 265-275.
Luzio, J.P., Newby, A.C. and Hales, C.N. (1976) Biochem. J. 154, 11-21.
Mackrell, D.J. and Sokal, J.E. (1969) Diabetes 18, 724-732.
Mahler, R., Stafford, W.S., Tarrant, M.E. and Ashmore, J. (1964)
Diabetes 1^3, 297-302.
Maier, V. and Pfeiffer, E.F. (1978) Horm. Metab. Res. 10, 177-182.
Mallette, L.E., Exton, J.H. and Park, C.R. (1969) J. Biol. Chem. 244,
5713-5723.
Manganiello, V. and Vaughan, M. (1973) J. Biol. Chem. 248, 7164-7170.
148.
Margoulies, M. (1968) in Protein and Polypeptide Hormones, part IV,
243-325. M. Margoulies, ed. Excerpta Medica Foundation, Amsterdam.
Markussen, J. and Sundby, F. (1973) Int. J. Peptide Prot. Res. 5_, 37-48.
McCumbee, W.D. and Hazelwood, R.L. (1977) Gen. Comp.Endocrinol. 33, 518-525.
McElroy, W.D. and Strehler, B.L. (1949) Arch. Biochem. Biophys. 22,
420-433.
McGarry, J.D., Wright, P.H. and Foster, D.W. (1975) J. Clin. Invest.
55, 1202-1209.
Meikle, A.W., Klain, G.J. and Hannon, J.P. (1973) Proc. Soc. Exp. Biol.
Med. 143, 379-381.
Menahan, L.A. and Wieland, 0. (1967) Biochem. Biophys. Res. Commun. 29,
880-885.
Menahan, L.A., Hepp, K.D. and Wieland, 0. (1969) Eur. J. Biochem. 8_,
435-443.
Mialhe, P. (1958) Acta Endocrinol. Copenh. Suppl. 36.
Mialhe, P. (1969) in Proceedings of the 3rd International Conference on
Endocrinology, Mexico, 158-163. Excerpta Medica, Amsterdam.
Mikami, S.I. and Ono, K. (1962) Endocrinology 71, 464-473.
Miller, E.A., Ingebretson, C., Clark, J.F., Ashmore, J. and Allen, D.O.
0.974) Proc. Soc. Exp. Biol. Med. 146, 186-189.
Minkowski, 0. (1893) Arch, ftir Exp. Path. u. Pharm. 31, 85-189.
Minkowski, 0. and von Mehring, J. (1889) Arch, ftir Exp. Path. u. Pharm.
_26, 371-387.
Mirsky, I.A. and Gitelson, S. (1957) Endocrinology 61_, 148-152.
Mirsky, I.A., Nelson, N., Grayman, I. and Kovenberg, M. (1941) Am. J.
Physiol. 135, 223-229.
Mirsky, I.A., Jinks, R. and Perisutti, G. (1964) Am. J. Physiol. 206,
133-135.
Mittal, C.K. and Murad, F. (1977) J. Cyclic. Nuc. Res. 3, 381-391.
149.
Mortimore, G.E. (1961) Am. J. Physiol. 2QQ, 1315-1319.
Murlin, J.R. and Kramer, B. (1913) J. Biol. Chem. 15, 365-383.
Murlin, J.R., Clough, H.D., Gibbs, C.B.F. and Stokes, A.M. (1923)
J. Biol. Chem. 56, 253-296.
Nairn, A.C. (1978) FEBS Lett. 92_, 287-293.
Nemecek, G.M. (1978) J. Cyclic Nuc. Res. 4_, 299-309.
Neville, D.M. Jr. (1968) Biochim. Biophys. Acta 154, 540-552.
Newerly, K. and Berson, S.A. (1957) Proc. Soc. Exptl. Biol. Med. 94,
751-755.
Nimmo, H.G. and Cohen, P. (1977) Adv. Cyclic Nuc. Res. 8_, 145-266.
Nottey, J-J. and Rosselin, G. (1971) CR Acad. Sci. Paris 273, 2118-2121.
Nuttal, F.Q. (1972) in Handbook of Physiology, Section 7, Endocrinology,
Vol. 1, 395-413. R.O. Greep and E.B. Astwood, eds. Waverly Press
Inc., Baltimore.
O'Hea, E.R. and Leveille, G.A. (1969a) Comp. Biochem. Physiol. _30, 149-
159.
O'Hea, E.R. and Leveille, G.A. (1969b) J. Nutr. £9, 338-344.
O'Keefe, E. and Cuatrecasas, P. (1974) Biochim. Biophys. Acta 343, 64-77.
Olefsky, J.M. and Reaven, G.M. (1974) J. Clin. Endoc. Metab. _38_, 554-560.
Olefsky, J.M. and Chang, H. (1978) Diabetes 27_, 946-956.
Olefsky, J.M., Johnson, J., Liu, F., Edwards, P. and Baur, S. (1975)
Diabetes _24_, 801-810.
Orskov, H. and Christensen, N.J. (1969) Diabetes 1£, 653-659.
Park, C.R. and Exton, J.H. (1972) in Glucagon, Molecular Physiology,
Clinical and Therapeutic Implications, 77-108. P.J. Lefebvre and
R.H. Unger, eds. Pergamon Press.
Park, C.R., Crofford, O.B. and Kono, T. (1968) J. Gen. Physiol. 52,
296-318S.
150.
Pariza.M.W., Butcher, F.R., Becker, J.E. and Potter, V.R. (1977)
Proc. Nat. Acad. Sci. T4_, 23-4-237.
Pastan, I., Roth, J. and Macchia, V. (1965) Proc. Nat. Acad. Sci. 56,
1802-1809.
Paton, W. (1905) J. Physiol. _32, 59-64.
Paulson, L.G., Lovell-Smith, C.J., Manganiello, V.C. and Vaughan, M.
(1974) Proc. Nat. Acad. Sci. 71, 1639-1642.
Payne, J.W. (1976) in Chromatographic and Electrophoretic Techniques,
Vol. II, 321-346, 4th Edition. J. Smith, ed. Heinemann Medical
Books Ltd., Pitman Press, Bath.
Pecker, F. and Hanoune, J. (1977) FEBS Lett. £3_, 93-98.
Peterson, B., Beckner, S. and Blecher, M. (1978) Biochim. Biophys. Acta
542, 470-485.
Pfeuffer, T. (1977) J. Biol. Chem. 252, 7224-7234.
Phelps, B.H. and Varandi,P.T. (1977) Biochem. Biophys. Res. Comm. 75,
302-310.
Pilkis, S.J. and Park, C.R. (1974) Ann. Rev. Pharmacol. 14_, 365-388.
Pilkis, S.J., Exton, J.H., Johnson, R.A. and Park, C.R. (1974) Biochim.
Biophys. Acta 343, 250-267.
Pilkis, S.J., Claus, T.H., Johnson, R.A. and Park, C.R. (1975) J. Biol.
Chem. 250, 6328-6336.
Pilkis, S.J., Park, C.R. and Claus, T.H. (1978) Vitamins and Hormones
36, 383-460.
Pittman, R.P. and Hazelwood, R.L. (1973) Comp. Biochem. Physiol. 45A,
141-147.
Pohl, S.L., Birnbaumer, L. and Rodbell, M. (1971) J. Biol. Chem. 246,
1849-1856.
Pointer, R.H., Butcher, F.R. and Fain, J.N. (1976) J. Biol. Chem. 251,
2987-2992.
151.
Pollet, R.J., Standaert, M.L. and House, B.A. (1977) J. Biol. Chem. 252,
5828-5834.
Posner, B.I. (1974) Diabetes 23^, 209-217.
Posner, B.I., Josefsberg, Z. and Bergeron, J.J.M. (1978) J. Biol. Chem.
253, 4067-4073.
Potter, V.R. and Elvehjem, C.A. (1936) J. Biol. Chem. 114, 495-504.
Rail, T.W., Sutherland, E.W. and Wosilait, W.D. (1956) J. Biol. Chem.
218, 483-495.
Rail, T.W., Sutherland, E.W. and Berthet, J. (1957) J. Biol. Chem. 224,
463-475.
Randle, P.J. and Denton, R.M. (1973) Symp. Soc. Exp. Biol. Med. 27,
401-428.
Raskin, P., McGarry, J.D. and Foster, D.W. (1974) J. Biol. Chem. 249,
6029-6032.
Rasmussen, H. , Goodman, D.B.P. and Tenenhouse, A. (1972) Crit.. Rev.
Biochem. 1_, 95-148.
Redenbaugh, H.E., Ivy, A.C. and Koppanyi, T. (1926) Proc. Soc. Exp.
Biol. Med. 23, 756-757.
Rendell, M.S., Rodbell, M. and Berman, M. (1977) J. Biol. Chem. 252,
7909-7912.
Renner, R., Kemmler, W. and Hepp, K.D. (1974) Eur. J. Biochem. 49,
129-141.
Richert, N.D. and Ryan, R.J. (1977) Proc. Nat. Acad. Sci. 74_, 4857-4861.
Riou, J.P., Claus, T.H., Flockhart, D., Corbin, J. and Pilkis, S.J.
(1977) Proc. Nat. Acad. Sci. 74_, 4615-4619.
Riou, J.P., Claus, T.H. and Pilkis, S.J. (1978) J. Biol. Chem. 253,
656-659.
Robison, G.A., Butcher, R.W. and Sutherland, E.W. (1970) in Fundamental
Concepts in Drug-Receptor Interactions, 59-91. J.F. Danielli,
J.F. Morau and D.J. Triggle, eds. Academic Press, New York and London.
152.
Robison, G.A., Butcher, R.W. and Sutherland, E.W. (1971) Cyclic AMP,
232-284 (also eds.) Academic Press, New York and London.
Rodbard, D. (1973) in Receptors for Reproductive Hormones, 327-341.
B.W. O'Malley and A.R. Mearns, eds. Plenum Pub. Corp., New York.
Rodbell, M. (1964a) J. Biol. Chem. 239, 375-380.
Rodbell, M. (1964b) J. Biol. Chem. 239, 753-755.
Rodbell, M. (1972) in Glucagon, Molecular Physiology, Clinical and
Therapeutic Implications, 61-75. P.J. Lefebvre and R.H. Unger,
eds. Pergamon Press.
Rodbell, M. (1973) Fed. Proc. 32, 1854-1858.
Rodbell, M. (1977) J. Biol. Chem. 252, 5947-5950.
Rodbell, M. (1978) in Molecular Biology and Pharmacology of Cyclic
Nucleotides, 1-12. G. Folco and R. Paoletti, eds. Elsevier, Amsterdam.
Rodbell, M. and Jones, A.B. (1966) J. Biol. Chem. 241, 140-142.
Rodbell, M., Birnbaumer, L., Pohl, S.L. and Krans, H.M.J. (1971a)
J. Biol. Chem. 246, 1872-1876.
Rodbell, M., Krans, H.M.J., Pohl, S.L. and Birnbaumer, L. (1971b)
J. Biol. Chem. 246, 1861-1871.
Rodbell, M., Krans, H.M.J., Pohl, S.L. and Birhbaumer, L. (1971c)
J. Biol. Chem. 246, 1877-1882.
Rodbell, M., Lin, M.L. and Salomon, Y. (1974) J. Biol. Chem. 249, 59-65.
Ross, B.D., Hems, R. and Krebs, H.A. (1967) Biochem. J. 102, 942-951.
Rosselin, G. and Freychet, P. (1973) Biochim. Biophys. Acta 304, 541-551.
Rosselin, G., Freychet, P., Fouchereau, M., Rancon, F. and Broer, Y.
(1974) Horm. Metab. Res. 5_, Suppl. 78-86.
Roth, J. (1973) Metabolism 22, 1059-1078.
Rubalcava, B. and Rodbell, M. (1973) J. Biol. Chem. 248, 3831-3837.
Rubin, C.S. and Rosen, O.M. (1975) Ann. Rev. Biochem. 4_4_, 831-887.
Rudas, B. and Waldh&usl, W. (1969) Diabetologia 5_, 167-170.
Ryle, A.P., Sanger, F., Smith, L.F. and Kitai, R. (1955) Biochem. J. 60,
541-556.
153.
Samols, E., Marri, G. and Marks, V. (1965) Lancet ii, 415-416.
Samols, E., Tyler, J.M., Marks, V. and Mialhe, P. (1969) in Proceedings
of the 3rd International Conference on Endocrinology, Mexico,
206-219. Excerpta Medica, Amsterdam.
Samols, E., Tyler, J.M. and Marks, V. (1972) in Glucagon, Molecular
Physiology, Clinical and Therapeutic Implications, 151-173.
P.J. Lefebvre and R.H. Unger, eds. Pergamon Press.
Scatchard, G. (1949) Ann. N.Y. Acad. Sci. 51, 660-672.
Schwartz, R.H., Bianco, A.R., Handwerger, B.S. and Kahn, C.R. (1975)
Proc. Nat. Acad. Sci. 72_, 474-478.
Seglen, P.O. (1973) Exp. Cell. Res. 82_, 391-398.
Seglen, P.O. (1976) in Methods in Cell Biology, Vol. 13, 26-83.
D.M. Prescott, ed. Academic Press, New York and London.
Seitz, H.J., Mfiller, M.J. , Krone,W.,Tarnowski , W., Carsten, D.,
Dunkelman, B. and Harneit, A. (1977) Arch. Biochem. Biophys.
183, 647-663.
Seitz, I.J. and Ivy, A.C. (1929) Proc. Soc. Exp. Biol. Med. 26_, 463-464.
Sherline, P., Lynch, A. and Glinsmann, W.H. (1972) Endocrinology 91,
680-690.
Shlatz, L. and Marinetti, G.V. (1972) Science 176, 175-177.
Shoemaker, W.C., Carruthers, P.J., Elwyn, D.H. and Ashmore, J. (1962)
Am. J. Physiol. 203, 919-925.
Siddle, K., Kane-Maguire, B. and Campbell, A.K. (1973) Biochem. J. 132,
765-773.
Siddle, K. , Davies, C.J., Shetty, K.J. and Elkeles, R.S. (1976) Clin.
Sci. Mol. Med. 50, 487-491.
Silverstein, S.C., Steinman, R.M. and Cohn, Z.A. (1977) Ann. Rev.
Biochem. 46, 669-722.
Simon, J. (1979) Biochim. Biophys. Acta 585, 563-574.
154.
Simon, J., Freychet, P. and Rosselin, G. (1974) Endocrinology 95_, 1439-
1449.
Simon, J., Freychet, P. and Rosselin, G. (1977a) Diabetologia 13, 219-
228.
Simon, J., Freychet, P., Rosselin, G. and DeMeyts, P. (1977b) Endocrinology
100, 115-121.
Sitbon, G. (1967) Diabetologia _3, 427-434.
Smith, L.F. (1966) Am. J. Med. 40, 662-666.
Smoake, J.A., Song, S. and Cheung, W.V. (1974) Biochim. Biophys. Acta
341, 402-411.
Soderling, T.R., Hickenbottom, J.P., Reimann, E.M., Hunkelar, F.L.,
Walsh, D.A. and Krebs, E.G. (1970) J. Biol. Chem. 245 , 6317-6328.
Sodoyez, J.L., Sodoyez-Goffaux, F., Goff, M.M., Zimmerman, A.E. and
Arquilla, E.R. (1975) J. Biol. Chem. 250, 4268-4277.
Sokal, J.E., Saricone, E.J. and Henderson, A.M. (1964) Endocrinology
74, 930-938.
Sokal, J.E., Aydin, A. and Kraus, G. (1966) Am. J. Physiol. 211, 1334-
1338.
Soli, A.H., Goldfine, I.D., Roth, J., Kahn, C.R. and Neville, D.M. Jr.
(1974) J. Biol. Chem. 249, 4127-4131.
Soman, V. and Felig, P. (1978) Nature 272, 829-832.
Sonne, 0., Berg, T. and Christoffersen, T. (1978) J. Biol. Chem. 253,
3203-3210.
Sprague, R. and Ivy, A.C. (1936) Am. J. Physiol. 115, 389-394.
Stadie, W.C., Haugaard, N. and Vaughan, M. (1953) J. Biol. Chem. 20Q,
745-757.
Staichfield, J.E. and Yager, J.D. (1978) Exp. Cell. Res. 116, 239-252.
Stamler, J., Bolene, C., Katz, L.N., Harris, R. and Pick, R. (1950)
Fed. Proc. 9, 121 (Abs.).
155.
Staub, A., Sinn, L. and Behrens, O.K. (1953) Science 117, 628-629.
Staub, A., Sinn, L. and Behrens, O.K. (1955) J. Biol. Chem. 214, 619-632.
Steiner, A.L., Kipnis, D.M., Utiger, R. and Parker, C. (1969) Proc. Nat.
Acad. Sci. 64_, 367-373.
Steiner, D.F. (1977) Diabetes 26_, 322-340.
Strehler, B.L. (1974) in Methods of Enzymatic Analysis 4_, 2112-2126.
4th Edition. H.U. Bergmeyer, ed. Academic Press, New York and
London.
Sulakhe, P.V.,Sulakhe, S.J., Leung, N.L-K., St. Louis, P.J. and
Hickie, R.A. (1976) Biochem. J. 157, 705-712.
Sundby, F., Frandsen, E.K., Thomsen, J., Kristiansen, K. and Brunfeldt, K.
(1972) FEBS Lett. 26, 289-293.
Takeda, Y., Ichihara, A., Tanioka, H. and Inoue, H. (1964) J. Biol. Chem.
239, 3590-3596.
Tarlow, D.M., Watkins, P.A., Reed, R.E., Miller, R.S., Zwergel, E.E. and
Lane, M.D. (1977) J. Cell. Biol. 7_3, 332-353.
Terris, S. and Steiner, D.F. (1975) J. Biol. Chem. 250, 8389-8398.
Terris, S. and Steiner, D.F. (1976) J. Clin. Invest. 57_, 885-896.
Terris, S., Hofmann, C. and Steiner, D.F. (1979) Can. J. Biochem. 57,
459-468.
Thompson, W.J., Williams, R.H. and Little, S.A. (1973) Biochim. Biophys.
Acta 302, 329-337.
Thompson, W.J., Johnson, D.G., Lavis, V.R. and Williams, R.H. (1974)
Endocrinology 94_, 276-278.
Thompsen, J., Kristiansen, K., Brunfeldt, K. and Sundby, F. (1972)
FEBS Lett. _21, 315-319.
Tolbert, M.E.M. and Fain, J.N. (1974) J. Biol. Chem. 249, 1162-1166.
Tolbert, M.E.M., Butcher, F.R. and Fain, J.N. (1973) J. Biol. Chem.
248, 5686-5692.
156.
Tria, E., Scapin, S., Cocco, C. and Lucy, P. (1976) Biochim. Biophys.
Acta 496, 77-87.
Turner, s.d. and Hazelwood, r.l. (1974) Comp. Biochem. Physiol. 47a,
303-313.
Unger, R.H. (1972a) in Impact of Insulin on Metabolic Pathways, 78-83.
E. Shafrir, ed. Academic Press, London.
Unger, R.H. (1972b) Israel J. Med. Sci. 8_, 252-257.
Unger, R.H. and Lefebvre, P.J. (1972) in Glucagon, Molecular Physiology,
Clinical and Therapeutic Implications, 213-244. P.J. Lefebvre and
R.H. Unger, eds. Pergamon Press,
van Obberghen, E., DeMeyts, P. and Roth, J. (1976) J. Biol. Chem. 251,
6844-6851.
van de Werve, G., Hue, L. and Hers, H.G. (1977) Biochem. J. 162, 135-
142.
Varandani, P.T., Shroyer, L.A. and Nafz, M.A. (1972) Proc. Nat. Acad. Sci.
69, 1681-1684.
Varandani, P.T., Raveed, D. and Nafz, M.A. (1978) Biochim. Biophys. Acta
538, 343-353.
Wagle, S.R. (1975) Biochem. Biophys. Res. Commun. 67_, 1019-1027.
Waisman, D.M., Singh, T.J. and Wang, J.H. (1978) J. Biol. Chem. 253,
3387-3390.
Wallach, D., Anderson, W. and Pastan, I. (1978) J. Biol. Chem. 253,
24-26.
Watkins, P.A. and Lane, M.D. (1976) Fed. Proc. _35_, 1428 (Abs.).
Weast, R.C. (1977) ed. in Handbook of Chemistry and Physics, 57th Edition,
p. C767.
Weintraud, W. (1894) Arch, ftir Exp. Path. u. Pharm. 34_, 303-312.
Weitzel, G., Renner, R., Kemmler, W. and Rager, K. (1972) Hoppe-Seyler's
Z. Physiol. Chem. 353, 980-986.
157.
Welton, A.F., Lad, P.M., Newby, A.C., Yamamura, H., Nicosia, S. and
Rodbell, M. (1977) J. Biol. Chem. 252, 5947-5950.
Westwood, S.A. and Siddle, K. (1979) Biochem. Soc. Trans. 1_, 1032-1033.
Wieland, O.H. and Siess, E.A. (1970) Proc. Nat. Acad. Sci. 65_, 947-954.
Williams, G.M. and Gunn, J.M. (1974) Exp. Cell. Res. 89_, 139-142.
Williams, T.F., Exton, J.H., Friedmann, N. and Park, C.R. (1971) Am. J.
Physiol. 221, 1645-1651.
Wohltmann, H.J. and Narahara, H.T. (1966) J. Biol. Chem. 241, 4931-4939.
Wool, I.G. (1968) in Proteins and Polypeptide Hormones, Part I, 285-295.
M. Margoulies, ed. Excerpta-Medica Foundation, Amsterdam.
Yagi, K., Yazawa, M., Kakiuchi, S., Ohshima, M. and Uenishi, K. (1978)
J. Biol. Chem. 253, 1338-1340.
Yalow, R.S. and Berson, S.A. (1966) Nature 212, 357-358.
Yamamura, H., Lad, P.M. and Rodbell, M. (1977) J. Biol. Chem. 252,
7964-7966.
Zietler, K.L. (1966) Am. J. Med. £0, 735-739.
Zinman, B. and Hollenberg, C.H. (1974) J. Biol. Chem. 249, 2182-2187.
